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Abstract 	  The	   synthetic	   studies	   disclosed	   in	   this	   Thesis	   were	   focused	   on	   exploiting	   new	  cross-­‐coupling	   and	   reductive	   cyclization	   protocols	   for	   the	   synthesis	   of	   certain	  
Aspidosperma	  and	  Kopsia	  alkaloids	  including	  compounds	  2	  and	  3.	  	  
	  	  Chapter	   One	   provides	   a	   brief	   introduction	   to	   the	   Aspidosperma	   alkaloids,	  specifically	  limaspermidine	  (2)	  and	  1-­‐acetylaspidoalbidine	  (3).	  This	  is	  followed	  by	  a	   discussion	   of	   a	   Pd[0]-­‐catalyzed	   Ullmann	   cross-­‐coupling	   protocol	   used	   to	  synthesize	   Ƚ-­‐aryl	   enones	   such	   as	   59	   (from	   precursors	   57	   and	   58)	   and	   the	  reductive	  cyclization	  reactions	  of	  such	  compounds	  so	  as	  to	  form	  annulated	  indoles	  such	  as	  60.	   Selected	  applications	  of	   these	  processes	   in	  natural	  product	  synthesis	  are	  also	  presented.	  	  
	  	  The	  research	  detailed	  in	  Chapter	  Two	  was	  focused	  on	  the	  synthesis	  of	  compound	  
101	   and	   its	  conversion,	  using	  a	   tandem	  reductive	  cyclization	  protocol	   (mediated	  by	  Raney-­‐cobalt),	  into	  tetracycle	  102,	  a	  key	  precursor	  to	  (±)-­‐limaspermidine.	  The	  successful	   formation	   of	   (±)-­‐1-­‐acetylaspidoalbidine	   from	   (±)-­‐limaspermidine	   is	  then	   described,	   as	   are	   the	   possibilities	   for	   adapting	   the	   reported	   chemistry	   to	  enantioselective	  syntheses	  of	  either	  the	  (+)-­‐	  or	  (Ϋ)-­‐forms	  of	  both	  alkaloids	  2	  and	  3.	  	  
	  	  viii	  
	  	  Chapter	   Three	   provides	   an	   introduction	   to	   the	   recently	   discovered	   Kopsia	  alkaloids	   known	   as	   kopsihainanines	   A	   and	   B.	   In	   initial	   attempts	   to	   synthesize	  kopsihainine	   A	   (125),	   the	   cis-­‐configured	   tetracycle	   102	  was	   converted	   into	   its	  
trans-­‐congener	  158	   using	   a	   novel,	   two-­‐step	   isomerization	   protocol	   involving	   an	  initial	  amine	  oxidation	  reaction.	  Efforts	  to	  convert	  intermediate	  158	  into	  the	  target	  natural	  product	  revealed	   interesting	  variations	   in	  the	  chemical	  behaviours	  of	   the	  
cis-­‐	  and	  trans-­‐	  isomeric	  systems	  102	  and	  158,	  respectively.	  	  
	  	  A	   second-­‐generation	   approach	   to	   kopsihainanine	   A	   is	   outlined	   in	   Chapter	   Four.	  This	  work	  focused	  on	  utilizing,	  at	  a	  later	  stage	  in	  the	  synthetic	  sequence,	  the	  cis	  to	  
trans	   conversion	   protocol	   described	   in	   Chapter	   Three.	   By	   such	  means	   a	   formal	  synthesis	   of	   the	   racemic	   modification	   of	   the	   target	   natural	   product	   125	   was	  realized.	  	  Finally,	   Chapter	   Five	   contains	   the	   experimental	   detail	   that	   underpins	   the	   work	  described	  in	  the	  preceding	  Chapters.	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Glossary 
	  Å	   Ångstrom	   	   	  Ac	   acetyl	  AcOH	   acetic	  acid	  AIBN	   ʹǡʹǯ-­‐azobis(isobutyronitrile)	  
aq.	   aqueous	  atm	   standard	  atmospheric	  pressure	  (i.e.	  101.325	  kPa)	  Bn	   benzyl	  Boc	   tert-­‐butyloxycarbonyl	  
ca.	   circa	  (approximately)	  cat.	   catalyst	  or	  catalystic	  amount	  Cbz	   carboxybenzyl	  
cf.	   confer	  (compare)	  conc.	   concetrated	  COSY	   correlation	  spectroscopy	  CSA	   camphorsulfonic	  acid	  d	   doublet	  °C	   degrees	  Celsius	  
Ɂ	   chemical	  shift	  (parts	  per	  million,	  ppm)	  DIB	   (diacetoxyiodo)benzene	  DMA-­‐DMA	   dimethylacetamide	  dimethyl	  acetal	  DMAP	   4-­‐(N,N-­‐dimethylamino)pyridine	  DMF	   N,N-­‐dimethylformamide	  2,2-­‐DMP	   2,2-­‐dimethoxypropane	  DMSO	   dimethylsulfoxide	  EDCI	   	  1-­‐[3-­‐(dimethylamino)propyl]-­‐3-­‐ethylcarbodiimide	  hydrochloride	  EDTA	   ethylenediaminetetraacetic	  acid	  ee	   enantiomeric	  excess	  
e.g.	   exempli	  gratia	  (for	  example)	  EI	   electron	  impact	  (mass	  spectrometry)	  equiv.	   equivalent	  (mole)	  ESI	   electrospray	  ionization	  (mass	  spectrometry)	  Et	   ethyl	  
et	  al.	   et	  alia	  (and	  others)	  
	  	  x	  
exp.	   experiment	  FGI(s)	   functional	  group	  interconversion(s)	  g	   	   	   gram(s)	  GC	   	   	   gas	  chromatography	  h	   	   	   hour(s)	  HMBC	   	   heteronuclear	  multiple-­‐bond	  correlation	  
hɋ	   	   	   light	  	  HREIMS	   	   high	  resolution	  electron	  impact	  mass	  spectrometry	  HRESIMS	   	   high	  resolution	  electrospray	  ionization	  mass	  spectrometry	  HSQC	   	   heteronuclear	  single-­‐quantum	  coherence	  Hz	   	   	   Hertz	  IBX	   	   	   iodoxybenzoic	  acid	  
i.e.	   	   	   id	  est	  (that	  is)	  
i-­‐propyl	   	   iso-­‐propyl	  IR	   	   	   infra	  red	  
J	   	   	   coupling	  constant	  (Hz)	  kbar	   	   	   kilobar(s)	  L	   	   	   litre(s)	  LAB	   	   	   lithium	  aminoborohydride	  LDA	   	   	   lithium	  diisopropylamide	  lit.	   	   	   literature	  value	  m	   	   	   multiplet	  M+y	   	   	   molecular	  ion	  Me	   	   	   methyl	  MeCN	   	   acetonitrile	  MeOH	   	   methanol	  MHz	   	   	   mega-­‐Hertz	  min	   minute(s)	  mL	   millilitre(s)	  
ɊL	   microlitre(s)	  mm	   millimetre(s)	  mmol	   millimole(s)	  mol	   mole(s)	  m.p.	   melting	  point	  (°C)	  
	  	   xi	  
Ms	   mesyl	  MS	   mass	  spectrometry	  
m/z	   mass-­‐to-­‐charge	  ratio	  NCS	   N-­‐chlorosuccinimide	  NMR	   nuclear	  magnetic	  resonance	  
ɋmax	   infra	  red	  absorption	  maxima	  (cm-­‐1)	  ORTEP	   Oak	  Ridge	  Thermal	  Ellipsoid	  Program	  p	   pentet	  PCC	   pyridinium	  chlorochromate	  PDC	   pyridinium	  dichromate	  Pd2(dba)3	   tris(dibenzylideneacetone)dipalladium(0)	  PG	   protecting	  group	  pH	   logarithm	  of	  the	  reciprocal	  of	  the	  hydrogen	  ion	  concentration,	  i.e.	  -­‐log10[H+]	  
Ɏ	   denotes	  double	  bond	  
p-­‐TsOH	   para-­‐toluenesulfonic	  acid	  q	   quartet	  Ref.	   reference	  Rf	   retardation	  factor	  r.t.	   room	  temperature	  (approx.	  18	  °C)	  s	   singlet	  
sp.	   species	  T	   temperature	  (°C)	  t	   triplet	  
t-­‐BuOH	   tert-­‐butyl	  alcohol	  TBDMS/TBS	   tert-­‐butyldimethylsilyl	  temp	   temperature	  (°C)	  TEMPO	   2,2,6,6-­‐tetramethyl-­‐1-­‐piperidinyloxy	  TFA	   trifluoroacetic	  acid	  TFAA	   trifluoroacetic	  anhydride	  THF	   tetrahydrofuran	  TLC	   thin	  layer	  chromatography	  TM	   trademark	  TMP	   tetramethylpiperidine	  
	  	  xii	  
TMS	   trimethylsilyl	  
viz.	   videlicit	  (that	  is,	  namely)	  
vs.	   versus	  v/v	   unit	  volume	  per	  unit	  volume	  (ratio)	  W	   Watt(s)	  w/v	   unit	  weight	  per	  unit	  volume	  (%)	  
Z	   zusammen	  (together)	  >	   greater	  than	  <	   less	  than	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Chapter One. 




1.1.	   Introduction	  to	  the	  Aspidosperma	  Alkaloids	  




Figure	  1-­‐1.	  (+)-­‐Aspidospermidine	  (1)	  embodies	  the	  pentacyclic	  core	  common	  to	  all	  Aspidosperma	  alkaloids.	  
	  The	   Banwell	   group	   has	   expended	   considerable	   effort	   in	   devising	   synthetic	  approaches	  to	  the	  Aspidosperma	  alkaloids.4	  As	  part	  of	  ongoing	  studies	  in	  the	  area,	  the	   alkaloids	   limaspermidine	   (2)	   and	   1-­‐acetylaspidoalbidine	   (3)	  were	   chosen	   as	  targets	  for	  the	  studies	  reported	  in	  the	  body	  of	  this	  thesis.	  Isolated	  from	  the	  bark	  of	  
A.	   rhombeosignatum	  MARKGRAF	   in	   Venezuela,5	   limaspermidine	   (2)	   is	   the	   C21-­‐hydroxylated	   derivative	   of	   aspidospermidine	   (1).	   1-­‐Acetylaspidoalbidine	   (3),	   on	  the	  other	  hand,	  was	   isolated	   from	   the	  Peruvian	  plant	  Vallesia	  dichotoma	  RUIZ	  et	  PAV	  in	  1963	  by	  Djerassi.6	  It	  is	  thought	  to	  arise	  in	  vivo	  from	  fendleridine	  (4),	  itself	  first	   isolated	  by	  Burnell	   in	  1964	  from	  the	  Venezuelan	  tree	  A.	  fendleri	  WOODSON.7	  
	  	  2	  
Embedded	  within	   the	  ABCDE-­‐framework	  of	  each	  of	  compounds	  3	   and	  4	   is	  an	  N-­‐	  and	  O-­‐substituted	  quaternary	  carbon	  arising	  from	  the	  linking	  of	  the	  C21	  oxygen	  to	  the	  nitrogen-­‐substituted	  C19	  carbon.	  	  





1.2.	   Previous	   Syntheses	   of	   Limaspermidine	   and	   1-­‐
Acetylaspidoalbidine	  
	  The	   first	   total	   synthesis	   of	   (±)-­‐limaspermidine	   (2)	  was	   reported	   by	   Ban	   and	   co-­‐workers	   in	   the	   mid-­‐1970s	   and	   from	   which	   they	   were	   also	   able	   to	   acquire	   (±)-­‐fendleridine	  (4)	  (Scheme	  1-­‐1).8	  This	  work	  provided	   the	  benchmark	  synthesis	   for	  both	  natural	  products.	  The	   first	   total	   synthesis	  of	  1-­‐acetylaspidoalbidine	  (3)	  was	  also	   disclosed	   by	   the	   same	   group	   in	   19759	   and	   served	   to	   confirm	   the	   original	  structural	   assignments	   of	   these	   alkaloids	   proposed	   by	   Djerassi.	   A	   key	   feature	   of	  the	   synthesis	   was	   the	   application	   of	   a	   cyclization	   protocol	   wherein	   mercury(II)	  acetate-­‐promoted	  oxidation	  at	  C19	  (of	  2)	  was	  followed	  by	  nucleophilic	  addition	  of	  the	  C21	  oxygen	  to	  the	  ensuing	  iminium	  ion	  (9)	  thus	  resulting	  in	  the	  formation	  of	  
	  	   3	  
the	  pivotal	  N-­‐	  and	  O-­‐substituted	  quaternary	  carbon	  associated	  with	  compounds	  3	  and	   4.	   To	   date,	   this	   oxidative	   cyclization	   protocol	   remains	   the	   only	   method	  available	  for	  the	  construction	  of	  the	  heterocyclic	  F-­‐ring	  of	  these	  alkaloids.	  	  	  	  
	  	  
Scheme	  1-­‐1.	  ǯkey	  oxidative	  cyclization	  of	  (±)-­‐limaspermidine	  (2)	  to	  form	  (±)-­‐
fendleridine	  (4).	  Reagents	  and	  conditions:	  (i)	  Hg(OAc)2,	  5%	  aq.	  AcOH,	  75	  oC,	  40-­‐45	  h.	  	  	  In	   1991	   Overman	   published10	   an	   impressive	   formal	   synthesis	   of	   1-­‐acetylaspidoalbidine	   (3)	   involving	   an	   aza-­‐Cope	   rearrangement-­‐Mannich	  cyclization	  cascade	  to	  assemble	  the	  pentacyclic	  framework	  of	  the	  natural	  product.	  By	   such	   means,	   limaspermidine	   (2)	   and	   1-­‐acetylaspidoalbidine	   (3)	   were	   each	  prepared	  in	  racemic	  form	  (Scheme	  1-­‐2).	  In	  2010	  Boger	  and	  co-­‐workers	  reported11	  the	   first	   enantioselective	   total	   synthesis	   of	   both	   enantiomers	   of	   1-­‐acetylaspidoalbidine	   (3)	   and	   fendleridine	   (4)	   and	   thereby	   establishing	   the	  absolute	   configurations	   of	   each	   of	   these	   natural	   products	   (Scheme	   1-­‐3).	   These	  elegant	   syntheses	   are	   detailed	   in	   the	   following	   section.	   Certain	   relevant	   work	  reported	   by	   other	   research	   groups	   on	   methods	   for	   the	   assembly	   of	   the	   ABCDE	  pentacyclic	   framework	   of	   the	  Aspidosperma	  alkaloids	   are	   also	   presented.	   As	  will	  become	   evident,	   the	   strategies	   now	   available	   for	   the	   synthesis	   of	   the	   skeletal	  framework	   of	   these	   alkaloids	   are	   many	   and	   varied,	   and	   the	   breadth	   of	   the	  literature	   in	   this	   field	   stands	   as	   testimony	   to	   the	   merits	   of	   targeting	   the	  
Aspidosperma	   alkaloids	   as	   a	   vehicle	   for	   the	   development	   of	   new	   synthetic	  methodologies	  and	  chemical	  transformations.	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1.2.1.	   Overman:	  An	  aza-­‐Cope	  rearrangement-­‐Mannich	  cyclization	  cascade	  
	  The	  key	  elements	  of	  ǯapproach10	   to	   (±)-­‐limaspermidine	   [(±)-­‐2]	  were	  a	  [3,3]-­‐sigmatropic	   rearrangement	   of	   an	   iminium	   cation	   and	   an	   intramolecular	  Mannich	  cyclization	  of	  the	  isomeric	  iminium	  species	  so-­‐formed	  (Scheme	  1-­‐2).	  Such	  
ǲǳ	   allowed	   for	   the	   construction	   of	   alkaloid	   scaffolds	   of	   varying	  complexities.	  So,	  as	  well	  as	  allowing	  access	   to	   (±)-­‐1-­‐acetylaspidoalbidine	  (3),	   the	  first	  total	  syntheses	  of	  (±)-­‐meloscine,	  (±)-­‐epimeloscine,	  and	  (±)-­‐deoxapodine	  were	  also	  realized	  by	  such	  means.	  	  The	   substrate	   required	   for	   the	   pivotal	   cyclization	   cascade	  mentioned	   above	  was	  prepared,	  as	  shown	  in	  Scheme	  1-­‐2,	  by	  reacting	  the	  silyl-­‐protected	  cyanohydrin	  10	  with	   the	   annulated	   cyclopentanone	   11	   to	   form	   adduct	   12.	   On	   treatment	   with	  LiOH/MeOH	   this	   last	   compound	  underwent	   an	   intramolecular	   acylation	   reaction	  to	   form	   oxazolidinone	   13.	   Wittig	   methenylation	   of	   the	   ketone	   carbonyl	   residue	  within	  compound	  13	  followed	  by	  base	  hydrolysis	  of	  the	  carbamate	  and	  pivalamide	  groups	  then	  afforded	  diaminoalcohol	  14,	  the	  immediate	  precursor	  to	  the	  substrate	  required	  for	  the	  cyclization	  cascade.	  In	  the	  event,	  when	  compound	  14	  was	  treated	  with	  paraformaldehyde,	  compound	  15	  was	   formed	  and	  this	   then	  treated	  with	  an	  excess	   of	   camphorsulfonic	   acid	   (CSA)	   so	   as	   to	   form	   the	   iminium	   cation	  16	   that	  underwent	   an	   intramolecular	   Mannich	   reaction	   to	   yield	   ketone	   17.	   This	   last	  compound	  engaged,	  under	  the	  acidic	  conditions	  used,	  in	  a	  Schiff	  base	  condensation	  process	  with	  the	  product	  aniline	  to	  form	  the	  pentacyclic	   imine	  18	  in	  quantitative	  yield	   (from	  precursor	  14).	  Reduction	  or	   reductive	   cleavage	   of	   the	   imine,	   benzyl,	  and	  alkene	  residues	  within	  product	  18,	  which	  embodies	  the	  full	  framework	  of	  the	  
Aspidosperma	  alkaloids,	  then	  provided	  1-­‐acetyllimaspermidine	  19.	  The	  acquisition	  of	  compound	  19	  constitutes	  a	  formal	  total	  synthesis	  of	  (±)-­‐1-­‐acetylaspidoalbidine	  (3)	  since	  Ban	  had	  already	  established	  a	  direct	  method8,9	  for	  the	  conversion	  of	  the	  former	  into	  the	  latter	  using	  a	  mercury(II)	  acetate-­‐mediated	  cyclization	  protocol.	  	   	  








1.2.2.	   Boger:	  An	  intramolecular	  [4+2]/[3+2]	  cycloaddition	  cascade	  	  
ǯ11	  was	  a	  	  [4+2]/[3+2]	  cycloaddition	  cascade	  of	  a	   1,3,4-­‐oxadiazole	   incorporating	   a	   tethered	   dienophile	   (Scheme	   1-­‐3).	   By	   such	  means	   four	   CΫC	   bonds	   are	   formed	   in	   the	   one	   pot	   and	   so	   resulting	   in	   the	  
	  	  6	  
particularly	   efficient	   assembly	   of	   the	   targeted	   pentacyclic	   skeleton.	  Moreover,	   in	  the	   same	   process	   the	   correct	   oxidation	   state	   was	   established	   at	   C19	   and	   so	  providing	  a	  novel	  method	  for	  the	  installation	  of	  the	  heterocyclic	  F-­‐ring	  associated	  with	  target	  4.	  	  The	  substrate,	  22,	  required	  for	  the	  pivotal	  [4+2]/[3+2]	  cycloaddition	  cascade,	  was	  prepared	   (Scheme	   1-­‐3)	   by	   coupling	   1,3,4-­‐oxadiazole	  20	  with	   carboxylic	   acid	  21	  using	   1-­‐[3-­‐(dimethylamino)propyl]-­‐3-­‐ethylcarbodiimide	   hydrochloride	   (EDCI)	  and	   4-­‐dimethylaminopyridine	   (DMAP).	   To	   trigger	   the	   key	   events,	   compound	  22	  was	   heated	   at	   180	   °C	   in	  o-­‐dichlorobenzene	   and	   the	   anticipated	   product	   thereby	  obtained	   in	   55-­‐71%	   yield.	   In	   the	   first	   step	   of	   this	   cascade	   a	   [4+2]	   cycloaddition	  reaction	  of	   the	  1,3,4-­‐oxadiazole	  with	   the	   tethered	  dienophile	  presumably	  affords	  adduct	   23	   and	   upon	   extrusion	   of	   N2	   the	   1,3-­‐dipole	   24	   so-­‐formed	   engages	   in	   a	  cycloaddition	  reaction	  with	  the	  pendant	  indole	  residue	  to	  give	  the	  isolable	  adduct	  
25.	  By	  such	  means,	  the	  complete	  skeleton	  of	   the	  natural	  product	  was	  assembled.	  The	   carbomethoxy	   moiety	   within	   compound	   25	   was	   then	   converted,	   over	   two	  steps	  and	  in	  90%	  yield,	   into	  the	  nitrile	  26	  and	  the	  tetrahydrofuran	  ring	  was	  then	  installed	  by	   treatment	  of	   the	   latter	  with	  HF/pyridine.	   In	   this	   transformation,	   the	  iminium	  ion	  generated	  by	  the	  protonation	  then	  opening	  of	  the	  oxido	  bridge	  within	  compound	  26	  was	  trapped	  by	  the	  pendant	  alcohol	  resulting	  from	  the	  cleavage	  of	  the	  t-­‐butyldimethylsilyl	  ether	  and	  so	  forming	  product	  27.	  The	  ketone	  arising	  from	  cyanohydrin	   27	   was	   then	   subjected	   to	   diastereoselective	   reduction	   with	   Na-­‐SelectrideTM	   and	   so	   affording	   alcohol	   28	   that	   was	   deoxygenated	   under	   Barton-­‐McCombie	  conditions	  to	  yield	   the	  hexacyclic	  product	  29.	  Compound	  29	  was	  then	  converted	  into	  fendleridine	  (4)	  in	  68%	  yield	  over	  three	  steps.	  This	  involved	  initial	  conversion	   of	   the	   lactam	   residue	   into	   the	   corresponding	   thiolactam	   using	  
ǯ	  and	  this	  was	  itself	  subjected	  to	  reductive	  desulfurization	  with	  Raney-­‐Ni.	  The	  N-­‐benzyl	  group	  was	  removed	  using	  Na	  and	  t-­‐BuOH	  in	  THF/NH3	  to	  afford	  racemic	  fendleridine	  (4).	  The	  constituent	  enantiomers	  were	  separated	  on	  a	  semi-­‐preparative	   chiral	   HPLC	   column.	   Treatment	   of	   each	   enantiomer	   of	  fendleridine	   (4)	   with	   Ac2O	   in	   pyridine	   then	   afforded	   (+)-­‐	   and	   (Ϋ)-­‐1-­‐acetylaspidoalbidine	   (3).	   The	   consistent	   dextrorotatory	   sign	   of	   the	   rotations	  recorded	  for	  both	  compound	  3	  and	  the	  naturally-­‐derived	  material	  was	  used	  for	  the	  assignments	  of	  the	  absolute	  configuration.	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Scheme	   1-­‐3.	   ǯ   (+)-­‐fendleridine	   (4)	   and	   (+)-­‐1-­‐
acetylaspidoalbidine	  (3).	  Reagents	  and	  conditions:	  (i)	  EDCI,	  DMAP,	  DCM,	  18	  oC,	  10	  h;	  (ii)	  1,2-­‐dichlorobenzene,	  180	  oC,	  48	  h;	  (iii)	  (a)	  NH3,	  MeOH,	  70	  oC,	  3	  h;	  (b)	  TFAA,	  pyridine,	   dioxane,	   0	   to	   18	   oC,	   1	   h;	   (iv)	   HF-­‐pyridine,	   THF,	   0	   oC,	   0.5	   h;	   (v)	   Na-­‐selectride,	  THF,	  2	  min;	  (vi)	  (a)	  NaH,	  imidazole,	  THF,	  0	  oC,	  1	  h,	  then	  CS2,	  THF,	  18	  oC,	  1	  h,	  then	  MeI,	  THF,	  1	  h;	  (b)	  AIBN,	  Bu3SnH,	  100	  oǡͳǢȋȌȋȌǯǡPhMe,	  60	  oC,	  1	  h;	  (b)	  Ra-­‐Ni,	  THF,	  0	  oC,	  1	  h,	  then	  18	  oC,	  1	  h;	  (c)	  Na,	  NH3,	  t-­‐BuOH,	  THF,	  
Ϋ78	   oC,	   0.5	   h;	   chiral	   HPLC	   chromatographic	   separation	   of	   the	   constituent	  enantiomers;	  (viii)	  Ac2O,	  pyridine,	  18	  oC,	  0.5	  h.	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1.3.	   General	  Studies	  on	  the	  Assembly	  of	  the	  ABCDE-­‐Ring	  Framework	  
of	  the	  Aspidosperma	  Alkaloids	  
	  
1.3.1.	   Heathcock:	  A	  TFA-­‐mediated	  intramolecular	  cascade	  cyclization	  	  
  ǯ synthesis	   of	   racemic	   aspidospermidine	   (1)	   relies	   on	   a	  cyclization	  cascade12	  to	  form	  the	  B,	  C	  and	  D	  rings	  of	  the	  target	  framework	  in	  a	  one-­‐pot	  process	  as	  detailed	  below.	  In	  addition,	  this	  work	  provides	  a	  robust	  protocol	  for	  the	  installation	  of	  the	  E-­‐ring	  of	  the	  Aspidosperma	  framework,	  a	  non-­‐trivial	  process	  that	  had	  been	  the	  ǲǯǳ	  of	  various	  earlier	  syntheses.	  	  The	  synthesis	  began	  (Scheme	  1-­‐4)	  with	   the	  Ⱦ-­‐ketoester	  30	   that	  was	   converted,	   over	   eight	   steps,	   into	   the	   substrate	  31	   for	   the	  pivotal	   cyclization	  cascade.	   Thus,	   ozonolysis	   of	   compound	   31	   gave	   keto-­‐aldehyde	   32	   that	   was	  treated,	   in	   situ,	   with	   TFA	   and	   thereby	   engaging	   it	   in	   a	   two-­‐fold	   Schiff	   base	  condensation	  reaction,	  wherein	  the	  deprotected	  aniline	  cyclizes	  onto	  the	  pendant	  ketone	   residue	   to	   give	   an	   indole,	   and	   the	  aldehyde	   carbonyl	   and	  amide	  nitrogen	  condense	  to	  form	  an	  iminium	  ion	  as	  embodied	  within	  compound	  33.	  Nucleophilic	  addition	   of	   the	   reactive	   C3	   position	   of	   the	   indole	   onto	   the	   tethered	   iminium	   ion	  then	  gave	   the	   isolable	   tetracyclic	   compound	  34	   (37%	  yield	  over	   two	   steps	   from	  compound	  31).	  To	  effect	  the	  final	  ring	  closure,	  chloride	  34	  was	  converted	  into	  the	  corresponding	   iodide	   under	   Finkelstein	   conditions	   and	   the	   latter	   treated	   with	  silver	   triflate	  so	  as	   to	  effect	  a	   intramolecular	  Friedel-­‐Crafts	  alkylation	  reaction	  at	  C3	  of	  the	  indole	  residue	  and	  so	  yielding	  pentacycle	  35	  in	  86%	  over	  the	  two	  steps.	  Exhaustive	   reduction	   of	   compound	   35	   using	   LiAlH4	   then	   provided	   (±)-­‐aspidospermidine	  (1)	  in	  82%	  yield.	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Scheme	   1-­‐4.	   ǯ s	   of	   (±)-­‐aspidospermidine	   (1).	   Reagents	   and	  conditions:	  (i)	  (a)	  O3,	  DCM,	  Ϋ78	  oC,	  then	  Me2S,	  18	  oC,	  1	  h;	  (b)	  TFA/DCM	  (1:1),	  18	  oC,	  0.25	  h;	   (ii)	   (a)	  NaI,	  acetone,	   reflux,	  2	  h;	   (b)	  AgOTf,	  THF,	  18	   oC,	  0.5	  h;	   (iii)	  LiAlH4,	  THF,	  18	  oC,	  0.5	  h,	  then	  reflux,	  4	  h.	  	  
	  
	  
1.3.2.	   Macmillan:	  An	  organocascade	  catalysis	  
	  
ǯ     ȋΫ)-­‐aspidospermidine	   (1),	   along	   with	  five	  other	  alkaloids	  of	  the	  Strychnos,	  Aspidosperma	  and	  Kopsia	   families,	  exploits	  a	  series	  of	  organocatalyzed	  transformations	  all	  of	  which	  take	  place	  within	  the	  one-­‐pot.13	  These	  alkaloids	  were	  all	  synthesized	  from	  a	  common	  intermediate	  that	  could	  be	  generated	  exceptionally	  efficiently	  and	  so	  setting	  a	  spectacular	  new	  benchmark	  for	  the	  development	  of	  subsequent	  syntheses	  of	  all	  of	  these	  alkaloids.	  	  The	   synthetic	   sequence	   leading	   to	   (Ϋ)-­‐aspidospermidine	   started	   (Scheme	   1-­‐5)	  with	  the	  N-­‐benzyl	  protection	  of	  compound	  36.	  Oxidative	  cleavage	  of	  the	  associated	  piperidine	   ring,	   followed	   by	   a	   Horner-­‐Wadsworth-­‐Emmons	   reaction	   of	   the	  resulting	   aldehyde	   yielded	   the	   C2-­‐alkeneylated	   indole	  37	   in	   61%	  over	   the	   three	  steps	  involved.	  Diene	  37	  was	  subjected	  to	  an	  intermolecular	  Diels-­‐Alder	  reaction	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with	   propynal	   catalyzed	   by	   imidazolidinone	   A.	   The	   cycloaddition	   reaction	  presumably	   involves	   initial	   formation	   of	   the	   iminium	   ion	   38	   that	   loses	   the	  methylselenyl	   anion	   to	   form	   the	   dicationic	   intermediate	   39.	   Addition	   of	   the	  tethered	  protected	  primary	  amine	  to	  the	  conjugated	  imine	  in	  a	  1,4-­‐fashion	  within	  substrate	  39	  then	  provides	  compound	  40	  that	  embodies	  the	  E-­‐ring	  of	  the	  target	  1.	  Upon	   hydrolytic	   cleavage	   (with	   accompanying	   regeneration	   of	   catalyst	   A),	   the	  pivotal	   intermediate	   41	  was	   obtained	   in	   53%	   yield	   and	   97%	   ee.	   To	   install	   the	  necessary	   carbons	   required	   for	   the	   D-­‐ring	   of	   aspidospermidine,	   the	   Boc	   group	  within	   compound	   41	   was	   first	   removed,	   and	   the	   resulting	   secondary	   amine	  alkylated	   with	   (Z)-­‐3-­‐bromo-­‐1-­‐iodoprop-­‐1-­‐ene.	   A	   Heck	   cyclization	   of	   the	   alkenyl	  iodide	   residue	   within	   product	   42	   onto	   the	   pendant	   and	   tri-­‐substituted	   double	  bond	   then	   followed	   to	   provide	   triene	  43	   and	   so	   completing	   the	   assembly	   of	   the	  carbon	   skeleton	   for	   the	   natural	   product.	   Finally,	   exhaustive	   hydrogenation	  together	   with	   hydrogenolysis	   of	   the	   N-­‐benzyl	   residue	   within	   compound	   45	  afforded	   (+)-­‐aspidospermidine	   (1)	   and	   thereby	   completing	   the	   synthesis	   in	  nine	  linear	   steps	   and	   23%	   overall	   yield.	   This	   work	   represents	   the	   shortest,	  enantioselective	  synthesis	  of	  aspidospermidine	  reported	  thus	  far.	  	   	  




Scheme	   1-­‐5.	   ǯ   ȋήȌ-­‐aspidospermidine	   (1).	   Reagents	   and	  conditions:	  (i)	  (a)	  NaH,	  BnBr,	  DMF,	  18	  oC,	  3	  h;	  (b)	  SeO2,	  dioxane/H2O,	  100	  oC,	  5	  h;	  (c)	  (EtO)2P(O)CH2SeMe,	  18-­‐crown-­‐6,	  KHMDS,	  THF,	  Ϋ78	  to	  18	  oC,	  3	  h;	  (ii)	  propynal,	  




1.4.	   Raney-­‐Cobalt	  in	  Synthesis	  
	  The	   distinctly	   limited	   body	   of	   literature	   on	   the	   use	   of	   Raney-­‐cobalt	   in	   chemical	  synthesis	  makes	   it	  clear	  that	   this	  catalyst	  has	  been	  accorded	  much	   less	  attention	  than	  its	  nickel	  counterpart,	  viz.	  Raney-­‐nickel,14	  in	  chemical	  synthesis.	  This	  may	  be	  due	   to	   the	   higher	   cost	   and	   lower	   activity	   of	   cobalt.	   Nevertheless,	   recent	   studies	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carried	  out	  in	  our	  laboratories15,16	  	  have	  sought	  to	  exploit	  Raney-­‐cobalt	  because	  of	  the	   excellent	   chemoselectivities	   it	   displays,	   selected	   examples	   of	   which	   will	   be	  presented	  in	  the	  following	  sections.	  Of	  particular	  interest	  is	  its	  ability	  to	  selectively	  reduce	  nitrile	  groups	  in	  the	  presence	  of	  other	  functionalities	  that	  would	  normally	  be	   susceptible	   to	   reaction.	   The	   essentially	   unique	   chemoselectivities	   of	   Raney-­‐cobalt	  have	  not	  been	  exploited	  widely	  within	  the	  synthetic	  community	  and	  so	  one	  
   ǯ           the	  synthesis	  of	  the	  abovementioned	  Aspidosperma	  alkaloids.17	  	  	  
1.4.1.	   Application	  of	  Raney-­‐cobalt	  to	  the	  synthesis	  of	  the	  lycorine	  framework	  
	  The	   pursuit	   of	   a	   total	   synthesis	   of	   limaspermidine	   (2)	   and	   the	   related	   1-­‐acetylaspidoalbidine	  (3),	  as	  detailed	  below	  and	  representing	  a	  major	  focus	  of	  the	  
ǯ  ǡ	   was	   prompted	   by	   previous	   work18	   carried	   out	   within	   the	  Banwell	   group	   on	   the	   assembly	   of	   the	   framework	   associated	   with	   the	   lycorine	  alkaloids.	   Lycorine	   (44),	   isolated	   from	   daffodil	   bulbs,	   represents	   the	   most	  abundant	  of	  the	  nitrogen	  bases	  of	  the	  Amaryllidaceae	  family	  of	  alkaloids.	  The	  key	  step	  of	  the	  synthetic	  sequence	  was	  a	  Raney-­‐cobalt-­‐mediated	  reduction	  of	  nitrile	  45	  in	  the	  presence	  of	  dihydrogen	  and	  thereby	  leading	  to	  the	  complete	  framework	  of	  the	  title	  alkaloid.	  
ǯ	  details	  of	  this	  earlier	  work	  are	  presented	  in	  Scheme	  1-­‐6.	  	  
	  	  Thus,	  when	  nitrile	  45	  was	  treated	  with	  dihydrogen	  (at	  30	  atm)	  in	  the	  presence	  of	  Raney-­‐cobalt	   and	   using	   ammoniacal	   methanol	   as	   solvent,	   the	   initially	   formed	  primary	   amine	   47	   underwent	   a	   spontaneous	   SNǯ    allylic	  lactone	  residue	  and	  so	  forming	  the	  secondary	  amine	  48	  (Scheme	  1-­‐6).	  This	  last	   compound	   was	   not	   isolated	   as	   it	   immediately	   engaged	   in	   a	   lactamization	  reaction	   with	   the	   just	   revealed	   carboxylic	   acid	   moiety	   and	   thereby	   generating	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compound	  49	   embodying	   the	   tetracyclic	   framework	   of	   lycorine.	   Lactam	  49	   was	  converted,	  over	   two	  steps,	   into	   compound	  50,	   a	  degradation	  product	  of	   lycorine	  that	   played	   an	   important	   role	   in	   the	   elucidation	   of	   the	   structure	   of	   the	   natural	  product.19	  	  	  	  
	  	  
Scheme	   1-­‐6.	   Rapid	   assembly	   of	   the	   lycorine	   framework	   using	   Raney-­‐cobalt.	  Reagents	  and	  conditions:	  (i)	  Raney-­‐Co,	  H2	  (30	  atm),	  MeOH/NH3,	  80	  oC,	  3	  h.	  	  	  Significantly,	  under	  the	  reaction	  conditions	  used	  in	  the	  pivotal	  step	  of	  the	  reaction	  sequence	  the	  potentially	  reducible	  CΫC	  double	  bond	  and	  carbonyl	  units	  associated	  with	   substrate	  46	  were	   preserved.	   This	   outcome	  highlights	   the	   utility	   of	   Raney-­‐cobalt	  in	  chemoselectively	  reducing	  nitrogen-­‐containing	  groups	  in	  the	  presence	  of	  other	  unsaturated	  functionalities.	  While	  the	  Raney-­‐cobalt-­‐mediated	  reduction	  just	  described	  had	  to	  be	  carried	  out	  at	  high	  pressures,	  it	  has	  since	  been	  established	  that	  related	   transformations	   can	   be	   performed	   at	   atmospheric	   pressure	   simply	   by	  (significantly)	  increasing	  the	  amount	  of	  Raney-­‐cobalt	  catalyst	  employed.20	  	  	  
1.4.2.	   Application	   of	   Raney-­‐cobalt	   to	   the	   synthesis	   of	   the	   ABED-­‐ring	  
substructure	  of	  strychnine	  
	  In	   a	   relatively	   recent	   study	   carried	   out	   in	   the	   Banwell	   group,	   the	   ABED-­‐ring	  structure	   of	   the	   Strychnos	   alkaloid	   strychnine	   was	   assembled20	   in	   a	   relatively	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concise	  manner	  via	  a	  Raney-­‐cobalt-­‐mediated	  tandem	  reductive	  cyclization	  process	  as	   shown	   in	   Scheme	   1-­‐7.	   Thus,	   when	   arylenone	   51	  was	   heated	   with	   200	   wt%	  Raney-­‐cobalt	  under	  an	  atmosphere	  of	  dihydrogen	  in	  acidic	  MeOH	  or	  THF	  then	  the	  anticipated	  tetracycle	  was	  isolated	  in	  72%	  yield.	  	  	  
	  	  
Scheme	   1-­‐7.	   Raney-­‐cobalt-­‐mediated	   tandem	   reductive	   cyclization	   leading	   to	   the	  
ABDE	  ring	  system	  of	  strychnine.	  Reagents	  and	  conditions:	  (i)	  Raney-­‐Co	  (200	  wt%),	  H2	  (1	  atm),	  pTsOHyH2O,	  THF,	  reflux,	  18	  h.	  	  
	  Specifically	   then	   (and	   without	   implying	   a	   particular	   order	   in	   which	   the	  reduction/bond	   forming	   processes	   proceed),	   in	   the	   opening	   stages	   of	   the	  sequence,	   the	   aromatic	   nitro	   residue	   of	   substrate	   51	   is	   reduced	   to	   the	  corresponding	  aniline	  52.	  Under	  the	  acidic	  conditions	  employed	  an	  intramolecular	  Schiff	   base	   condensation	   process	   also	   occurs	   and	   provides	   isoindole	   53.	   The	  associated	  nitrile	  residue	  (of	  51)	  is	  also	  reduced	  and	  the	  primary	  amine	  (perhaps	  in	   the	   form	   of	  54)	   so-­‐formed	   then	   engages	   in	   a	   1,4-­‐conjugate	   addition	   reaction	  with	   the	   unsaturated	   iminium	   residue	   and	   thereby	   generating	   the	   observed	  tetracyclic	   indole	  55	  that	  embodies	   the	  ABDE	   framework	  of	   (Ϋ)-­‐strychnine	   (56).	  Notably,	  all	  other	  catalysts	  surveyed	  (including	  Raney-­‐nickel,	  palladium	  on	  carbon,	  zinc,	  magnesium)	  failed	  to	  provide	  any	  trace	  of	  this	  desired	  tetracycle20	  and	  thus	  highlighting	   the	   utility	   of	   Raney-­‐cobalt	   in	   effecting	   such	   tandem	   reductive	  cyclization	  sequences.	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Encouraged	   by	   these	   results,	   it	   was	   envisaged	   that	   the	   ABCD-­‐ring	   of	  limaspermidine	   (2)	   could	  be	  accessed	  via	   a	   related	   tandem	  reductive	   cyclization	  process.	  Certain	  aspects	  of	  the	  proposed	  route	  to	  target	  2	  that	  form	  the	  basis	  of	  the	  
ǯother	  earlier	  studies	  in	  the	  Banwell	  group	  and	  so	  it	  is	  appropriate	  to	  detail	  these	  (along	  with	  those	  just	  described)	  prior	  to	  discussing	  the	  proposed	  synthesis	  of	  limaspermidine.	  	  	  	  
1.5.	   The	  Pd[0]-­‐Catalyzed	  Ullmann	  Cross-­‐Coupling	  Reaction	  in	  Natural	  
Product	  Synthesis	  	  The	   development	   of	   a	   synthetic	   strategy	   for	   the	   assembly	   of	   limaspermidine	  stemmed,	  in	  part,	  from	  previous	  work4c,d	  on	  the	  synthesis	  of	  (±)-­‐aspidospermidine	  (1)	   carried	   out	   some	   years	   ago	   in	   the	   Banwell	   group.	   As	   noted	   earlier,	  aspidospermidine	  (1)	  is	  simply	  the	  C21-­‐deoxygenated	  analogue	  of	  limaspermidine	  (2)	  (Figure	  1-­‐2).	  	  
	  
	  
Figure	  1-­‐2.	  Aspidospermidine	  (1)	  and	  limaspermidine	  (2)	  share	  the	  signature	  
ABCDE-­‐framework	  associated	  with	  the	  Aspidosperma	  alkaloids.	  	  Since	  it	  is	  relevant	  to	  the	  ǯstudies,	  as	  described	  in	  the	  following	  Chapter,	  a	  previously	   reported	   and	   general	   method	   for	   the	   synthesis	   of	   indoles22	   is	   now	  detailed.	   Specifically,	   in	   2003	   Banwell	   et	  al.	  reported	   a	   two-­‐step	  method	   for	   the	  efficient	   assembly	   of	   indoles.22a	   The	   first	   involved	   a	   Pd[0]-­‐catalyzed	   Ullmann	  cross-­‐coupling	   reaction	   between	   an	   o-­‐halonitrobenzene	  57	   and	   a	   haloenone	  58	  (Scheme	  1-­‐8),	  and	  the	  product	  Ƚ-­‐arylenone	  59	  was	  then	  subjected	  to	  a	  reductive	  cyclization	  process	  and	  by	  which	  means	  the	  target	  indole	  60	  was	  obtained.	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Scheme	  1-­‐8.	  ǯǤReagents	  and	  conditions:	  (i)	  Pd[0],	  Cu[0],	  DMSO,	  50-­‐70	  oC,	  2	  h;	  (ii)	  Pd/C,	  H2,	  MeOH,	  18	  oC,	  1	  h.	  	  
	  The	   Pd[0]-­‐catalyzed	   Ullmann	   cross-­‐coupling	   reaction23	   has	   since	   been	   used	  extensively	   in	   the	   Banwell	   group	   for	   the	   linking	   of	   various	  Ƚ-­‐halonitrobenzenes	  with	   a	  wide	   range	   of	   Ƚ-­‐haloenones	   and	   related	   compounds.	   This	   cross-­‐coupling	  reaction	   is,	   by	   virtue	   of	   its	   cost-­‐effectiveness,	   an	   attractive	   alternative	   to	   other	  widely	   used	   protocols	   including	   the	   Stille	   coupling	   process	   wherein	   toxic	  stannanes	   must	   be	   employed.	   Extensive	   studies	   carried	   out	   within	   the	   group22a	  have	  allowed	  for	  the	  identification	  of	  optimized	  conditions	  for	  effecting	  the	  Pd[0]-­‐catalyzed	  Ullmann	  cross-­‐coupling	  reaction.	  In	  particular,	  it	  was	  found	  that	  DMSO	  is	  the	  best	  solvent	  for	  the	  reaction,	  and	  that	  5-­‐10	  equivalents	  of	  Cu[0]	  bronze	  (used	  as	  a	  fine	  powder)	  is	  required.	  It	  was	  also	  established	  that	  although	  a	  wide	  range	  of	  palladium	  catalysts	  could	  be	  employed,	  Pd2(dba)3	  generally	  gave	  the	  best	  results.	  Unsurprisingly,	   the	   iodinated	   versions	   of	   the	   coupling	   partners	   were	   more	  effective	  than	  their	  bromo-­‐counterparts,	  although	  both	  could	  be	  employed.	  Under	  the	  conditions	   just	  defined,	   these	  reactions	  could	  be	  carried	  out	  at	   temperatures	  much	   lower	   than	   those	  required	   for	  a	  standard	  Ullmann	  cross-­‐coupling	  reaction.	  Typically	   temperatures	  of	   ca.	  50-­‐70	   oC	   (vs.	  200	   oC	   for	   the	   conventional	   reaction)	  could	   be	   used	   and	   so	   greatly	   enhancing	   the	   efficiency	   of	   the	   cross-­‐coupling	  reaction.	  While	   some	   homo-­‐coupling	   of	   the	   relevant	   o-­‐halonitroarene	   (to	   afford	  
ʹǡʹǯ-­‐dinitrobiphenyls)	   was	   also	   observed	   this	   was	   usually	   kept	   to	   a	   minimum	  under	  the	  optimized	  reaction	  conditions.	  	  A	  possible	  mechanism24	  for	  the	  catalytic	  cycle	  associated	  with	  this	  useful	  variant	  of	  the	  Ullmann	  cross-­‐coupling	  reaction	  is	  shown	  in	  Scheme	  1-­‐9.	  
	   	  





Scheme	  1-­‐9.	  Possible	  mechanistic	  pathway	  for	  the	  Pd[0]-­‐catalyzed	  Ullmann	  cross-­‐
coupling	  reaction.	  	  	  Thus,	  in	  the	  initial	  and	  oxidative	  addition	  step	  of	  the	  reaction,	  Pd[0]	  inserts	  across	  the	  carbon-­‐halogen	  bond	  of	  enone	  58	  to	  give	  adduct	  61.	  The	  aryl	  copper	  species	  
62	   formed	   through	   the	   reaction	   of	   o-­‐halonitrobenzene	   57	   with	   copper	   then	  undergoes	   transmetalation,	   at	   palladium,	  with	   compound	  61	   to	   give	   adduct	  63.	  Finally,	   reductive	   elimination	   within	   the	   last	   compound	   completes	   the	   cycle	   by	  forming	  the	  cross-­‐coupled	  product	  59	  while	  simultaneously	  regenerating	  Pd[0].	  
	  Clearly,	  the	  Pd[0]-­‐catalyzed	  Ullmann	  cross-­‐coupling	  reaction	  provides	  a	  means	  for	  generating	  substrates	  that	  can	  be	  subjected	  to	  reductive	  cyclization	  reactions	  so	  as	  to	  generate	  a	  range	  of	  alkaloid	  frameworks.	  Certain	  examples	  of	  such	  sequences	  of	  processes	  have	  already	  been	  presented	  in	  Schemes	  1-­‐7	  and	  1-­‐8.	  Another	  means	  of	  using	   such	   products,	   this	   time	   in	   the	   synthesis	   of	   (±)-­‐aspidospermidine,	   is	  discussed	  below.	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1.5.1.	   Application	  of	  the	  Pd[0]-­‐catalyzed	  Ullmann	  cross-­‐coupling	  reaction	  to	  
the	  synthesis	  of	  (±)-­‐aspidospermidine	  
	  In	  2005	  Banwell	  and	  Lupton	  reported	  a	  total	  synthesis	  of	  the	  racemic	  modification	  of	   aspidospermidine	   (1)	   in	   23	   steps	   from	   commercially	   available	   3-­‐ethoxycyclohexenone	  (65).4c,d	  A	  pivotal	   feature	  of	   the	   reaction	  sequence	  was	   the	  use	  of	  a	  Pd[0]-­‐catalyzed	  Ullmann	  cross-­‐coupling	  reaction.	  Details	  are	  presented	  in	  Scheme	  1-­‐10.	  Thus,	  in	  the	  key	  steps	  of	  the	  synthetic	  sequence,	  the	  first	  quaternary	  centre	   in	   the	   natural	   product	   was	   established	   via	   an	   Ireland-­‐Claisen	  rearrangement	   of	   allylic	   acetate	   65	   (derived	   from	   compound	   64)	   to	   form	  cyclohexene	  66	  that	  would	  eventually	  become	  the	  C-­‐ring	  of	  the	  target	  molecule.	  A	  one-­‐carbon	   homologation	   of	   the	   alcohol-­‐containing	   side	   chain	   was	   achieved	   in	  87%	   yield	   over	   four	   steps	   including	   a	   Wittig	   olefination	   reaction	   to	   install	   the	  necessary	   carbons	   required	   for	   the	   D-­‐ring	   of	   the	   molecule.	   Compound	   67,	   the	  product	  of	  the	  reaction	  sequence	  just	  described,	  was	  subjected	  to	  oxidation	  at	  the	  allylic	   carbon	  centre	  using	   t-­‐butyl	  hydroperoxide	   in	   the	  presence	  of	   a	   chromium	  hexacarbonyl	  (as	  catalyst)	  to	  afford	  enone	  68.	  By	  applying	  the	  Johnson	  iodination	  protocol25	   the	   corresponding	   Ƚ-­‐iodoenone	   was	   obtained	   and	   this	   served	   as	   the	  substrate	   for	   the	  key	  Pd[0]-­‐catalyzed	  Ullmann	  cross-­‐coupling	  reaction.	  Thus,	   this	  iodoenone	  was	  reacted	  with	  o-­‐iodonitrobenzene	  using	  5	  mol	  equivalents	  of	  copper	  bronze	  powder	  in	  the	  presence	  of	  the	  catalyst	  Pd2(dba)3	  and	  thereby	  forming	  the	  
Ƚ-­‐arylenone	   69	   in	   75%	   yield	   over	   the	   two	   steps	   involved.	   The	   acetate	   residue	  within	  the	  last	  compound	  was	  then	  replaced,	  over	  three	  steps,	  by	  an	  azide	  moiety	  to	   give	   compound	  70,	   that	  was	   itself	   heated	   over	   an	   extended	  period	  of	   time	   to	  effect	  an	  intramolecular	  1,3-­‐dipolar	  cycloaddition	  with	  the	  CΫC	  double	  bond	  of	  the	  pendant	   enone	   and	   so	   forming	   the	   strained	   aziridine	   71	   in	   72%	   yield.	   In	   this	  process	  an	   intermediate	   triazoline,	  which	  was	  not	   isolated,	  was	  probably	   formed	  first,	  but	  upon	  expulsion	  of	  N2	  delivered	  compound	  71,	  the	  substrate	  required	  for	  the	   subsequent	   reductive	   cyclization	   process.	   Thus,	   an	   acid-­‐promoted	   ring-­‐opening	   of	   the	   aziridine	   71	   followed	   by	   reductive	   cyclization	   of	   the	   nitroarene	  functionality	  using	  titanium(III)	  chloride	  gave	  tetrahydrocarbazole	  72	  as	  a	  single	  diastereomer	   in	   41%	  yield	   over	   the	   two	   steps	   involved.	  With	   the	  ABCD-­‐rings	   of	  target	  1	  in	  place,	  the	  final	  E-­‐ring	  was	  installed	  following	  the	  three-­‐step	  procedure	  reported	   by	   Heathcock	   and	   Toczko12	   (see	   Scheme	   1-­‐4)	   and	   so	   generating	  pentacycle	  73	  in	  35%	  yield	  over	  the	  three	  steps	   involved.	  Finally,	  and	   in	  the	  one	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pot,	   the	   lactam	   and	   imine	   residues	   within	   pentacycle	   73	   were	   reduced	   using	  LiAlH4	  to	  give	  (±)-­‐aspidospermidine	  (1)	  in	  77%	  yield	  (from	  compound	  73).	  	  	  
	  	  
Scheme	   1-­‐10.	   ǯ   ȋΰȌ-­‐aspidospermidine	   (1).	   Reagents	   and	  conditions:	  (i)	  (a)	  EtMgBr,	  THF,	  0	  oC,	  3	  h,	  then	  10%	  aq.	  HCl,	  18	  oC,	  16	  h;	  (b)	  NaBH4,	  MeOH,	  0	   to	  18	   oC,	   16	  h;	   (c)	  Ac2O,	  DMAP,	  pyridine,	   0	   to	  18	   oC,	   10	  h;	   (ii)	   (a)	   LDA,	  TBDMS-­‐Cl,	  THF,	  Ϋ78	  oC	  to	  reflux,	  6	  h,	  then	  MeOH,	  18	  oC,	  16	  h;	  (b)	  LiAlH4,	  THF,	  0	  to	  18	   oC,	   2	   h;	   (iii)	   (a)	   4-­‐AcN(H)TEMPO,	   PhI(OAc)2,	   DCM,	   18	   oC,	   3	   h;	   (b)	   NaHMDS,	  CH3OCH2PPh3Cl,	  THF,	  0	  to	  18	   oC,	  16	  h;	  (c)	  3	  M	  aq.	  HCl,	  THF,	  0	  to	  18	   oC,	  16	  h;	  (d)	  NaBH4,	  MeOH,	  0	  oC,	  3	  h;	  (iv)	  (a)	  Ac2O,	  DMAP,	  pyridine,	  0	  to	  18	  oC,	  1.5	  h;	  (b)	  Cr(CO)6,	  70%	  t-­‐BuOOH,	  MeCN,	  reflux,	  16	  h;	  (v)	  (a)	  I2,	  CCl4/pyridine	  (1:1),	  18	  oC,	  16	  h;	  (b)	  o-­‐iodonitrobenzene,	  Cu,	  Pd2(dba)3,	  DMSO,	  70	  oC,	  5	  h;	  (vi)	  (a)	  1	  M	  aq.	  K2CO3,	  MeOH,	  18	   oC,	  16	  h;	   (b)	  MsCl,	  NEt3,	  Et2O,	  0	   to	  18	   oC,	  2	  h;	   (c)	  NaN3,	  DMF,	  67	   oC,	  3	  h;	   (vii)	  benzene,	  reflux,	  72	  h;	  (viii)	  (a)	  1	  M	  HCl	  in	  Et2O,	  DCM,	  Ϋ15	  oC,	  1.5	  h;	  (b)	  TiCl3y3THF,	  H2O/2.5	   M	   aq.	   NH4OAc/acetone	   (1:2:2),	   18	   oǡ ͲǤ͵͵ Ǣ ȋȌ ȋȌ Ƚ-­‐chloroacetyl	  chloride,	  NEt3,	  DCM,	  0	  to	  18	  oC,	  2	  h;	  (b)	  NaI,	  acetone,	  reflux,	  2	  h;	  (c)	  AgOTf,	  THF,	  18	  oC,	  0.5	  h;	  (x)	  LiAlH4,	  THF,	  reflux,	  4	  h.	  	  	  An	  alternative	  strategy	  for	  the	  formation	  of	  tetracyclic	  indoles	  such	  as	  compound	  
72	   could	   involve	  a	  Raney-­‐cobalt-­‐mediated	   tandem	  reductive	   cyclization	  protocol	  of	  the	  type	  discussed	  above.	  Significantly,	  this	  might	  allow	  for	  the	  establishment	  of	  a	  more	  efficient	  route	  to	   limaspermidine,	  and	  thus	  providing	  an	  attractive	  means	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for	   the	  assembly	  of	   the	  polycyclic	   framework	  of	   these	  and	   related	  alkaloids.	  The	  outcomes	   of	    ǯ	   investigations	   into	   such	   matters	   are	   detailed	   in	   the	  following	  Chapter.	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Chapter Two.  




2.1.	   Retrosynthetic	  Analysis	  
	  In	   light	   of	   the	   successful	   reductive	   cyclization	   of	   compound	   53	   to	   give	   the	  tetracyclic	  product	  54	  (Scheme	  2-­‐1),	  it	  was	  thought	  that	  an	  analogous	  reaction	  of	  
 Ƚ-­‐arylated	  enone	  74	  would	  provide	   compound	  75	   that	  embodies	   the	  ABCD-­‐ring	  framework	  of	  limaspermidine	  (2).	  	  	  
	  	  
Scheme	  2-­‐1.	  Synthetic	  strategy	  associated	  with	  the	  assembly	  of	  the	  ACBD-­‐rings	  of	  
limaspermidine	  (2)	  that	  parallels	  previously	  reported	  work.	  
	  	  A	   full	   retrosynthetic	   analysis	   of	   (±)-­‐limaspermidine	   (2)	   and	   (±)-­‐1-­‐acetylaspidoalbidine	  (3)	  based	  on	  this	  key	  reductive	  cyclization	  process	  is	  shown	  in	  Scheme	  2-­‐2.	  In	  order	  to	  obtain	  1-­‐acetylaspidoalbidine	  (3)	  from	  limaspermidine	  (2)	   the	   tetrahydrofuran	   unit	   of	   the	   former	   natural	   product	   would	   need	   to	   be	  assembled.	   It	  was	   thought	   this	   could	  be	   achieved	   through	   cyclization	  of	   the	  C21	  hydroxyl	   residue	   of	   the	   side	   chain	   associated	   with	   compound	   2	   onto	   C19	   by	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   ǡ        ǯoriginal	  synthesis	  (see	  Scheme	  1-­‐1).	  	  The	  E-­‐ring	  of	   limaspermidine	  could	  be	   installed	   from	  tetracyclic	   intermediate	  75	  using	  the	  Heathcock	  protocol	  described	   in	  the	  preceding	  Chapter	  (see	  Scheme	  1-­‐4).	  Assembly	  of	  the	  tetracyclic	  framework	  of	  compound	  75	  was,	  in	  turn,	  expected	  to	   be	   achieved	   through	   the	   foreshadowed	   and	   pivotal	   Raney-­‐cobalt-­‐mediated	  tandem	  reductive	  cyclization	  reaction	  of	  Ƚ-­‐aryl	  enone	  74,	  the	  latter	  being	  obtained	  by	   the	   Pd[0]-­‐catalyzed	   Ullmann	   cross-­‐coupling	   reaction	   of	   o-­‐iodonitrobenzene	  with	   compound	   76,	   the	   Ƚ-­‐iodinated	   derivative	   of	   enone	   77.	   Compound	   77	   was	  thought	   likely	   to	   be	   accessible	   from	   allylic	   alcohol	   78	   via	   a	   two-­‐step	   sequence.	  Specifically,	  Claisen	   rearrangement	  of	   an	  ester	  of	   compound	  78	  would	  provide	  a	  cyclohexene	  containing	   the	  pivotal	  quaternary	  carbon	  centre	  associated	  with	   the	  natural	  product	   and,	   following	  allylic	  oxidation	  of	   the	   resulting	  cyclohexene	   (not	  shown),	  enone	  77	  could	  be	  generated.	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Scheme	  2-­‐2.	  Retrosynthetic	  analysis	  of	  (±)-­‐limaspermidine	  (2)	  and	  	  (±)-­‐1-­‐acetylaspidoalbidine	  (3).	  
R	  =	  alkyl	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2.2.	   Synthetic	  Work	  on	  (±)-­‐Limaspermidine	  
	  
2.2.1.	   Installation	  of	  the	  first	  quaternary	  carbon	  centre	  (C5)	  
	  Initial	   attempts	   to	   obtain	   the	   substrate,	   78,	   required	   for	   the	   proposed	   Claisen	  rearrangement	   reaction	   are	   shown	   in	   Scheme	   2-­‐3.	   The	   first	   step	   involved	  halogenation	   of	   commercially	   available	   1,3-­‐cyclohexanedione	   (79),	   under	  Vilsmeier	   conditions,26	   so	   as	   to	   form	   the	   previously	   reported26	   Ⱦ-­‐bromo-­‐ȽǡȾ-­‐unsaturated	  ketone	  80.	  This	  last	  compound	  was	  treated	  with	  Bu3SnH	  and	  AIBN,27	  and	   the	   alkenyl	   radical	   so-­‐formed	  was	   reacted	  with	   acrylonitrile	   to	  generate	   the	  previously	  reported	  alkylated	  compound	  81,	   albeit	   invariably	  contaminated	  with	  essentially	  irremovable	  tin-­‐derived	  impurities.	  Despite	  this,	  sufficient	  quantities	  of	  enone	   81	   were	   obtained	   to	   allow	   it	   to	   be	   carried	   through	   the	   next	   step	   of	   the	  synthetic	   sequence.	   Thus,	   compound	   81	   was	   subjected	   to	   standard	   Luche	  reduction	  conditions	  to	  give	  allylic	  alcohol	  78	   in	  70%	  yield.	  However,	  the	  tedious	  nature	  of	   this	   sequence	   (due	   to	   the	  poor	  yield	  associated	  with	   the	   conversion	  of	  compound	   80	   into	   nitrile	   81)	   prompted	   the	   search	   for	   an	   alternate	   route	   to	  compound	  78	  that	  could	  provide	  it	  in	  a	  more	  efficient	  manner.	  	  	  
	  	  
Scheme	  2-­‐3.	  Synthesis	  of	  allylic	  alcohol	  78.	  Reagents	   and	   conditions:	   (i)	   (COBr)2,	  DMF,	  DCM,	  18	  oC,	  0.5	  h;	  (ii)	  acrylonitrile,	  AIBN,	  Bu3SnH,	  benzene,	  reflux,	  6	  h;	  (iii)	  NaBH4,	  CeCl3yH2O,	  MeOH,	  0	  oC,	  0.5	  h.	  	  	  Zard	   and	   co-­‐workers28	   have	   described	   the	   triethylborane-­‐mediated	   and	   efficient	  addition	  of	   xanthate-­‐derived	   radicals	   to	  vinyl	   epoxides	   as	  a	  means	   for	  preparing	  various	   allylic	   alcohols.	   In	   the	   representative	   reaction	   shown	   in	   Scheme	   2-­‐4	  opening	   of	   the	   three-­‐membered	   ring	   in	   alkenyl	   epoxides	   of	   the	   general	   form	  82	  proceeds	  via	  conjugate	  addition	  of	  various	  alkyl	  radicals	  derived	  from	  the	  reaction	  of	  a	  precursor	  xanthate	  83	  with	  triethylborane	  and	  O2.	  The	  ensuing	  alkoxy	  radical	  
85	   is	   rapidly	  quenched	  by	   triethylborane	   to	   give	  borinate	  86	   and	  upon	  aqueous	  workup	  this	  is	  hydrolyzed	  to	  give	  the	  observed	  allylic	  alcohol	  84.	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Scheme	  2-­‐4.	  ǯ-­‐mediated	  alkylation	  of	  alkenyl	  epoxides;	  R	  =	  
ǡǯǳεǤ	  Reagents	  and	  conditions:	  (i)	  Et3B,	  O2,	  DCM,	  18	  oC,	  16	  h.	  	  	  In	  order	   to	  exploit	  ǯ  in	  a	   synthesis	  of	   the	   required	  allylic	   alcohol	  
78,	   the	   relevant	   substrates	   had	   to	   be	   prepared	   (Scheme	   2-­‐5).	   Specifically,	   then,	  xanthate	  87	  was	   synthesized	  by	   reacting	   chloroacetonitrile	   (88)	  with	  potassium	  ethyl	  xanthate	  (89)	  in	  acetone.	  The	  latter	  compound	  was	  itself	  prepared	  by	  simply	  stirring	   carbon	   disulfide	   and	   potassium	   hydroxide	   in	   ethanol.29	   The	   required	  alkenyl	  epoxide	  90	  was	  prepared	  following	  a	  reported,	  30	  two-­‐step	  procedure	  from	  cyclohexenone	   91.	   Thus,	   nucleophilic	   epoxidation	   of	   the	   CΫC	   double	   bond	   in	  cyclohexenone	   91	   followed	   by	   Wittig	   methylation	   of	   the	   ketone	   residue	   in	   the	  resulting	   oxirane	   92	   furnished	   the	   required	   alkenyl	   epoxide	   9030	   in	   59%	   yield	  over	  the	  two	  steps	  involved.	  	  	  
	  	  
Scheme	  2-­‐5.	  Synthesis	  of	  the	  radical	  addition	  substrates	  87	  and	  90.	  Reagents	  and	  conditions:	  (i)	  acetone,	  18	  oC,	  2	  h;	  (ii)	  H2O2,	  15%	  aq.	  NaOH,	  MeOH,	  0	  oC,	  0.5	  h;	  (iii)	  Ph3PMeBr,	  n-­‐BuLi,	  THF,	  0	  oC,	  1	  h.	  	  	  
	  	  26	  
In	  the	  pivotal	  step,	  a	  mixture	  of	  xanthate	  87	  and	  alkenyl	  epoxide	  90	  was	  treated,	  at	  room	   temperature,	   with	   triethylborane	   in	   the	   presence	   of	   atmospheric	   oxygen	  (Scheme	   2-­‐6).	   A	   slight	   excess	   of	   either	   substrate	   was	   required	   to	   effect	   the	  otherwise	   sluggish	   radical	   addition	   reaction	   efficiently.	   By	   such	   means,	   allylic	  alcohol	  78	  was	  obtained	   in	  79%	  yield	  and,	  as	  such,	   this	  method	   for	  synthesizing	  the	   compound	   proved	   far	   more	   efficient	   than	   the	   three-­‐step	   one	   used	   earlier	  (Scheme	  2-­‐3).	   Furthermore,	   avoiding	   the	  use	  of	   toxic	  and	  otherwise	  problematic	  tin	  species,	  as	  required	  in	  the	  initial	  route,	  allowed	  for	  the	  safe,	  practical	  and	  large-­‐scale	  production	  of	  substrate	  78.	  	  	  
	  	  
Scheme	  2-­‐6.	   Improved	  synthesis	  of	  allylic	  alcohol	  78.	  Reagents	   and	   conditions:	   (i)	  Et3B,	  O2,	  DCM,	  18	  oC,	  16	  h.	  
	  
	  The	  next	  step	  of	  the	  synthetic	  sequence	  required	  a	  Claisen-­‐type	  rearrangement	  of	  allylic	  alcohol	  78	  so	  as	  to	  establish	  the	  first	  quaternary	  centre	  (C5)	  associated	  with	  target	   2.	   Noting	   the	   success	   of	   the	   Ireland-­‐Claisen	   rearrangement	   in	   the	  Banwell/Lupton	  synthesis	  of	  (±)-­‐aspidospermidine	  (1),	  allylic	  alcohol	  78	  was	  first	  treated	  with	   Ac2O	   and	   DMAP	   in	   pyridine	   to	   afford	   the	   acetylated	   derivative	   93.	  However,	  when	  this	  last	  compound	  was	  subjected	  to	  the	  usual	  conditions	  applied	  in	  effecting	   the	  desired	   rearrangement	  no	  evidence	   for	   the	   formation	  of	  product	  
94	   was	   obtained.	   Only	   starting	   material	   was	   returned.	   Disappointingly,	   several	  other	   variants	   of	   the	   Claisen	   rearrangement	   reaction	   were	   attempted	   but,	   as	  summarized	  in	  Scheme	  2-­‐7,	  all	  to	  no	  avail.	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Scheme	   2-­‐7.	   Failed	   attempts	   at	   the	   Claisen	   rearrangement.	   Reagents	   and	  conditions:	   (i)	   CH3C(OC2H5)3,	   2-­‐nitrophenol	   (5	  mol%),	   sealed	   tube,	  140	   oC,	   16	  h;	  (ii)	  CH3C(OC2H5)3,	  CH3CH2COOH,	  reflux,	  16	  h;	  (iii)	  Ac2O,	  DMAP	  (1	  mol%),	  pyridine,	  18	   oC,	   1	   h,	   then	   MeOH;	   (iv)	   TMP,	   TIPS-­‐OTf,	   DCM,	   18	   oC,	   16	   h;	   (v)	   n-­‐BuLi,	  diisopropylamine,	  TBDMS-­‐Cl,	  THF,	  reflux,	  16	  h.	  	  	  In	  stark	  contrast,	  when	  allylic	  alcohol	  78	  was	  heated	  with	  N,N-­‐dimethylacetamide	  dimethyl	   acetal	   (DMA-­‐DMA)31	   at	   elevated	   temperatures,	   the	   product	   97	   arising	  from	  the	  Eschenmoser-­‐Claisen	  reaction	  was	  obtained	  in	  89%	  yield	  (Scheme	  2-­‐8).	  Despite	   the	   inevitable	   incorporation	   of	   a	   tertiary	   amide	   group	   rather	   than	   a	  carboxylic	  acid	  or	  ester	  (as	  would	  have	  been	  generated	  had	  the	  preceding	  types	  of	  Claisen	  rearrangement	  reaction	  been	  successful),	  it	  was	  envisaged	  that	  the	  amide	  moiety	   could	   be	   reduced	   to	   the	   required	   primary	   alcohol	   at	   a	   later	   stage.	  Accordingly,	   the	   Eschenmoser-­‐Claisen	   rearrangement	   product	   97	   was	   carried	  forward	  in	  the	  synthetic	  sequence.	  	  	  
	  	  
Scheme	   2-­‐8.	   Eschenmoser-­‐Claisen	   rearrangement.	   Reagents	   and	   conditions:	   (i)	  
N,N-­‐dimethylacetamide	  dimethyl	  acetal,	  toluene,	  reflux,	  16	  h.	  	  
	  	  28	  
2.2.2.	   Synthesis	   of	   the	   substrate	   for	   the	   tandem	   reductive	   cyclization	  
reaction	  
	  Having	  obtained	  compound	  97,	  which	  embodies	  the	  first	  (C5)	  quaternary	  centre	  of	  limaspermidine	   (2),	   efforts	   became	   focused	   on	   installing	   the	   necessary	  functionalities,	   viz	  an	  Ƚ-­‐arylenone,	   required	   for	   the	   pivotal	   reductive	   cyclization	  reaction.	   In	   initial	   attempts	   to	   oxidize	   cyclohexene	   97	   ǯ  examined	  in	  the	  hope	  of	  emulating	  a	  related	  conversion	  successfully	  carried	  out	  in	  the	   Banwell/Lupton	   synthesis	   of	   (±)-­‐aspidospermidine	   (1).	   However,	   recurring	  difficulties	  with	  chromium	  impurities	  remaining	  in	  the	  product	  enone	  98	  and	  the	  attendant	   low	  yields	  of	  this	  product	  prompted	  the	  examination	  of	  other	  methods	  for	   effecting	   allylic	   oxidations.	   The	   Riley	   oxidation	   protocol32	   using	   selenium	  dioxide	  and	  hydrogen	  peroxide	  was	  not	  successful	  in	  our	  hands,	  simply	  providing	  a	  complex	  mixture	  of	  partially	  oxidized	  intermediates	  (such	  as	  allylic	  alcohol	  99)	  that,	  despite	  various	  efforts,	  could	  not	  be	  converted	  into	  the	  target	  ketone	  (Scheme	  2-­‐9).	  	  	  
	  	  
Scheme	  2-­‐9.	  Failed	  attempts	  at	  the	  allylic	  oxidation	  of	  97.	  Reagents	  and	  conditions:	  (i)	  CrO3,	  3,5-­‐DMP,	  DCM,	  Ϋ20	  oC,	  4	  h,	  then	  NaOH	  (5M);	  (ii)	  SeO2,	  1,4-­‐dioxane,	  reflux,	  1	  h;	  (iii)	  PCC,	  NaOAc,	  DCM,	  18	  oC,	  2	  h.	  	  	  In	  2006	  Shing	  and	  co-­‐workers	  reported33	  an	  allylic	  oxidation	  protocol	  using	  t-­‐butyl	  hydroperoxide	   in	   the	   presence	   of	   catalytic	   quantities	   of	   manganese(III)	   acetate	  and	  so	  allowing	  access	   to	  a	  wide	   range	  of	   enones	   from	  alkenes	  of	  varying	   types.	  The	   mild	   conditions	   involved	   as	   well	   as	   the	   excellent	   regio-­‐	   and	   chemo-­‐selectivities	   reported	   were	   appealing.	   Gratifyingly,	   when	   cyclohexene	   97	   was	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subjected	   to	   ǯ	   conditions	   (Scheme	   2-­‐10)	   the	   desired	   enone	   98	   was	  consistently	  obtained	  in	  ca.	  70%	  yield	  on	  a	  multi-­‐gram	  scale.	  Furthermore,	  and	  as	  reported	  by	  Shing,	   it	  was	   found	   that	   reduced	  equivalents	  of	  both	   the	  manganese	  catalyst	  and	  t-­‐butyl	  hydroperoxide	  could	  be	  employed	  if	  the	  reaction	  was	  carried	  out	  under	  an	  atmosphere	  of	  oxygen	  (and	  without	  any	  attendant	  decrease	  in	  yield).	  
	  The	  subsequent	  steps	  needed	   to	   furnish	   the	  Ƚ-­‐aryl	  enone	  (101)	   required	   for	   the	  tandem	   reductive	   cyclization	   step	   were	   straightforward	   and	   exploited	  transformations	  routinely	  carried	  out	   in	  the	  Banwell	   laboratories	  (Scheme	  2-­‐10).	  So,	  enone	  98	  was	  first	  subjected	  to	  Johnson-­‐type	  iodination	  using	  molecular	  iodine	  and	  pyridine	  in	  CHCl3,	  and	  the	  resulting	  iodinated	  derivative	  100	  (75%	  yield)	  was	  used	   as	   the	   cross-­‐coupling	   partner	   in	   a	   Pd[0]-­‐catalyzed	   Ullmann	   reaction	   with	  commercially	  available	  o-­‐iodonitrobenzene.	  By	  such	  means	  the	  Ƚ-­‐aryl	  enone	  101	  was	  obtained	  in	  80-­‐85%	  yield.	  The	  reaction	  time	  required	  for	  this	  cross-­‐coupling	  process	  was	  brief	   (0.5	   h)	   even	  when	   conducted	  on	   a	  multi-­‐gram	  scale,	   and	  with	  consistently	   high	   yields	   being	   obtained.	   This	   conversion	   highlights	   the	   utility	   of	  this	   variant	   of	   the	   Ullman	   cross-­‐coupling	   reaction	   for	   the	   preparation	   of	   Ƚ-­‐aryl	  enones.	  With	  Ƚ-­‐aryl	   enone	  101	   in	   hand	   the	   key	   Raney-­‐cobalt-­‐mediated	   tandem	  reductive	  cyclization	  reaction	  could	  be	  attempted.	  Details	  of	   the	  outcomes	  of	   the	  relevant	  experiments	  are	  presented	  in	  the	  following	  section.	  	  	  
	  
	  
Scheme	  2-­‐10.	  Preparation	  of	  the	  reductive	  cyclization	  substrate	  101.	  Reagents	  and	  conditions:	   (i)	   Mn3(OAc)9y2H2O,	   t-­‐BuOOH,	   EtOAC,	   18	   oC,	   16	   h;	   (ii)	   I2,	  pyridine/CHCl3	  (1:1),	  18	  oC,	  16	  h;	  (iii)	  o-­‐iodonitrobenzene,	  Cu,	  Pd2(dba)3	  (1	  mol%),	  DMSO,	  70	  oC,	  0.5	  h.	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2.2.3.	   Raney-­‐cobalt	  
	  
2.2.3.1.	   Tandem	  reductive	  cyclization	  	  In	  the	  pivotal	  step	  of	  the	  synthetic	  sequence	  and	  following	  the	  method	  employed	  in	  the	  strychnine	  work	  outlined	  in	  the	  previous	  Chapter	  (see	  Scheme	  1-­‐7),	  Ƚ-­‐aryl	  enone	  101	  was	  exposed,	  at	  40	  oC,	  to	  a	  large	  excess	  (200	  wt%)	  of	  freshly	  prepared	  Raney-­‐cobalt	   in	  MeOH	  containing	  5	  mol	  equiv	  of	  p-­‐TsOH.	  When	  the	  reaction	  was	  stopped	  as	  soon	  as	  complete	  consumption	  of	  starting	  material	  was	  observed	  (ca.	  4	  h	   as	   determined	   by	   TLC	   analysis)	   then	   a	   mixture	   of	   two	   chromatographically	  separable	  compounds	  was	  obtained	  (Scheme	  2-­‐11),	  namely	  the	  desired	  indole	  102	  (85%)	  and	  its	  N-­‐hydroxy	  counterpart	  103	  (variable	  yields).	  The	  structure	  of	  each	  of	   these	  products	  was	  confirmed	  by	  single-­‐crystal	  X-­‐ray	  analysis	  and	  the	  derived	  ORTEPs	   are	   shown	   in	   Figures	   2-­‐1	   and	   2-­‐2.	   Pleasingly,	   it	   was	   found	   that	   the	  N-­‐hydroxyl	   moiety	   associated	   with	   compound	   103	   could	   be	   cleaved	   upon	   re-­‐subjection	   of	   this	   material	   to	   the	   reductive	   cyclization	   conditions	   and	   so	  generating	  additional	  quantities	  of	  congener	  102.	  More	  conveniently,	  running	  the	  original	  reductive	  cyclization	  process	  for	  extended	  reaction	  times	  (6	  h)	  resulted	  in	  the	  exclusive	  formation	  of	  the	  desired	  indole	  102	  which	  could	  be	  obtained	  in	  85%	  yield	  after	  column	  chromatographic	  purification.	  	  	  
	  	  
Scheme	   2-­‐11.	  Raney-­‐cobalt-­‐mediated	   tandem	  reductive	  cyclization.	  Reagents	   and	  conditions:	  (i)	  Raney-­‐Co	  (200	  wt%),	  H2	  (1	  atm),	  p-­‐TsOHyH2O,	  MeOH,	  40	  oC,	  4	  h.	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Figure	  2-­‐1.	  ORTEP	  derived	  from	  the	  single-­‐crystal	  X-­‐ray	  analysis	  of	  the	  tetracycle	  
102	  (with	  labelling	  of	  non-­‐hydrogen	  atoms).	  	  	  
	  	  
Figure	  2-­‐2.	  ORTEP	  derived	  from	  the	  single-­‐crystal	  X-­‐ray	  analysis	  of	  the	  	  
N-­‐hydroxylated	  tetracycle	  103	  (with	  labelling	  of	  non-­‐hydrogen	  atoms).	  	  	  There	  were	   several	   interesting	   features	   associated	  with	   the	   conversion	  of	  Ƚ-­‐aryl	  enone	  101	  into	  indole	  102.	  Thus,	  exclusive	  formation	  of	  the	  cis-­‐ring	  fused	  product	  was	   observed	   and	   despite	   various	   efforts,	   including	   carrying	   out	   the	   reaction	   at	  higher	   temperatures,	   none	   of	   its	   trans-­‐configured	   counterpart	   could	   be	   isolated.	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Furthermore,	   the	   reaction	  would	  not	   proceed	   at	   temperatures	   lower	   than	  40	   oC.	  These	  observations	  suggest	   that	   the	  cyclization	  event	   leading	  to	  the	   formation	  of	  the	   D-­‐ring-­‐containing	   product	  102	   proceeds	   via	   a	   kinetically	   controlled	   process	  (the	   trans-­‐configured	   product	   is	   presumed	   to	   be	   the	   thermodynamically	   more	  stable	  one).	  Also,	  it	  appears	  that	  the	  cyclization	  process	  leading	  to	  the	  formation	  of	  the	  B-­‐ring	  proceeds,	   at	   least	   in	  part,	   through	   the	  hydroxylamine	   (104a)	  derived	  from	   partial	   reduction	   of	   the	   nitroarene	   in	   precursor	   101	   (Pathway	   B).	  Accordingly,	   it	   is	   suggested	   that	   the	   conversion	  of	   compound	  101	   into	   congener	  
102	  proceeds	  as	  outlined	  in	  Scheme	  2-­‐12.	  	  	  
	  	  
Scheme	  2-­‐12.	  Proposed	  pathways	  for	  the	  conversion	  of	  substrate	  101	  into	  product	  
102.	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In	  the	  first	  step	  of	  the	  process,	  reduction	  of	  the	  nitro	  group	  within	  substrate	  101	  is	  followed	  by	  Schiff	  base	  condensation	  of	  the	  resulting	  aniline	  104	  with	  the	  pendant	  enone	  carbonyl	  residue	  to	  form	  the	  conjugated	  imine	  105.	  Reduction	  of	  the	  nitrile	  residue	  within	  the	   last	  compound	  and	  subsequent	   intramolecular	  hetero-­‐Michael	  addition	   (of	   the	   so-­‐formed	  primary	  amine	  106)	   to	   the	  extended	   iminium	  moiety	  then	   completes	   the	   assembly	   of	   the	   tetracyclic	   ring	   system	   embodied	   within	  compound	  102.	  Given	  the	  exclusive	  formation	  of	  the	  cis-­‐fused	  tetracycle	  102,	  the	  conjugate	   addition	   of	   the	   primary	   amine	   to	   the	   iminium	  moiety	   in	   intermediate	  
106	  appears	  to	  occur	  on	  the	  face	  opposite	  to	  the	  tertiary	  amide	  tether,	  likely	  due	  to	  favourable	  orbital	  overlap	  between	  the	  nucleophile	  (-­‐NH2ȌȾ-­‐carbon	  of	  the	  Michael	  acceptor,	  ensuring	  that	   this	   irreversible	  cyclization	  process	  proceeds	  in	  a	  kinetic	   fashion.	  The	   transition	   state	   required	   for	   the	  pathway	   leading	   to	   the	  
trans-­‐isomer	  is	  presumably	  significantly	  higher	  in	  energy	  and	  so	  this	  product	  was	  not	  observed.	  In	  addition,	  the	  cleavage	  of	  the	  N-­‐hydroxyl	  group	  within	  compound	  
103	  (formed	  as	  a	  result	  of	  the	  cyclization	  process	  proceeding	  through	  Pathway	  B	  
via	  the	  partially	  reduced	  intermediate	  104a,	  in	  parallel	  with	  Pathway	  A)	  is	  likely	  to	  be	  a	  late-­‐stage	  process.	  	  	  
2.2.3.2.	   Comparison	  with	  Raney-­‐nickel	  
	  While	  Raney-­‐cobalt	  has	  clearly	  served	  rather	  effectively	   in	  delivering	   target	  102,	  other	  Raney-­‐catalysts	  were	  investigated	  so	  as	  to	  determine	  if	  these	  could	  effect	  the	  same	  transformation.	  Accordingly,	  the	  optimized	  conditions	  presented	  above	  were	  reinvestigated	  but	  with	  Raney-­‐nickel	  being	  used	  as	  the	  catalyst	  rather	  than	  Raney-­‐cobalt	  (Scheme	  2-­‐13).	  Under	  such	  conditions	  the	  partially	  cyclized	  primary	  amine	  
107	  was	   isolated	   in	   24%	   yield	   together	  with	   the	   desired	   tetracycle	   102	   (48%).	  Compound	  107	   necessarily	  arises	   from	   reduction	  of	   the	  CΫC	  double	  bond	  of	   the	  enone	   residue	   of	   substrate	   101	   at	   an	   early	   stage	   and	   thus	   preventing	   the	  intramolecular	  hetero-­‐Michael	  addition	   reaction	   required	   for	  D-­‐ring	   formation,	   a	  phenomenon	  not	  observed	  with	  Raney-­‐cobalt.	  When	  Raney	  2724*	  was	  employed,	  the	  desired	  indole	  102	  was	  obtained	  in	  65%	  yield,	  but	  a	  significant	  amount	  (15%)	  of	  amine	  107	  was	  still	  isolated.	  This	  result	  demonstrates	  that	  the	  presence	  of	  even	  a	   trace	   amount	   of	   nickel	   in	   the	   catalyst	   can	   be	   detrimental	   to	   the	   reductive	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *Raney	  2724	  is	  an	  active	  cobalt-­‐based	  catalyst	  provided	  by	  Grace	  Davison.	  Trace	  amounts	  of	  nickel	  (1-­‐4%	  nickel	  in	  86%	  cobalt)	  are	  present	  in	  this	  material.	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cyclization	  event	  because	  of	   the	   intervention	  of	  Raney-­‐nickel-­‐mediated	  reduction	  of	  the	  CΫC	  double	  bond.	  	  	  
	  
	  
Catalyst	   Yield	  of	  	  compound	  102	  
Yield	  of	  	  
compound	  107	  Raney-­‐cobalt	   85%	   Not	  observed	  Raney-­‐nickel	   48%	   24%	  Raney	  2724	   65%	   15%	  
	  
Scheme	  2-­‐13.	  Comparison	  of	  Raney	  catalysts	   in	  the	  reductive	  cyclization	  reaction.	  Reagents	   and	   conditions:	   (i)	   Catalyst	   (200	   wt%,	   see	   Table),	   H2	   (1	   atm),	   p-­‐TsOHyH2O,	  MeOH,	  40	  oC,	  6	  h.	  	  	  These	  results	  further	  demonstrate	  the	  seemingly	  unique	  ability	  of	  Raney-­‐cobalt	  to	  chemoselectively	   reduce	   nitrile	   and	   nitro	   residues	   while	   preserving	   CΫC	   double	  bonds	  and	  thus	  allowing	  for	  the	  efficient	  conversion	  of	  the	  Ƚ-­‐aryl	  enone	  101	  into	  tetracycle	  102.	  	  	  
2.2.5.	   End-­‐game:	  Installation	  of	  the	  final	  ring	  
	  With	  compound	  102	   in	  hand	  attention	   turned	   to	  effecting	  E-­‐ring	  annulation	  and	  thereby	  completing	  the	  synthesis	  of	  the	  pentacyclic	  framework	  of	  limaspermidine.	  To	   this	  end,	   the	  ring	  annulation	  protocol	  developed	  by	  Toczko	  and	  Heathcock	   in	  their	   synthesis	   of	   the	   Aspidosperma	   alkaloids	   was	   pursued.	   This	   protocol	   was	  
ǯȋ±)-­‐aspidospermidine	  (as	  outlined	  in	  Chapter	  One,	  Scheme	  1-­‐10).	  Accordingly,	  and	  as	  shown	  in	  Scheme	  2-­‐14,	  amine	  
102	  Ƚ-­‐chloroacetyl	  chloride	   in	  the	  presence	  of	   triethylamine	  to	  
Ƚ-­‐chloroacetamide	  108	  (60%	  yield).	  This	  last	  compound	  was	  then	  subjected	  to	   a	   Finkelstein	   reaction	   (using	   sodium	   iodide	   in	   acetone)	   in	   which	   the	  chloroacetamide	   residue	   was	   converted	   into	   its	   iodide	   counterpart.	   Following	  workup	  the	  thus	  obtained	  iodide	  was	  immediately	  treated	  with	  silver(I)	  triflate	  in	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DCM	  so	  as	  to	  effect	  an	  intramolecular	  Friedal-­‐Crafts	  alkylation	  at	  C3	  of	  the	  indole	  residue	  and	  thus	   forming	  the	  lactam	  E-­‐ring.	  In	  this	  manner	  the	  pentacyclic	   imine	  
109	  was	  obtained	  in	  61%	  yield	  over	  the	  two	  steps	  involved.	  	  	  
	  	  
Scheme	  2-­‐14.	  Heathcock	  ring	  annulation	  protocol.	  Reagents	  and	  conditions:	  (i)	  Ƚ-­‐chloroacetyl	  chloride,	  NEt3,	  DCM,	  0	  to	  18	  oC,	  2	  h;	  (ii)	  NaI,	  acetone,	  reflux,	  2	  h;	  (iii)	  AgOTf,	  DCM,	  18	  oC,	  0.5	  h.	  	  	  In	  an	  effort	  to	  increase	  the	  yield	  of	  the	  product	  arising	  from	  this	  E-­‐ring	  annulation	  protocol,	  Ƚ-­‐bromoacetyl	  bromide	  was	  used	  as	  the	  acylating	  agent	  and	  so	  leading	  to	  the	   Ƚ-­‐bromoacetamide	   110.	   However,	   direct	   treatment	   of	   the	   latter	   compound	  with	  silver(I)	  triflate	  only	  afforded	  pentacyle	  109	  in	  31%	  yield	  (Scheme	  2-­‐15).	  	  	  
	  
	  
Scheme	   2-­‐15.	   Ring	   annulation	   with	   Ƚ-­‐bromoacetamide	   110.	   Reagents	   and	  conditions:	  (i)	  AgOTf,	  DCM,	  18	  oC,	  0.5	  h.	  	  	  Different	   solvents	   were	   also	   screened,	   and	   DCM	  was	   found	   to	   provide	   the	   best	  result.	  The	  use	  of	   THF	  as	   the	   reaction	   solvent	   resulted	   in	   inseparable	   impurities	  while	  no	  reaction	  was	  observed	  when	   the	  cyclization	  was	   attempted	   in	  MeCN	  or	  MeOH.	   Heating	   the	   reaction	   in	   various	   refluxing	   solvents	   only	   gave	   complex	  mixtures	  of	  products.	  As	  such,	  it	  was	  concluded	  that	  the	  E-­‐ring	  annulation	  process	  could	  only	  be	  carried	  out	  at	  ambient	  temperatures.	  Of	   the	  various	  silver	  reagents	  screened,	   silver(I)	   tetrafluoroborate	   (AgBF4)	   gave	   similar	   results	   to	   those	  observed	   using	   silver(I)	   triflate,	   although	   the	   highly	   hygroscopic	   nature	   of	   the	  former	   silver	   salt	   renders	   its	   use	   inconvenient.	   No	   reaction	  was	   observed	  when	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silver(I)	   carbonate	  was	  employed,	  presumably	  due	   to	   its	   lack	  of	   solubility	   in	   the	  relevant	  organic	  solvents.	  	  	  
2.2.6.	   Global	  reduction	  
	  With	   the	   complete	   framework	  of	   limaspermidine	   (2)	   in	  place,	   efforts	   focused	  on	  effecting	   a	   global	   reduction	   of	   pentacycle	   109	   and	   thereby	   completing	   the	  synthesis	  of	  the	  target	  natural	  product.	  This	  process	  would	  require	  simultaneous	  removal	  of	  the	  lactam	  carbonyl,	  reduction	  of	  the	  imine	  moiety	  as	  well	  as	  reduction	  of	  the	  N,N-­‐dimethyl	  amide	  residue	  to	  reveal	  the	  required	  primary	  alcohol.	  In	  a	  first	  attempt	  to	  effect	  such	  a	  global	  reduction	  process,	  pentacycle	  109	  was	  treated	  with	  LiAlH4	  in	  refluxing	  THF.	  As	  a	  result	  tertiary	  amine	  111	  was	  obtained	  (65%)	  as	  the	  major	  product	  of	  the	  reaction.	  This	  result	  was	  unsurprising	  as	  LiAlH4	  is	  known	  to	  reduce	   tertiary	   amides	   to	   the	   corresponding	   amines	   via	   CΫO	   bond	   cleavage.	   In	  contrast,	   when	   LiEt3BH	   was	   employed	   as	   the	   reducing	   agent	   then	   a	   complex	  mixture	  of	  unidentifiable	  compounds	  was	  obtained	  (Scheme	  2-­‐16).	  	  	  
	  	  
Scheme	   2-­‐16.	   Failed	   attempts	   at	   global	   reduction.	   Reagents	   and	   conditions:	   (i)	  LiEt3BH,	  THF,	  18	  oC,	  16	  h;	  (ii)	  LiAlH4,	  THF,	  reflux,	  16	  h.	  	  	  In	   1994,	   Singaram	   and	   co-­‐workers	   introduced34	   lithium	   aminoborohydrides	  (LABs)	   as	   selective	   reducing	   agents.	   According	   to	   their	   studies,	   tertiary	   amides	  could	  be	  reduced	  selectively	  to	  either	  the	  corresponding	  tertiary	  amine	   (112)	  or	  alcohol	   (113)	   depending	   on	   the	   steric	   environment	   of	   the	   amine	   portion	   of	   the	  particular	  LAB	  reagent	  employed	  (the	  mechanistic	  origins	  of	  such	  selectivities	  are	  shown	  in	  Scheme	  2-­‐17).	  The	  selectivity	  of	  the	  reduction	  centres	  on	  the	  fate	  of	  the	  intermediate	  114,	   resulting	   from	   initial	   reduction	  of	   the	  amide.	  This	   species	   can	  react	   by	   one	   of	   two	   pathways	   and	   so	   affording	   either	   an	   amine-­‐	   or	   alcohol-­‐containing	   product.	   In	   the	   first	   pathway,	   the	   intermediate	   115	   is	   formed	   and,	  following	   expulsion	   of	   the	   lithium	   dihydroaminoborinate	   residue,	   the	   iminium	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species	   116	   is	   generated.	   Rapid	   reduction	   of	   the	   iminium	   group	   to	   the	  corresponding	  amine	   then	   follows	   to	  deliver	   amines	  of	   the	  general	   form	  112.	   In	  the	  second	  pathway,	  complexation	  of	   the	  aminoborane	  to	  the	  nitrogen	   forms	  the	  ammonium	   moiety	   117,	   rendering	   it	   a	   good	   leaving	   group	   and	   such	   that	   the	  diaminodihydridoborohydride	  moiety	  is	  expelled	  to	  provide	  aldehyde	  118	  that	  is	  itself	  reduced	  to	  the	  corresponding	  alcohol	  113.	  	  	  Significantly,	   when	   LAB	   reagents	   are	   used,	   ring-­‐cleavage	   of	   lactam	   rings	   is	   not	  observed	  and	  so	  reduction	  of	  such	  moieties	  with	  these	  reagents	  only	  results	  in	  the	  corresponding	  cyclic	  amines.35	  As	  such,	  these	  reagents	  seemed	  appropriate	  for	  the	  present	  purposes.	  	  	  
	  	  
Scheme	  2-­‐17.	  Selective	  reduction	  of	  amides	  using	  LABs.	  	  	  In	   the	   event	   (Scheme	   2-­‐18),	   when	   compound	   109	   was	   treated	   with	   lithium	  dimethylaminoborohydride	   (LiH3BNMe2)	   in	   refluxing	   THF,	   a	   mixture	   of	   two	  compounds	  was	  obtained.	  Although	  the	  desired	  alcohol	  2	  (ie	  limaspermidine)	  was	  isolated	  in	  36%	  yield,	  amine	  111	  was	  also	  isolated	  in	  39%	  yield.	  It	  was	  anticipated	  that	  by	  reducing	  the	  steric	  bulk	  of	  the	  amine	  component	  of	  the	  LAB	  reducing	  agent,	  CΫN	  bond	  cleavage	  would	  be	  favoured.	  Gratifyingly,	  when	  the	  parent	  LAB	  reagent,	  
viz	  lithium	  amidoborohydride	  (LiH3BNH2),	  was	  employed	  and	  the	  reaction	  carried	  out	  at	  room	  temperature,	  then	  the	  desired	  global	  reduction	  occurred	  and	  thereby	  providing	  (±)-­‐limaspermidine	  (2)	  in	  60%	  yield	  (Scheme	  2-­‐18).	  Essentially	  none	  of	  the	  corresponding	  amine	  111	  was	  observed.	  The	  spectroscopic	  data	  acquired	  on	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compound	  2	  were	  in	  complete	  accord	  with	  those	  reported	  by	  Overman5	  (Table	  2-­‐1),	  and	  the	  structure	  of	  this	  product	  was	  confirmed	  by	  single-­‐crystal	  X-­‐ray	  analysis	  (Figure	  2-­‐3).	  	  	  
	  
	  
Reagent/Conditions	   Yield	  of	  	  amine	  111	  
Yield	  of	  
(±)-­‐limaspermidine	  (2)	  LiH3BHNMe2,	  THF,	  reflux,	  16	  h	   39%	   36%	  LiH3BNH2,	  THF,	  18	  oC,	  16	  h	   Not	  observed	   60%	  
	  
Scheme	  2-­‐18.	  Outcome	  of	  the	  global	  reduction	  of	  compound	  109	  using	  differing	  
LAB	  reagents.	  	  	  	  
	  	  
Figure	  2-­‐3.	  ORTEP	  derived	  from	  the	  single-­‐crystal	  X-­‐ray	  analysis	  of	  
(±)-­‐limaspermidine	  (2)	  (with	  labelling	  of	  non-­‐hydrogen	  atoms).	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Table	   2-­‐1.	   Comparison	   of	   the	   13C	  NMR	  data	   recorded	   on	   compound	  2	  with	   those	  
reported10	  by	  Overman.	  	  
Compound	  (±)-­‐2	  	  
obtained	  in	  this	  worka	  
ɁC	   ǯ	  materialb	  ɁC	   ȟɁC	  149.5	   149.4	   +0.1	  135.3	   135.2	   +0.1	  127.4	   127.3	   +0.1	  122.7	   122.7	   0.0	  119.2	   119.2	   0.0	  110.5	   110.5	   0.0	  70.7	   70.7	   0.0	  65.3	   65.3	   0.0	  58.6	   58.6	   0.0	  53.7	   53.7	   0.0	  53.4	   53.4	   0.0	  52.8	   52.8	   0.0	  40.5	   40.5	   0.0	  38.6	   38.5	   +0.1	  35.4	   35.4	   0.0	  29.7	   29.7	   0.0	  28.2	   28.2	   0.0	  24.3	   24.2	   +0.1	  21.7	   21.7	   0.0	  adata	  obtained	  at	  200	  MHz	  in	  CDCl3	  bdata	  obtained	  at	  125	  MHz	  in	  CDCl3	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2.3.	   Synthesis	  of	  (±)-­‐1-­‐Acetylaspidoalbidine:	  Oxidative	  Cyclization	  	  In	   deriving	   (±)-­‐1-­‐acetylaspidoalbidine	   (3)	   from	   (±)-­‐limaspermidine	   (2),	   it	   was	  anticipated	   that	   the	   required	   N,O-­‐ketal	   unit	   could	   be	   formed	   via	   a	   process	  involving	  initial	  oxidation	  of	  the	  CΫN	  bond	  at	  C19	  within	  the	  N-­‐acetyl	  derivative	  of	  the	  latter	  compound	  so	  as	  to	  generate	  the	  iminium	  ion	  119,	  the	  activated	  carbon	  of	  which	   would	   be	   attacked,	   in	   situ,	   by	   the	   pendant	   C21	   hydroxyl	   group	   and	   so	  generating	  the	  target	  F-­‐ring	  of	  compound	  3	  (Scheme	  2-­‐19).	  	  	  	  
	  	  
Scheme	  2-­‐19.	  End-­‐game	  strategy	  for	  the	  synthesis	  of	  (±)-­‐1-­‐acetylaspidoalbidine	  (3).	  	  	  To	   such	   ends,	   (±)-­‐limaspermidine	   (2)	   was	   first	   treated	   with	   Ac2O	   in	   DCM	   to	  furnish	   the	   N-­‐acetylated	   product	   120,	   the	   substrate	   required	   for	   the	   proposed	  oxidative	   cyclization	   reaction.	   In	   efforts	   to	   effect	   the	   pivotal	   transformation,	  various	  oxidants	  were	  screened	  and	  the	  outcomes	  of	  such	  studies	  are	  summarized	  in	  Scheme	  2-­‐20.	  	  	   	  




Reagents/Conditions	   Outcome	  1.	  Tropylium	  tetrafluoroborate,	  MeCN,	  18	  oC	  or	  reflux	   NR	  2.	  K3Fe(CN)6	  a)	  base:	  NaHCO3,	  solvent:	  t-­‐BuOH/H2O	  b)	  base:	  NaH,	  solvent:	  DMSO/THF	  c)	  base:	  2	  M	  KOH,	  solvent:	  MeOH	   NR	  3.	  ClO2,	  H2O,	  0	  to	  18	  oC	   NR	  4.	  H2O2,	  MeOH,	  18	  oC;	  then	  trifluoroacetic	  anhydride,	  DCM,	  0	  to	  18	  oC	   NR	  NR	  =	  No	  reaction	  
	  
Scheme	  2-­‐20.	  Acetylation	  of	  (±)-­‐limaspermidine	  (2)	  and	  attempts	  to	  effect	  oxidative	  
cyclization	  of	  acetamide	  120.	  Reagents	  and	  conditions:	  (i)	  Ac2O,	  DCM,	  18	  oC,	  1	  h.	  	  	  Encouraged	  by	  the	  reports	  of	  Lambert	  and	  co-­‐workers36	  Ƚ-­‐cyanation	  of	  tertiary	  amines	  mediated	  by	  tropylium	  ion,	  compound	  120	  was	  treated	  (Entry	  1)	   with	   tropylium	   tetrafluoroborate	   in	   MeCN.	   However,	   no	   evidence	   for	   the	  formation	   of	   iminium	   species	   119	   or	   cyclized	   product	   3	   was	   obtained.	   In	   their	  pioneering	   work	   on	   the	   synthesis	   of	   (+)-­‐aspidophytine	   (121),	   Corey	   and	   co-­‐workers	  successfully	  effected37	  an	  oxidative	  lactonization	  of	  amino	  acid	  122	  via	  a	  single-­‐electron	  transfer	  (SET)	  process	  using	  potassium	  ferricyanide	  (Scheme	  2-­‐21)	  and	  employing	  a	  weak	  base	  to	  deprotonate	  the	  acid	  residue	  and	  with	  the	  ensuing	  carboxylate	  residue	  adding,	  in	  a	  nucleophilic	  manner,	  to	  the	  cationic	  carbon	  centre	  of	   the	   ferricyanide-­‐oxidized	   CΫN	   bond.	   The	   lactone	   123	   was	   thus	   obtained	   in	  excellent	  yield.	  	   	  





of	   (+)-­‐aspidophytine	   (121).	   Reagents	   and	   conditions:	   (i)	   K3Fe(CN)6,	   NaHCO3,	   t-­‐BuOH/H2O	  (1:2),	  18	  oC,	  0.15	  h.	  	  	  In	   contrast,	  when	   substrate	  120	   was	   subjected	   to	   the	   same	   reaction	   conditions,	  only	   starting	   material	   was	   recovered.	   Although	   the	   CΫN	   bond	   was	   presumably	  readily	   oxidized	   by	   potassium	   ferricyanide,	   a	   stronger	   base	   was	   required	   to	  deprotonate	  the	  hydroxyl	  group	  that	  would	  be	  much	  less	  acidic	  than	  the	  carboxylic	  acid	   residue	   associated	   with	   substrate	   122.	   Various	   bases	   and	   solvents	   were	  screened	  in	  an	  effort	  to	  effect	  this	  transformation	  but	  all	  to	  no	  avail	  (Entry	  2).	  	  Other	  methods	  investigated	  included	  a	  chlorine	  dioxide	  amine	  oxidation	  method38	  (Entry	   3),	   as	   well	   as	   a	   modified	   Polonovski	   protocol39	   reported	   by	   Lounasmaa	  (Entry	  4)	  whereby	  imine	  formation	  could	  be	  effected	  via	  generation	  of	  an	  N-­‐oxide	  using	   hydrogen	   peroxide.	   Disappointingly,	   no	   evidence	   for	   the	   formation	   of	   any	  cyclized	  products	  was	  obtained	  when	  these	  methods	  were	  employed.	  	  On	  the	  basis	  of	  the	  foregoing	  results,	  it	  was	  clear	  that	  the	  only	  obvious	  means	  for	  
         ǯprotocol	   as	   used	   in	   their	   syntheses	   of	   (±)-­‐fendleridine	   and	   (±)-­‐1-­‐acetylaspidoalbidine	   (see	   preceding	   Chapter).	   To	   implement	   this	   protocol,	  compound	  120	  was	   treated	  with	   stoichiometric	   excess	   of	  mercury(II)	   acetate	   in	  5%	  aq.	  AcOH	  at	  75	  °C	  for	  16	  h.	  In	  this	  manner,	  (±)-­‐1-­‐acetylaspidoalbidine	  (3)	  was	  finally	   obtained	   in	   30%	   yield	   from	   substrate	   120	   (Scheme	   2-­‐22).	   The	   1H	   NMR	  spectral	  data	  acquired	  on	  compound	  3	  were	  in	  full	  agreement	  with	  those	  reported	  for	  the	  naturally	  derived11	  material	  (Table	  2-­‐2).	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Scheme	   2-­‐22.	   ǯ  method.	   Reagents	   and	   conditions:	   (i)	  Hg(OAc)2,	  5%	  AcOH/H2O,	  75	  oC,	  16	  h.	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Table	  2-­‐2.	  Comparison	  of	  the	  1H	  NMR	  data	  recorded	  on	  compound	  3	  with	  those	  
reported	  for	  1-­‐acetylaspidoalbidine.	   	  
	  	  	  
Position	   Naturala	  Ɂ,	  ppm	  (multiplicity,	  J,	  Hz)	   Syntheticb*	  Ɂ,	  ppm	  (multiplicity,	  J,	  Hz)	  4	   8.1	  (dd,	  J	  =	  7.7,	  1.3	  Hz,	  1H)	   8.14	  (d,	  J	  =	  7.6	  Hz,	  1H)	  1	   7.6	  (dd,	  J	  =	  7.7,	  1.3	  Hz,	  1H)	   7.59	  (d,	  J	  =	  7.6	  Hz,	  1H)	  2	   7.2	  (td,	  J	  =	  7.7,	  1.3	  Hz,	  1H)	   7.19	  (t,	  J	  =	  7.6	  Hz,	  1H)	  3	   7.1	  (td,	  J	  =	  7.7	  Hz,	  1H)	   7.05	  (td,	  J	  =	  7.2,	  1.2	  Hz,	  1H)	  11	   4.15	  (t,	  J	  =	  10.8	  Hz,	  1H)	   4.17	  (t,	  J	  =	  8.4	  Hz,	  1H)	  
ͳͳǯ	   4.05	  (ddd,	  J	  =	  10.8,	  8.2,	  6.0	  Hz,	  1H)	   4.09	  (m,	  1H)	  14	   3.85	  (dd,	  J	  =	  10.6,	  5.8	  Hz,	  1H)	   3.86	  (dd,	  J	  =	  10.4,	  5.2	  Hz,	  1H)	  6	   3.0	  (td,	  J	  =	  8.5,	  4.3	  Hz,	  1H)	   3.02	  (td,	  J	  =	  8.8,	  4.4	  Hz,	  1H)	  
͸ǯ	   2.9	  (m,	  1H)	   2.92	  (m,	  1H)	  7	   2.8	  (td,	  J	  =	  8.5,	  4.3	  Hz,	  1H)	   2.79	  (tm,	  J	  =	  11.6	  Hz,	  1H)	  
͹ǯ	   2.6	  (m,	  1H)	   2.65	  (dm,	  J	  =	  10.8	  Hz,	  1H)	  
ͳͷǯ	   2.3	  (s,	  3H)	   2.26	  (s,	  3H)	  5	   2.1-­‐1.6	  (m,	  8H)	   2.09	  (m,	  1H)	  
ͷǯǡͳʹǡͳ͵ǡ
ͳ͵ǯǡͳͲǡͺǡͻǯ	   	   1.98-­‐1.68	  (m,	  7H)	  8	   1.55	  (m,	  1H)	   1.55	  (overlapping	  H2O	  signal)	  
ͳʹǯ	   1.45	  (dt,	  J	  =	  13.7,	  3.5	  Hz,	  1H)	   1.43	  (dt,	  J	  =	  14.0,	  4.0	  Hz,	  1H)	  
ͻǯ	   1.35	  (br	  d,	  J	  =	  8.0	  Hz,	  1H)	   1.38	  (br	  d,	  J	  =	  10.8	  Hz,	  1H)	  
ͳͲǯ	   1.25	  (dd,	  J	  =	  12.0,	  6.0	  Hz,	  1H)	   1.26	  (m,	  1H)	  adata	  obtained	  at	  300	  MHz	  in	  CDCl3	  bdata	  obtained	  at	  400	  MHz	  in	  CDCl3	  *major	  rotamer	  (1:0.2)	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2.4.	   A	  Possible	  Asymmetric	  Approach	  	  With	   protocols	   for	   the	   synthesis	   of	   both	   (±)-­‐limaspermidine	   (2)	   and	   (±)-­‐1-­‐acetylaspidoalbidine	   (3)	   in	   hand,	   the	   potential	   for	   accessing	   enantiomerically	  enriched	  materials	  was	  considered.	  One	  approach	  would	   involve	  establishing	   the	  relevant	  absolute	  stereochemistry	  early	  in	  the	  synthetic	  sequence	  by	  carrying	  out	  the	   epoxidation	   of	   cyclohexenone	   91	   in	   an	   asymmetric	   fashion	   using	   chiral	  aminocatalysts	   (Scheme	   2-­‐23).	   An	   extensive	   study	   on	   this	   matter	   has	   been	  reported	  by	  List	  and	  co-­‐workers.40	  	  	  	  
	  	  
Scheme	  2-­‐23.	  Access	  to	  chiral	  building	  blocks	  from	  the	  asymmetric	  epoxidation	  of	  
cyclohexenone	  91.	  	  	  Merging	  ǯwith	  the	  synthetic	  route	  just	  described,	  cyclohexenone	  91	  was	   epoxidized	   enantioselectively	   following	   the	   reported	   protocol40	   using	   the	  trifluoroacetate	   salt	   of	   9-­‐amino-­‐9-­‐deoxyepiquinine	   (124)	   as	   catalyst	   (Scheme	   2-­‐24).	   In	   this	  way,	   the	  (+)-­‐enantiomer	  of	  compound	  92	  was	  obtained	   in	  92%	  ee	  as	  determined	  by	  chiral	  GC	  analysis.	  The	  reactions	  following	  this	  conversion,	  namely	  the	   xanthate	   radical	   addition	   and	   Eschenmoser-­‐Claisen	   rearrangement	   steps,	  should	   then	   predictably	   convert	   the	   resulting	   chiral	   allylic	   alcohol	   into	   the	  corresponding	  enantiopure	  unsaturated	  amides,31	  the	  chirality	  of	  which	  should,	  in	  principle,	   be	   translated	   throughout	   the	   above-­‐mentioned	   synthetic	   sequence	   to	  furnish	  the	  natural	  product	  in	  enantiomerically	  enriched	  form.	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Scheme	   2-­‐24.	   Asymmetric	   epoxidation	   of	   cyclohexenone	   91.	   Reagents	   and	  conditions:	  (i)	  catalyst	  124	  (10	  mol%),	  H2O2	  (30%	  aq.),	  1,4-­‐dioxane,	  40	  oC,	  1	  h.	  	  	  	  
2.5.	   Conclusion	  
	  The	  work	  detailed	  above	  has	  provided	  an	  efficient,	  protecting	  group-­‐free	  synthesis	  of	   the	   Aspidosperma	   alkaloids	   (±)-­‐limaspermidine	   (2)	   and	   (±)-­‐1-­‐acetylaspidoalbidine	   (3).	   This	   constitutes	   the	   most	   concise	   approach	   to	   either	  alkaloid	  (11	  linear	  steps)	  reported	  thus	  far	  (see	  Scheme	  2-­‐25	  for	  a	  summary).	  The	  key	   step	   was	   the	   Raney-­‐cobalt-­‐mediated	   tandem	   reductive	   cyclization	   of	  compound	  101	   in	  which	   the	  B-­‐	   and	  D-­‐rings	   of	   the	   target	   natural	   products	  were	  formed	  in	  a	  completely	  chemo-­‐	  and	  stereo-­‐selective	  fashion,	  and	  thus	  allowing	  for	  the	  rapid	  construction	  of	  the	  ABCD-­‐substructure	  associated	  with	  the	  Aspidosperma	  alkaloids.	   Furthermore,	   the	   protocols	   reported	   here	   should	   be	   amenable	   to	   the	  enantioselective	  synthesis	  of	  either	  the	  (+)-­‐	  or	  (Ϋ)-­‐forms	  of	  the	  title	  alkaloids	  given	  the	   now	   ready	   availability	   of	   both	   (S,S)-­‐	   and	   (R,R)-­‐configured	   cyclohexanone	  epoxides	   and	   the	   capacity	   of	   the	   Eschenmoser-­‐Claisen	   reaction	   to	   faithfully	  convert,	   in	   a	   predictable	   manner,31	   chiral	   non-­‐racemic	   allylic	   alcohols	   into	   the	  corresɀǡɁ-­‐unsaturated	  amides.	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Scheme	  2-­‐25.	  Summary	  of	  the	  key	  aspects	  of	  the	  reported	  total	  syntheses	  of	  (±)-­‐
limaspermidine	  (2)	  and	  (±)-­‐1-­‐acetylaspidoalbidine	  (3).	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Chapter Three. 
Extensions of the Raney-Cobalt-Mediated Tandem Reductive 
Cyclization Protocol: Attempted Application to the Synthesis of 
the Kopsia Alkaloid Kopsihainanine A 	  	  Having	  established	  a	  method	  for	  the	  ready	  assembly	  of	  tetracyclic	  indoles	  such	  as	  compound	  102	  using	   a	  Raney-­‐cobalt-­‐mediated	   tandem	   reductive	   cyclization	   and	  successfully	   applying	   this	   to	   the	   total	   syntheses	   of	   limaspermidine	   (2)	   and	   1-­‐acetylaspidoalbidine	  (3),	  its	  application	  to	  the	  synthesis	  of	  other	  natural	  products	  became	   the	   next	   focus	   of	   the	   studies	   reported	   herein.	   The	   recently	   isolated41	  
Kopsia	  alkaloid	  kopsihainanine	  A	  (125)	  (Scheme	  3-­‐1)	  was	  chosen	  as	  a	  new	  target	  for	   its	   structural	   similarities	   to	   the	   ABCD-­‐tetracyclic	   substructure	   of	   the	  
Aspidosperma	  alkaloids	   and	   thus	   raising	   the	   possibility	   of	   developing	   a	   route	   to	  this	  natural	  product	  from	  the	  common	  intermediate	  102.	  	  	  
	  	  
Scheme	  3-­‐1.	  Potential	  for	  divergent	  syntheses	  of	  limaspermidine	  (2)	  and	  
kopsihainanine	  A	  (125)	  via	  the	  common	  tetracyclic	  intermediate	  102.	  
	  	  The	   critical	   difference	   in	   the	   structural	   frameworks	  of	   kopsihainanine	  A	   and	   the	  alkaloids	  of	   the	  Aspidosperma	   class	   is	   the	  relative	  stereochemistry	  about	   the	  CD-­‐ring	   junction	   -­‐	   kopsihainanine	  A	   embodies	  a	   trans-­‐fused	  octahydroquinoline	  CD-­‐ring	   embedded	   within	   its	   tetracyclic	   substructure,	   while	   in	   the	   Aspidosperma	  alkaloids	   the	   equivalent	   junction	   is	   cis-­‐configured.	   Furthermore,	   the	   differing	  mode	   of	   E-­‐ring	   annulation	   to	   the	   ABCD-­‐scaffold	   also	   poses	   significant	   synthetic	  challenges.	  In	  limaspermidine	  (2)	  the	  E-­‐ring	  is	  fused	  to	  the	  indoline	  moiety,	  while	  in	  kopsihainanine	  A	  (125)	  the	  E-­‐ring	  embodies	  an	  Ƚ-­‐hydroxy	  lactam	  that	  extends	  from	  the	  nitrogen	  of	   the	  octahydroquinoline	  residue	  to	  the	  remote	  carbon	  of	   the	  CD-­‐ring	  junction	  and	  so	  resulting	  in	  a	  rather	  strained	  caged	  structure.	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3.1.	   Introduction	  to	  the	  Kopsia	  Alkaloids	  
	  
	  
	  The	   novel	   monoterpenoid	   alkaloid	   kopsihainanine	   A	   (125)	   as	   well	   as	   the	  biogenetically	   related	  kopsihainanine	  B	   (126)	  were	   isolated	   in	  2011	  by	  Gao	  and	  co-­‐workers41	  from	  the	  leaves	  and	  stems	  of	  Kopsia	  hainanensis,	  a	  plant	  native	  to	  the	  Hainan	  Province	  of	  China.	  While	  this	  species	  of	  evergreen	  shrub	  has	  been	  used	  in	  folk	  medicine	   for	   the	  treatment	  of	  dropsy,	  pharyngitis,	   tonsillitis	  and	  rheumatoid	  arthritis,	   broader	   pharmacological	   investigations	   on	   the	   Kopsia	   alkaloids	   have	  revealed	   other	   promising	   bioactivities.	   In	   particular,	   they	   display	   antitumor,	  antimitotic,	   antileishmanial	   and	   antitussive	   properties.41	   Of	   interest	   to	   the	  synthesis	   chemist	   is	   the	   strained	   pentacyclic	   6/5/6/6/6-­‐ring	   framework	   of	  kopsihainanine	   A	  which	   also	   features	   a	   novel	   C6-­‐N4	   connection	   involving	   an	   Ƚ-­‐hydroxy	   lactam	  E-­‐ring,	  and	  a	   trans-­‐fused	  CD-­‐ring	   junction.	  As	  such	  the	  structural	  framework	  of	   this	  alkaloid	   is	  unique.	  Kopsihainanine	  A	   is	   thought	  to	  arise	   in	  vivo	  from	   the	   fragmentation	   of	   kopsihainanine	   B	   (Scheme	   3-­‐2).41	   Specifically,	  decarboxylative	  fragmentation	  of	  natural	  product	  126	  would	  lead	  to	  the	  formation	  of	  the	  tetracyclic	  enone	  127	  now	  embodying	  an	  indole	  moiety.	  Oxidative	  fission	  of	  
   Ƚ-­‐ketoaldehyde	  
128	  and	  internal	  condensation	  of	  the	  secondary	  amine	  with	  the	  pendant	  aldehyde	  
Ƚ-­‐ketoaminal	  129	  that	  upon	  keto-­‐enol	  tautomerisation	  would	   collapse,	   via	   the	   bis-­‐enol	   intermediate	   130,	   to	   deliver	   kopsihainanine	   A	  (125).	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Scheme	  3-­‐2.	  The	  proposed	  biosynthetic	  pathway	  leading	  to	  kopsihainanine	  A	  (125)	  
from	  co-­‐occurring	  kopsihainanine	  B	  (126).	  
	  
	  Due	   to	   the	   limited	  amounts	  of	  material	   available	   from	  natural	   sources,	   intensive	  pharmacological	  profiling	  of	  compounds	  125	  and	  126	  has	  yet	  to	  be	  carried	  out.	  As	  such	  the	  development	  of	  efficient	  total	  syntheses	  of	  these	  natural	  products	  would	  be	  advantageous.	  
	  
	  
3.2.	   Synthetic	  Routes	  to	  Kopsihainanine	  A	  
	  The	   abovementioned	   and	   distinctive	   structural	   features	   of	   the	   Kopsia	  alkaloids	  
125	   and	   126	   pose	   considerable	   synthetic	   challenges.	   As	   a	   consequence	   these	  compounds	   have	   rapidly	   attracted	   the	   attention	   of	   synthetic	   organic	   chemists.	  Since	   the	   outset	   of	   our	   synthetic	   studies	   on	   kopsihainanine	   A	   there	   have	   been	  three	  reports	  on	  the	  total	  synthesis	  of	  this	  alkaloid.	  One	  formal	  total	  synthesis	  has	  also	   been	   described.	   The	   key	   steps	   associated	  with	   each	   of	   these	   syntheses	   are	  presented	  immediately	  below.	  
	  
	  
3.2.1	   ǯȋ±)-­‐kopsihainanine	  A	  
	  Shortly	  after	  the	  author	  commenced	  synthetic	  work	  on	  kopsihainanine	  A	  in	  2012,	  She	  and	  co-­‐workers	  reported42	  the	  first	  total	  synthesis	  of	  the	  racemic	  modification	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of	  the	  alkaloid	  (Scheme	  3-­‐3).	  Their	  strategy	  involved	  a	  one-­‐pot	  and	  acid-­‐catalyzed	  conjugate	  addition	  reaction	  involving	  ketoamide	  132	  as	  substrate	  which	  was	  itself	  derived	  from	  the	  commercially	  available	  carbazolone	  131.	  In	  the	  first	  ring-­‐closing	  step	   of	   the	   sequence,	   reduction	   of	   the	   ketone	   residue	   in	   compound	   132	   using	  LiAlH4	   followed	  by	   acid-­‐catalyzed	   dehydration	   of	   the	   resulting	   alcohol	  133	   gave	  iminium	  intermediate	  134.	  The	  primary	  amide	  residue	  within	  the	  last	  compound	  then	  added,	  in	  situ	  and	  in	  a	  conjugate	  fashion,	  to	  the	  tethered	  iminium	  moiety	  and	  so	  forming	  tetracycle	  135	   in	  98%	  yield.	  Following	  elaboration	  of	  the	  olefinic	  side	  chain	   (through	   steps	   including	   hydroboration-­‐oxidation	   of	   the	   olefinic	   residue	  followed	  by	  mesylation	   of	   the	   resulting	   primary	   alcohol)	  within	   compound	  135,	  the	  ensuing	  mesylate	  136	  was	  subjected	  to	  an	   internal	  nucleophilc	  displacement	  reaction	  upon	  deprotonation	  of	  the	  secondary	  amide	  with	  NaH.	  By	  such	  means	  the	  pentacyclic	  compound	  137	  was	  obtained	  in	  31%	  over	  the	  three	  steps	  involved	  and	  thus	  establishing	  the	  skeletal	  framework	  of	  the	  target	  natural	  product.	  Finally,	  and	  following	  a	  non-­‐trivial	  Ƚ-­‐hydroxylation	  of	  the	  lactam	  moiety	  in	  compound	  137	  and	  indole	  deprotection	  of	  the	  benzyl	  protecting	  group	  (85%	  yield	  over	  the	  two	  steps	  involved),	   (±)-­‐kopsihainanine	   A	   (125)	   was	   obtained	   in	   12%	   overall	   yield	   from	  carbazolone	  131.	  	   	  




Scheme	  3-­‐3.	  ǯ(±)-­‐kopsihainanine	  A	  (125).	  Reagents	  and	  




3.2.2	   ǯȋ+)-­‐kopsihainanine	  A	  
	  Soon	   after	   publication	   of	   the	   She	   synthesis	   of	   kopsihainanine	   A,	   Lupton	   and	  Gartshore	   reported43	   methods	   for	   enantioselective	   and	   Pd-­‐catalyzed	  decarboxylative	   allylation	   as	   a	   means	   of	   obtaining	   a	   wide	   range	   of	   chiral	  carbazolones	   funtionalized	   at	   the	   carbon	   adjacent	   (alpha)	   to	   the	   ketone	   residue.	  Using	   this	   technology,	   and	   starting	   from	   the	   advanced	   intermediate	   137,	   they	  were	  able	  to	  synthesize	  carbazolone	  138	  in	  90%	  yield	  and	  94%	  ee	  using	  Pd2dba3	  as	  catalyst	  and	  compound	  139	  as	  the	  chiral	  ligand.	  Following	  manipulations	  of	  the	  nitrile	  moiety	  within	  product	  138,	  ketoamide	  132	  was	  acquired	  in	  94%	  yield	  over	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the	   two	   steps	   involved	   and	   thus	   intersecting	   with	   the	   advanced	   intermediate	  
ǯǤsynthesis	  of	  (+)-­‐kopsihainanine	  A	  (Scheme	  3-­‐4).	  	  	  
	  	  




3.2.3.	   ǯ(+)-­‐kopsihainanine	  A	  
	  Drawing	  inspiration	  from	  the	  biogenesis	  of	  kopsihainanine	  A	  as	  proposed	  by	  Gao,	  Mukai	  and	  co-­‐workers	  accomplished44	  the	  total	  synthesis	  of	  (+)-­‐kopsihainanine	  A	  using	   an	   asymmetric	   decarboxylative	   allylation	   protocol	   developed	   by	   Stoltz	   to	  achieve	   enantioselectivity	   (Scheme	   3-­‐5).	   In	   the	   key	   step	   of	   their	   synthesis,	  deprotection	   of	   lactam	  140	          ǯdecarboxylative	   allylation	   conditions	   (using	   the	   palladium	   catalyst	   derived	   from	  ligand	  142)	  afforded	   the	   lactam	  141	   in	  66%	  yield	  and	  71%	  ee.	  To	  assemble	   the	  ABCD-­‐tetracyclic	  core,	  compound	  141	  was	  treated	  with	  POCl3	  and	  thus	  engaging	  it	  in	   a	   BischlerΫNapieralski	   reaction.	   After	   reduction	   of	   the	   resulting	   iminium	   salt	  with	  NaBH4	  the	  tetracycle	  143	  was	  obtained	  as	  a	  single	  diastereomer	  in	  82%	  yield	  over	   the	   two	   steps	   involved.	   Protection	   of	   both	   the	   indole	   nitrogen	   and	   the	  secondary	   amine	   residues	   within	   this	   last	   compound	   with	   Boc2O	   and	   CbzCl,	  respectively,	   followed	   by	   dihydroxylation	   of	   the	   olefinic	   residue	   and	   subsequent	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deprotection	  of	  the	  Cbz-­‐protected	  secondary	  amine,	  afforded	  diol	  144.	  Compound	  
144	  was	  then	  oxidized,	  using	  IBX,	  and	  the	  resulting	  Ƚ-­‐ketoaldehyde	  spontaneously	  









3.2.4.	   ǯȋ±)-­‐kopsihainanine	  A	  
	  In	   a	   one-­‐pot	   and	   stereocontrolled	   process	   using	   an	   integrated	  oxidation/reduction/cyclization	   (iORC)	   sequence,	   Zhu	  and	   co-­‐workers	  were	   able	  to	  rapidly	  assemble45	  the	  pentacyclic	  core	  of	  kopsihainanine	  A	  (Scheme	  3-­‐6).	  Thus,	  the	   starting	   and	   readily	   accessible	   spirolactam	   146	   was	   subjected	   to	   oxidative	  cleavage	   via	   ozonolysis	   of	   the	   cyclopentene	   ring	   and	   so	   affording	   ketoaldehyde	  
147	  that	  is	  in	  tautomeric	  equilibrium	  with	  compound	  148.	  Reduction	  of	  the	  nitro	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residue	   within	   compound	   148	   under	   hydrogenolytic	   conditions	   using	   PtO2	   as	  catalyst	   produced	   indole	   149	   and	   following	   acidic	   workup	   the	   hydroxyl	   group	  eliminated	  to	   form	  the	  conjugated	   imine	  as	  embodied	  within	  tetracycle	  150.	  The	  amide	  nitrogen	  of	   this	   last	   compound	  added,	   in	  situ,	   to	   the	  pendant	  unsaturated	  iminium	   ion	   to	   furnish	   pentacycle	   151	   and	   so	   completing	   the	   assembly	   of	   the	  pentacyclic	  framework	  of	  the	  target	  natural	  product,	  which	  was	  obtained	  in	  63%	  yield	   from	   compound	   146.	   To	   complete	   the	   synthesis,	   a	   stereoselective	   Ƚ-­‐hydroxylation	  of	  the	  lactam	  residue	  within	  this	  last	  compound	  was	  effected	  using	  lithium	  dimethylamide	  (LDMA)	  as	  the	  base	  and	  bis(trimethylsilyl)peroxide	  as	  the	  oxidant.	   By	   such	  means	   (±)-­‐    ͻͳΨ Ǥ ǯsynthesis,	  comprising	  only	  nine	  linear	  steps,	  represents	  the	  shortest	  synthetic	  path	  to	  the	  title	  alkaloid	  reported	  thus	  far.	  	  	  
	  	  
Scheme	   3-­‐6.	   ǯ   (±)-­‐kopsihainanine	   A	   (125).	   Reagents	   and	  conditions:	  (i)	  O3ǡǡǡΫ͹ͺoC,	  then	  PPh3,	  18	  oC,	  0.5	  h,	  then	  PtO2,	  H2	  (1	  atm),	  MeOH,	  18	  oC,	  1.5	  h,	  then	  HCl	  (1	  M),	  50	  oC,	  1	  h;	  (ii)	  dimethylamine,	  HMPA,	  n-­‐
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3.3.	   Retrosynthetic	  Analysis	  
	  A	  possible	  approach	  to	  kopsihainanine	  A	  based	  on	  a	  strategy	  utilizing	  the	  readily	  available	   tetracyclic	   intermediate	   102	   described	   in	   the	   preceding	   Chapter	   is	  shown	  in	  retrosynthetic	  form	  in	  Scheme	  3-­‐7.	  	  	  
	  	  
Scheme	  3-­‐7.	  Retrosynthetic	  analysis	  of	  kopsihainanine	  A	  (125)	  that	  exploits	  
compound	  102	  as	  a	  precursor.	  	  	  Thus,	   as	   outlined	   in	   the	   preceding	   Chapter,	   an	   efficient	   Raney-­‐cobalt-­‐mediated	  tandem	   reductive	   cyclization	   process	   developed	   by	   the	   author	   results	   in	   the	  formation	   of	   the	   cis-­‐fused	   tetracycle	   102.	   However,	   it	   was	   envisaged	   that	   the	  presumably	   thermodynamically	   more	   stable	   trans-­‐fused	   congener	   could	   be	  accessed	   by	   inverting	   configuration	   at	   C21	   within	   compound	   102.	   The	   Ƚ-­‐hydroxylated	  lactam	  E-­‐ring	  of	  the	  natural	  product	  could	  then	  be	  installed	  using	  a	  protocol	   reported	  by	  Lounasmaa	  and	  co-­‐workers46	   in	   their	   synthesis	  of	   (±)-­‐17Ƚ-­‐	  and	   (±)-­‐17Ⱦ-­‐hydroxytacamonine.	   Specifically,	   and	   as	   illustrated	   in	   Scheme	   3-­‐8,	  they	  showed	  that	  direct	  nucleophilic	  addition	  of	  a	  cyano	  group	  derived	  from	  either	  KCN	   or	   TMSCN	   to	   aldehyde	   153	   provided	   cyanohydrin	   154	   that	   upon	   acid-­‐catalyzed	   hydrolysis	   of	   the	   nitrile	   residue	   engaged	   in	   a	   spontaneous	   (in	   situ)	  cyclization	   reaction	   of	   the	   carboxylic	   acid	   residue	   so-­‐formed	   onto	   the	   indole	  nitrogen.	  In	  this	  manner	  Ƚ-­‐hydroxylactam	  155	  was	  produced,	  as	  the	  sole	  reaction	  product,	  in	  a	  one-­‐pot	  addition/cyclization	  process.	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Scheme	  3-­‐8.	  ǯhydroxytacamonines.	  	  	  
	  
3.4.	   Synthetic	  Work	  
	  
3.4.1.	   Formation	  of	  the	  trans-­‐isomer,	  152,	  of	  compound	  102	  
	  During	   the	   course	   of	   efforts	   to	   identify	   reaction	   conditions	   that	   would	   provide	  compound	  152	   from	   its	   cis-­‐fused	   counterpart	  102ǡ   ǯ	   and	   co-­‐workers	  was	  uncovered.	  Specifically,	  in	  their	  total	  synthesis47	  of	  aspidospermidine	  (1)	   these	   researchers	   described	   the	   formation	   of	   the	   trans-­‐fused	   tetracycle	  157	  through	  reduction	  of	  the	  imine	  residue	  in	  compound	  156	  under	  various	  conditions	  (Scheme	  3-­‐9).	  	  	  
	  	  
Scheme	   3-­‐9.	   Exclusive	   formation	   of	   the	   trans-­‐fused	  decahydroquinoline	  157	   from	  
reduction	  of	   imine	  156.	  Reagents	   and	   conditions:	   NaBH3CN,	   AcOH,	   20	   oC,	   or	   H2,	  Pd/C,	  MeOH,	  or	  BH3-­‐Me2S	  complex,	  THF,	  20	  oC,	  or	  NaBH4,	  CeCl3,	  EtOH,	  20	  oC.	  	  	  They	   postulated	   that	   the	   trans-­‐stereochemistry	   was	   the	   result	   of	   the	   imine	  reduction	  taking	  place	  on	  the	  less	  sterically	  hindered	  Ɏ-­‐face	  anti	  to	  the	  ethyl	  side	  chain.	   This	   result	   suggests	   that	   inversion	   of	   the	   configuration	   about	   the	   CD-­‐ring	  junction	   could	   be	   achieved	   via	   formation	   of	   imine	   159	   from	   the	   cis-­‐fused	  intermediate	   102	   followed	   by	   its	   reduction.	   It	   was	   anticipated	   that	   imine	   159	  could	   be	   accessed	   by	   first	   attaching	   a	   ǲleaving	   groupǳ	   at	   the	   secondary	   amine	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residue	  within	   compound	  102	   (to	   give	   compound	  160)	  which	   upon	   elimination	  should	  provide	  the	  required	  imine	  (Scheme	  3-­‐10).	  	  	  
	  	  
Scheme	  3-­‐10.	  Retrosynthetic	  analysis	  associated	  with	  the	  formation	  of	  compound	  
158	  from	  its	  cis-­‐fused	  counterpart	  102.	  	  	  Attempts	   to	   implement	   this	   approach	   (Scheme	   3-­‐11)	   were	   made	   by	   treating	  compound	  102	  with	  N-­‐chlorosuccinimide	  in	  DCM	  (in	  the	  hope	  of	  chlorinating	  the	  free	  amine).	  However,	  upon	  workup	  and	  purification	  the	  anticipated	  chloro-­‐adduct	  
160	  was	  not	   isolated.	  Rather,	  a	  2:1	  mixture	  of	   the	   inseparable	  and	  regioisomeric	  imines	   159	   and	   161	   was	   obtained.	   The	   derived	   1H	   NMR	   spectrum	   is	   shown	   in	  Figure	   3-­‐1.	   This	   result	   implied	   that	   the	   initially	   formed	   N-­‐chloroamine	   readily	  engaged	   in	   a	   dehydrochlorination	   reaction	   under	   the	   conditions	   employed.	   This	  observation	   also	   suggested	   that	   the	   desired	   imine	   159	   was	   the	   more	  thermodynamically	  favored	  product,	  as	  might	  be	  anticipated	  due	  to	  its	  more	  highly	  conjugated	  and	  substituted	  nature.	  	  	   	  




Scheme	   3-­‐11.	   Formation	   of	   imine	   isomers	   159	   and	   161	   from	   compound	   102.	  Reagents	  and	  conditions:	  (i)	  NCS,	  DCM,	  0	  to	  18	  oC,	  3	  h.	  	  	  Bearing	  this	  selectivity	  in	  mind,	  it	  was	  anticipated	  that	  by	  subjecting	  the	  mixture	  of	  imines	  to	  base-­‐induced	  isomerization	  the	  yield	  of	  the	  conjugated	  imine	  159	  could	  be	   increased.	   Indeed,	   when	   the	   initially	   obtained	   mixture	   of	   these	   isomers	   was	  treated	  with	  potassium	  t-­‐butoxide	  in	  THF	  the	  isomeric	  ratio	  changed	  from	  1:0.5	  to	  1:0.2	  (Figure	  3-­‐2),	  with	  the	  major	  product	  now	  being	  the	  conjugated	  isomer	  159	  (Scheme	   3-­‐12).	   The	   ORTEP	   arising	   from	   the	   single	   crystal	   X-­‐ray	   analysis	   of	  compound	  159	  is	  shown	  in	  Figure	  3-­‐3	  and	  this	  served	  to	  confirm	  its	  structure.	  	   	  




Figure	  3-­‐1.	  400	  MHz	  1H	  NMR	  spectrum	  (in	  CD3OD)	  of	  imine	  mixture	  159	  and	  161	  




Figure	  3-­‐2.	  400	  MHz	  1H	  NMR	  spectrum	  (in	  CD3OD)	  of	  imine	  mixture	  159	  and	  161	  
after	  treatment	  with	  t-­‐BuOK.	  	  
	  	  62	  
	  
	  	  
Figure	  3-­‐3.	  ORTEP	  derived	  from	  the	  single-­‐crystal	  X-­‐ray	  analysis	  of	  
imine	  159	  (with	  labelling	  of	  non-­‐hydrogen	  atoms).	  	  Gratifyingly,	  when	   compound	  159	  was	   subjected	   to	   imine	   reduction	   (Scheme	  3-­‐12)	   under	   either	   Luche	   conditions	   or	   through	   hydrogenation	   in	   the	   presence	   of	  Pd/C,	  the	  trans-­‐isomer	  158	  was	  obtained	  as	  the	  sole	  product	  of	  the	  reaction.	  Such	  an	   outcome	   is	   in	   accord	    ǯǯ	   study.	   In	   an	   attempt	   to	   increase	   the	  efficiency	  of	  the	  chlorination/isomerization	  sequence,	  compound	  102	  was	  treated	  with	  N-­‐chlorosuccinimide	   in	   the	  presence	  of	  potassium	   t-­‐butoxide	   in	  the	  hope	  of	  effecting	   the	   two-­‐step	   sequence	   in	   a	   one-­‐pot	   process.	   However,	   under	   such	  conditions	  a	  mixture	  of	  inseparable	  products	  was	  observed.	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Scheme	  3-­‐12.	  Access	  to	  the	  trans-­‐	  congener	  via	  isomerization	  and	  reduction	  of	  the	  
imine	  mixture.	  Reagents	  and	  conditions:	  (i)	  t-­‐BuOK,	  THF,	  18	  oC,	  16	  h;	  (ii)	  H2,	  Pd/C,	  MeOH,	  18	  oC,	  0.5	  h,	  or	  NaBH4,	  CeCl3y7H2O,	  EtOH,	  18	  oC,	  0.15	  h.	  	  
	  
	  
3.4.2.	   An	  improved	  isomerization	  protocol	  
	  In	   a	   very	   useful	   protocol	   that	   remains	   distinctly	   underutilized,	   Larsen	   and	  Jørgensen	  reported48	  the	  successful	  oxidation	  of	  various	  secondary	  amines	  to	  the	  corresponding	  imines	  using	  iodosobenzene,	  an	  often-­‐overlooked	  periodinane	  that	  
ǲ-­‐transferǳcompounds	  and	  metal	  complexes.	  In	  the	  present	  context	  and	  in	  the	  first	  step	  of	  the	  oxidation	   process,	   the	   amine	  162,	   through	   its	   lone	   pair,	   nucleophilically	   attacks	  iodosobenzene	   (163)	   at	   iodine	   and	   so	   forming	   zwitterion	   164	   (Scheme	   3-­‐13).	  Collapse	  of	  this	   last	  species	  with	  loss	  of	  iodobenzene	  and	  water	  then	  leads	  to	  the	  product	  imine	  165.	  	  	  
	  	  
Scheme	  3-­‐13.	  Mechanism	  for	  the	  oxidation	  of	  amines	  to	  imines	  using	  
iodosobenzene.	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Although	   not	   commercially	   available,	   iodosobenzene	   is	   easily	   prepared49	   in	   two	  steps	   from	   iodobenzene	   by	   first	   oxidizing	   the	   parent	   compound	   to	   its	   diacetate	  derivative,	  then	  effecting	  cleavage	  of	  the	  associated	  acetate	  residues	  with	  sodium	  hydroxide.	  The	  thus-­‐formed	  iodosobenzene	  precipitates	  from	  the	  reaction	  mixture	  and	  can	  be	  collected	  by	  simple	  filtration.	  	  Gratifyingly,	   when	   compound	   102	   was	   treated	   with	   freshly	   prepared	  iodosobenzene	  in	  DCM	  at	  room	  temperature,	  and	  after	  removal	  of	  co-­‐products	  by	  filtration,	   imine	   159	   was	   obtained	   as	   the	   sole	   product	   in	   excellent	   yield.	   No	  evidence	  for	  the	  formation	  of	  isomer	  161	  was	  obtained.	  By	  removing	  the	  need	  for	  the	   isomerization	   process	   with	   potassium	   t-­‐butoxide,	   this	   protocol	   provided	  compound	  158	  in	  quantitative	  yield	  after	  reduction	  of	  the	  intermediate	  imine	  159	  under	  Luche	  conditions	  (Scheme	  3-­‐14).	  	  	  
	  	  
Scheme	   3-­‐14.	   Conversion	   of	   the	   stereochemistry	   about	   the	   CD-­‐ring	   junction	   of	  
compound	  102.	  Reagents	   and	   conditions:	   (i)	   PhI=O,	   DCM,	   18	   oC,	   1	   h;	   (ii)	   NaBH4,	  CeCl3y7H2O,	  MeOH,	  18	  oC,	  0.15	  h.	  	  	  With	  a	  reliable	  protocol	  now	  at	  hand	  for	  obtaining	  compound	  158,	  efforts	  turned	  to	   the	   manipulation	   of	   the	   associated	   tertiary	   amide	   tether	   so	   as	   to	   install	   the	  necessary	   functionalities	   to	  allow	  for	  cyclization	  and,	   thereby,	  assembly	  of	   the	  E-­‐ring	   of	   kopsihainanine	   A.	   Details	   of	   efforts	   directed	   towards	   such	   ends	   are	  presented	  in	  the	  following	  section.	  	  	  
3.4.3.	   Reduction	  of	  compound	  158	  
	  While	  compound	  102	  was	  very	  soluble	  in	  polar	  solvents	  such	  as	  MeOH,	  its	  trans-­‐counterpart	   158	   was	   only	   sparingly	   soluble	   in	   most	   organic	   solvents.	   This	  difference	  in	  physical	  properties	  is	  attributed	  to	  the	  former	  compound	  adopting	  a	  bowl-­‐shaped	   conformation	   while	   the	   trans-­‐configuration	   of	   the	   ring	   junction	   in	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compound	   158	   renders	   it	   significantly	   more	   planar.	   This	   planar	   shape	   of	  compound	   158	   would	   allow	   for	    Ɏ-­‐stacking	   interactions	   of	   the	  aromatic	   indole	   residues	   between	   adjacent	   molecules	   in	   the	   solid	   state	   and,	  perhaps,	  explaining	  its	  poor	  solubility	  in	  most	  solvents.	  	  The	   difference	   in	   configuration	   between	   isomers	   102	   and	   158	   also	   drastically	  altered	  the	  reactivity	  of	  the	  compounds.	  So,	  for	  example,	  when	  cis-­‐isomer	  102	  was	  treated	  with	  LiEt3BH	  in	  THF	  at	  room	  temperature,	  reduction	  of	  the	  amide	  moiety	  provided	   the	   corresponding	   alcohol	   (166)	   in	   excellent	   yield	   (Scheme	   3-­‐15).	   In	  contrast,	  when	  trans-­‐isomer	  158	  was	  subjected	  to	  the	  same	  conditions	  no	  reaction	  was	   observed.	   Perversely,	   heating	   this	   reaction	  mixture	   at	   reflux	   resulted	   in	   the	  unexpected	   formation	   of	   imine	   159	   (Scheme	   3-­‐16).	   The	   mechanism	   of	   this	  oxidation	  reaction	  remains	  unclear	  at	  the	  present	  time.	  	  	  
	  	  
Scheme	   3-­‐15.	   Facile	   reduction	   of	   the	   tertiary	   amide	   residue	   in	   the	   cis-­‐congener.	  Reagents	  and	  conditions:	  (i)	  LiEt3BH,	  THF,	  18	  oC,	  1	  h.	  	  	  Reaction	   of	   compound	   158	   with	   various	   other	   reducing	   agents	   resulted	   in	  similarly	   dismal	   outcomes	   (Scheme	   3-­‐16).	   Attempts	   to	   reduce	   the	   amide	   to	   the	  corresponding	   aldehyde	   under	   normally	   effective	   conditions	   failed.	   So,	   for	  example,	   when	   either	   DIBAL-­‐H	   or	   LiAlH(OEt)3	   were	   employed	   at	   various	  temperatures	   only	   starting	  material	  was	   returned.	   Compound	  158	  was	   similarly	  resistant	   to	   reduction	    ǯ 	   [zirconocene	   hydrochloride,	   viz.	  (C5H5)2ZrCl)].	   When	   compound	   158	  was	   treated	   with	   LiAlH4	  in	   refluxing	   THF	   a	  trace	   of	   imine	  159	  was	   obtained.	  No	   evidence	   for	   the	   formation	   of	   any	   reduced	  material	  was	  obtained.	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Scheme	   3-­‐16.	   Failed	   attempts	   at	   amide	   reduction	   using	   metal-­‐based	   reducing	  
reagents.	   Reagents	   and	   conditions:	   (i)	   LiEt3BH,	   or	   LiAlH4,	   or	   DIBAL-­‐H,	   or	  LiAlH(OEt)3,	  or	  (C5H5)2ZrCl,	  THF,	  various	  temperatures.	  	  	  The	   observation	   that	   the	   conversion	  158	   to	  159	   takes	   place	   under	   a	   variety	   of	  reducing	   conditions	  was	   an	   unexpected	   one.	   A	   possible	   explanation	   is	   shown	   in	  Scheme	  3-­‐17.	  Thus,	  the	  amine	  nitrogen	  and	  amide	  oxygen	  within	  compound	  158	  are	   appropriately	   arranged	   in	   a	   through-­‐space	   sense	   and	   such	   that	   they	   would	  constitute	   the	   donor	   groups	   of	   a	   bidentate	   ligand	   and	   thereby	   allowing	   for	   the	  ready	  formation	  of	  the	  illustrated	  metal	  complex	  158yM+.	  On	  contact	  with	  silica	  it	  is	  thought	  that	  this	  complex	  then	  collapses	  in	  the	  indicated	  (eliminative)	  manner	  such	  that	  imine	  159	  is	  produced.	  Such	  a	  complexation/elimination	  pathway	  is	  not	  available	   to	   the	   corresponding	   cis-­‐fused	   system	   102.	   Furthermore,	   this	   metal	  complexation	  phenomenon	  was	  only	  thought	  to	  take	  place	  at	  higher	  temperatures	  and	  thus	  accounting	  for	  the	  near	  quantitative	  recovery	  of	  the	  starting	  material	  at	  ambient	  temperatures.	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Scheme	  3-­‐17.	  Proposed	  mechanism	  for	  the	  formation	  of	  imine	  159	  from	  a	  metal	  
complex	  of	  compound	  158.	  	  	  Given	   the	   reaction	   outcomes	   detailed	   immediately	   above,	   it	   was	   pleasing	   to	  observe	   that	   when	   imine	   159	   was	   reacted	   with	   lithium	   amidoborohydride	  (LiBH3NH2)	   at	   room	   temperature,	   the	   corresponding	   amine	   alcohol	   167	   was	  isolated	   as	   the	   major	   product	   in	   72%	   yield	   (Scheme	   3-­‐18).	   The	   structure	   of	  compound	   167	   was	   confirmed	   by	   single-­‐crystal	   X-­‐ray	   analysis	   and	   the	   derived	  ORTEP	  is	  shown	  in	  Figure	  3-­‐4.	  	  	  
	  	  
Scheme	  3-­‐18.	  Reduction	  of	  compound	  159	  with	  LAB.	  Reagents	  and	  conditions:	   (i)	  LiBH3NH2,	  THF,	  18	  oC,	  16	  h.	  	  
	  The	  ability	  of	  the	  lithium	  aminoborohydride	  (LAB)	  reagents	  to	  reduce	  the	  tertiary	  amide	  of	   compound	  159	  where	   all	   other	   reductants	  have	   failed,	   and	  under	  mild	  conditions	  no	  less,	  further	  demonstrates	  the	  impressive	  utility	  and	  scope	  of	  these	  reagents	  in	  organic	  synthesis.	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Figure	  3-­‐4.	  ORTEP	  derived	  from	  the	  single-­‐crystal	  X-­‐ray	  analysis	  of	  trans-­‐fused	  amine	  alcohol	  167	  (with	  labelling	  of	  non-­‐hydrogen	  atoms).	  	  	  
3.4.4.	   Oxidation	  of	  alcohol	  167	  	  The	  next	  step	  of	  the	  reaction	  sequence	  required	  the	  oxidation	  of	  alcohol	  167	  to	  the	  corresponding	  aldehyde.	  This	  seemingly	  straightforward	  transformation	  proved	  to	  be	  problematic,	  perhaps	  because	   coordination	  of	   the	  hydroxyl	  moiety	  within	   the	  substrate	  to	  the	  secondary	  amine	  residue,	  presumably	  via	  H-­‐bonding	  interactions,	  suppressed	   its	   capacity	   to	   react	   with	   various	   oxidants.	   The	   low	   solubility	   of	  compound	  167	  in	  solvents	  other	  than	  MeOH	  further	  complicated	  matters.	  	  When	   the	   oxidation	   reaction	   was	   attempted	   using	   DessΫMartin	   periodinane	   in	  DCM	  at	   room	   temperature,	   only	   starting	  material	  was	   recovered	   (Scheme	  3-­‐19).	  
    Ɏ-­‐stacking	   interactions	   of	   this	   spatially	   planar	  molecule	   in	   the	   solvents	   used,	   which	   were	   thought	   to	   contribute	   to	   the	   poor	  solubility	   of	   the	  molecule,	   benzene	  was	   chosen	   as	   the	  medium	   for	   the	   oxidation	  reaction.	  Indeed,	  when	  compound	  167	  was	  subjected	  to	  Dess-­‐Martin	  oxidation	  in	  benzene,	  a	  compound	  believed	   to	  be	  the	  hemiaminal	  168	  (deduced	  based	  on	  the	  presence	  of	  a	  clear	  triplet	  signal	  integrating	  for	  one	  proton	  at	  5.17	  ppm	  in	  the	   1H	  NMR	  spectrum	  attributed	  to	  the	  proton	  adjacent	  to	  the	  alcohol)	  was	  isolated	  as	  the	  sole	   product	   of	   reaction	   (60%	   yield).	   Aldehyde	   152	   is	   presumably	   the	   initially	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formed	   species	   under	   these	   conditions	   but,	   because	   of	   the	   spatial	   relationship	  between	   this	   residue	   and	   the	   Ƚ-­‐amine	   unit,	   an	   internal	   nucleophilic	   addition	  reaction	   takes	   place	   to	   deliver	   compound	   168	   as	   a	   single	   diastereoisomer	   of	  undetermined	   configuration	   at	   the	   hydroxyl-­‐bearing	   carbon	   (only	   one	  stereoisomeric	  form	  of	  compound	  168	  was	  obtained).	  Oxidation	  of	  compound	  167	  using	  IBX	  in	  refluxing	  EtOAc50	  also	  gave	  hemiaminal	  168	  as	  the	  major	  product.	  	  	  
	  	  
Conditions	   Results	  1.	  Dess-­‐Martin	  periodinane,	  DCM,	  18	  oC	   No	  reaction	  2.	  Dess-­‐Martin	  periodinane,	  benzene,	  18	  oC	   Single	  product,	  ca.	  60%	  3.	  IBX,	  EtOAc,	  reflux	   Single	  product,	  ca.	  60%	  	  
Scheme	  3-­‐19.	  Oxidation	  of	  alcohol	  167	  leading	  to	  the	  formation	  of	  hemiaminal	  168.	  	  	  As	  hemiaminal	  168	  was	  assumed	  to	  exist	   in	  equilibrium	  with	  aldehyde	  152,	   this	  material	   was	   subjected	   to	   the	   Lounasmaa	   chain-­‐extension/cyclization	   protocol	  described	   earlier	   (see	  Scheme	  3-­‐8)	   in	   the	  hope	  of	   forming	   the	  Ƚ-­‐hydroxy	   lactam	  ring	  required	   in	  kopsihainanine	  A.	  The	  outcomes	  of	   relevant	  studies	  are	  detailed	  below.	  	  	  
3.4.5.	   Attempted	  cyanide	  additions	  to	  compound	  168	  
	  In	   the	   final	   steps	   of	   the	   proposed	   reaction	   sequence,	   it	   was	   anticipated	   that	  cyanide	  addition	  to	  compound	  168/152	  followed	  by	  acid	  hydrolysis	  would	  furnish	  the	  target	  natural	  product	  125	  in	  just	  one	  step	  (Scheme	  3-­‐20).	  
	   	  





Scheme	  3-­‐20.	  Proposed	  one-­‐step	  procedure	  to	  form	  kopsihainanine	  A	  (125)	  
following	  a	  procedure	  reported	  by	  Lounasmaa.	  
	  
	  Disappointingly,	  when	  hemiaminal	  168	  was	   treated	  with	  potassium	  cyanide	  and	  18-­‐crown-­‐6	  at	  either	  ambient	  or	  elevated	  temperatures,	  no	  reaction	  was	  observed.	  It	  was	   anticipated	   that	   the	   cyanation	   reaction	   could	   be	   facilitated	   if	   hemiaminal	  formation	   was	   averted,	   something	   that	   might	   be	   achieved	   by	   protecting	   the	  secondary	   amine	   nitrogen	   of	   compound	   167	   prior	   to	   oxidation	   of	   the	   alcohol.	  Accordingly,	   compound	   167	   was	   treated	   with	   CbzCl	   in	   the	   presence	   of	  triethylamine	  and	  N-­‐methylimidazole	   in	  DCM.	  After	  workup	  and	  purification,	   the	  only	   product	   isolated	   from	   the	   reaction	   mixture	   was	   not	   the	   expected	   Cbz-­‐protected	   compound	   170	   but	   pentacycle	   171,	   the	   structure	   of	   which	   was	  confirmed	  by	  single	  crystal	  X-­‐ray	  analysis	  (Figure	  3-­‐5).	  	  	  The	  formation	  of	  compound	  171	  under	  the	  conditions	  defined	  above	  presumably	  involves	   the	  hydroxyl	   residue	  of	   substrate	  167	   reacting	   in	   the	   expected	  manner	  with	   CbzCl	   to	   form	   the	   anticipated	   carbonate	   172,	   but	   this	   then	   engages	   in	   an	  internal	   nucleophilic	   displacement	   reaction	   with	   the	   amine	   nitrogen	   acting	   as	  nucleophile	   to	   give	   the	   observed	   pentacycle	  171	  while	   simultaneously	   releasing	  carbon	  dioxide	  gas	  and	  phenol	  (Scheme	  3-­‐21).	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Scheme	  3-­‐21.	  Unexpected	  formation	  of	  pentacycle	  171.	  Reagents	   and	   conditions:	  (i)	  CbzCl,	  NEt3,	  NMI,	  DCM,	  18	  oC,	  2	  h.	  	  	  Given	  the	  observed	  propensity	  for	  compound	  167,	  containing	  a	  trans-­‐ring	  junction	  between	  the	  associated	  piperidine	  and	  indole-­‐fused	  cyclohexane	  rings,	  to	  spontaneously	  cyclize	  in	  an	  unwanted	  manner,	  it	  was	  becoming	  clear	  that	  a	  different	  means	  for	  producing	  kopsihananine	  A	  was	  required.	  Accordingly,	  a	  late-­‐stage	  CD-­‐ring	  isomerization,	  (to	  be	  carried	  out	  only	  after	  manipulation	  of	  the	  side	  chain)	  was	  thought	  more	  likely	  to	  provide	  an	  effective	  route	  to	  the	  natural	  product.	  Details	  of	  such	  a	  revised	  (and	  successful)	  approach	  are	  discussed	  in	  the	  following	  Chapter.	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Figure	  3-­‐5.	  ORTEP	  derived	  from	  the	  single-­‐crystal	  X-­‐ray	  analysis	  of	  pentacycle	  171	  
(with	  labelling	  of	  non-­‐hydrogen	  atoms).	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Chapter Four. 
Second Generation Approach to Kopsihainanine A 
	  





Scheme	  4-­‐1.	  Premature	  cyclization	  reactions	  of	  derivatives	  of	  the	  trans-­‐fused	  
tetracycle	  167.	  
	   	  
	  These	   observations	   led	   to	   the	   proposal	   that	   the	   ordering	   of	   the	   necessary	  inversion	  of	  the	  stereochemistry	  at	  the	  CD-­‐ring	  junction	  (from	  cis	  to	  trans)	  within	  a	  precursor	  to	  compound	  167	  and	  the	  one-­‐carbon	  homologation	  (of	  the	  side	  chain)	  steps	  should	  be	  reversed.	  A	  new	  strategy	  embodying	  this	  approach	   is	  outlined	  in	  Scheme	  4-­‐2	  and	  the	  pursuit	  of	  this	  is	  detailed	  in	  the	  following	  pages.	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  Work	  described	  in	  the	  preceding	  Chapter:	  	  
	  	  	  Work	  described	  in	  this	  Chapter:	  	  
	  	  
Scheme	  4-­‐2.	  An	  alternative	  approach	  to	  kopsihainanine	  A.	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4.1.	   Retrosynthetic	  Analysis	  
	  The	   new	   approach	   to	   kopsihainanine	   A	   from	   the	   readily	   accessible	   tetracyclic	  intermediate	  102	   is	  outlined,	   in	  retrosynthetic	   form,	   in	  Scheme	  4-­‐3.	  Thus,	   it	  was	  envisioned	  that	  the	  lactam	  ring	  of	  the	  target	  molecule	  125	  could	  be	  assembled	  via	  an	   intermediate	   such	   as	   compound	   175.	   Indeed,	   given	   earlier	   observations,	   a	  spontaneous	   cyclization	   of	   the	   secondary	   amine	   residue	   within	   compound	   175	  onto	   the	  ester	  carbonyl	  moiety	  of	   the	  side	  chain	  was	  expected	   to	  occur	  after	   the	  now	   late-­‐stage	   isomerization	   of	   the	   CD-­‐ring	   junction	   was	   implemented.	   This	  isomerization	   would	   involve	   compound	   176	   as	   substrate	   and	   the	   Ƚ-­‐keto	   ester	  moiety	   within	   it	   was	   thought	   accessible	   through	   manipulation	   of	   the	   tertiary	  amide	   residue	   of	   the	   key	   tetracyclic	   intermediate	   102	   through	   a	   sequence	   of	  functional	  group	  interconversions	  including	  a	  one-­‐carbon	  homologation.	  	  	  
	  	  
Scheme	  4-­‐3.	  Retrosynthetic	  analysis	  of	  (±)-­‐kopsihainanine	  (125)	  and	  employing	  
compound	  102	  as	  the	  starting	  material;	  R	  =	  alkyl	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4.2.	   Synthetic	  Work	  
	  
4.2.1.	   Manipulation	  of	  the	  tertiary	  amide	  tether	  within	  compound	  102	  
	  It	   was	   hoped	   that	   the	   tertiary	   amide	   moiety	   within	   compound	   102	   could	   be	  converted,	  by	  conventional	  methods,	  into	  the	  corresponding	  ester	  177	  (Scheme	  4-­‐4)	   that	   upon	   nucleophilic	   addition	   of	   a	   cyanide	   unit	   would	   produce	   an	   Ƚ-­‐keto	  nitrile.	   Acid-­‐promoted	  methanolysis	   of	   the	   nitrile	  moiety	   should	   then	   afford	   the	  chain-­‐extended	   Ƚ-­‐keto	   ester	   178	   and	   thereby	   establishing	   all	   the	   constituent	  carbons	   of	   the	   skeletal	   framework	   of	   the	   target	   natural	   product.	   Unfortunately,	  when	   a	   methanolic	   solution	   of	   compound	   102	  was	   subjected	   to	   strongly	   acidic	  conditions,	   no	   reaction	   was	   observed.	   Thus,	   the	   starting	   material	   was	   always	  returned,	  even	  at	  elevated	  temperatures.	  	  	  
	  	  
Scheme	   4-­‐4.	   Attempts	   to	   effect	   methanolysis	   of	   amide	   102.	   Reagents	   and	  conditions:	  (i)	  conc.	  H2SO4,	  MeOH,	  various	  temperatures,	  16	  h.	  	  	  As	  a	  result,	  focus	  was	  turned	  to	  effecting	  a	  partial	  and	  direct	  reduction	  (using,	  for	  
ǡ      ǯ   -­‐H)	   of	   the	  amide	   residue	   to	   the	   corresponding	   aldehyde	   179	   (Scheme	   4-­‐5).	   However,	   no	  reaction	   was	   observed	   when	   either	   of	   these	   reagents	   was	   employed.	   Finally,	  treatment	  of	  compound	  102	  with	  LiEt3BH	  provided	   the	   free	  alcohol	  166	   in	  89%	  yield	  when	  the	  reaction	  was	  conducted	  at	  room	  temperature	  over	  one	  hour.	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Scheme	  4-­‐5.	  Reduction	  of	  the	  tertiary	  amide	  residue.	  Reagents	   and	   conditions:	   (i)	  Cp2ZrHCl	  or	  DIBAL-­‐H,	  THF,	  various	  temperatures,	  16	  h;	  (ii)	  LiEt3BH,	  THF,	  18	  oC,	  1	  h.	  	  	  It	  was	   anticipated	   (Scheme	  4-­‐6)	   that	   oxidation	  of	   the	   alcohol	  166	  would	  deliver	  aldehyde	   179	   and	   that	   acid-­‐catalyzed	   methanolysis	   of	   the	   derived	   cyanohydrin	  could	  provide	  the	  required	  chain	  extended	  Ƚ-­‐hydroxy	  ester	  174.	  However,	  none	  of	  the	  numerous	  conditions	  employed	  in	  investigating	  such	  possibilities	  provided	  the	  required	   aldehyde	   179.	   In	   most	   cases	   the	   alcohol	   was	   returned	   quantitatively	  (Scheme	  4-­‐6).	  	  	  	  
	  	  
Scheme	  4-­‐6.	  Attempts	  to	  oxidize	  alcohol	  166.	  Reagents	  and	  conditions:	  (i)	  NCS,	  or	  IBX,	  or	  DMP,	  or	   t-­‐BuOCl,	  or	  PCC,	  or	  TPAP,	  or	  TEMPO/PIDA,	  or	  TEMPO/PhI=O,	  or	  TEMPO/PIDA/PhI=O,	   or	   TEMPO/I2/NaHCO3,	   TEMPO/p-­‐TsOH,	   or	   MnO2,	  SO3ypyridine/DMSO,	   or	   PhI=O/KBr,	   or	   NCS/TEMPO/t-­‐butylammonium	   bromide,	  or	  CrO3/H2SO4,	  or	  Pd/C/NaBH4/K2CO3,	  MeOH.	  	  	  The	   unexpected	   lack	   of	   reactivity	   of	   compound	   166	   could	   be	   attributed	   to	   the	  intramolecular	  H-­‐bonding	  of	  the	  hydroxyl	  residue	  with	  the	  lone	  pair	  of	  electrons	  of	  the	   secondary	   amine.	   As	   a	   result,	   the	   oxygen	   cannot	   interact	   effectively	   with	  oxidants.	   As	   such,	   protection	   of	   the	   secondary	   amine	   should	   render	   the	   alcohol	  residue	  associated	  with	  compound	  166	  more	  susceptible	  to	  oxidation.	  To	  this	  end,	  compound	  166	  was	  reacted	  with	  di-­‐tert-­‐butyl	  dicarbonate	  (Boc2O).	   Interestingly,	  two	   products	  were	   observed	   to	   form	   prior	   to	   complete	   consumption	   of	   starting	  material.	  These	  proved	  to	  be	  the	  desired	  Boc-­‐protected	  compound	  180	  and	  its	  bis-­‐protected	   counterpart	  181.	  When	   an	   extra	   equivalent	   of	   the	   reagent	  was	   added	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and	   the	   reaction	   left	   to	   run	  until	   complete	   consumption	  of	   starting	  material	  was	  observed	  (approximately	  2	  h),	  the	  bis-­‐Boc-­‐protected	  compound	  181	  was	  isolated	  in	   65%	   yield	   and	   as	   the	   exclusive	   product	   of	   reaction.	   Thus,	   and	   somewhat	  unexpectedly,	   the	   hydroxyl	   residue	   within	   substrate	   166	   was	   reacting	  competitively	   with	   the	   secondary	   amine	   under	   the	   conditions	   employed.	   This	  competing	  reactivity	  is	  attributed	  to	  the	  spatial	  arrangement	  of	  the	  substrate	  Ȃ	  the	  concave	   or	   bowl-­‐like	   nature	   of	   tetracycle	   166	   (a	   consequence	   of	   the	   cis-­‐configuration	   at	   the	   CD-­‐ring	   junction)	   results	   in	   a	   shielding	   of	   the	   lone	   pair	   of	  electrons	  on	  the	  secondary	  amine	  and	  the	  exposure	  of	   the	  normally	   less-­‐reactive	  primary	  alcohol	  to	  the	  reagent	  (Figure	  4-­‐1).	  To	  cleave	  the	  carbonate	  (but	  not	  the	  carbamate)	   residue	   within	   compound	   181	   this	   was	   treated	   with	   potassium	  carbonate	   in	   MeOH	   (Scheme	   4-­‐7).	   By	   such	   means,	   the	   desired	   mono-­‐protected	  compound	  180	  was	  obtained	  in	  near	  quantitative	  yield	  from	  substrate	  166.	  	  	  
	  	  
Scheme	   4-­‐7.	   Boc	   protection	   of	   alcohol	  166.	  Reagents	   and	   conditions:	   (i)	   Boc2O,	  Et3N,	  DCM,	  0	  to	  18	  oC,	  2	  h;	  (ii)	  K2CO3,	  MeOH,	  18	  oC,	  16	  h.	  	  	  
	   	  	  
Figure	  4-­‐1.	  Molecular	  model	  (ex.	  Spartan	  14)	  of	  compound	  166	  depicting	  the	  
partial	  bowl-­‐like	  structure	  of	  the	  cis-­‐fused	  tetracycle.	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Several	   other	   conditions	   were	   explored	   in	   an	   effort	   to	   achieve	   a	   more	   efficient	  synthesis	  of	  compound	  180.	  Using	  DMAP	  as	  a	  catalyst	   in	  conjunction	  with	  Boc2O	  resulted	  in	  the	  tri-­‐protected	  product	  wherein	  the	  indole	  nitrogen	  had	  also	  reacted	  with	  the	  electrophile.	  Other	  conditions	  (including	  those	  involving	  Boc2O,	  I2,	  MeOH	  or	  Boc2O,	  H2O)	  51	  failed	  to	  effect	  any	  reaction	  whatsoever.	  Finally,	  it	  was	  found	  that	  by	   treating	   compound	   166	   with	   five	   equivalents	   of	   Boc2O	   and	   using	   sodium	  bicarbonate	  as	  the	  base	  in	  a	  biphasic	  THF/H2O	  solvent	  system,52	  the	  desired	  N-­‐Boc	  protected	  compound	  180	  was	  isolated	  as	  the	  sole	  product	  in	  87%	  yield	  (Scheme	  4-­‐8).	  	  	  
	  	  
Scheme	   4-­‐8.	   Optimized	   conditions	   for	   the	   Boc-­‐protection	   of	   compound	   166.	  Reagents	  and	  conditions:	  (i)	  Boc2O,	  NaHCO3,	  THF/H2O,	  18	  oC,	  16	  h.	  	  	  	  
4.2.2.	   Oxidation	  of	  the	  N-­‐Boc-­‐protected	  alcohol	  180	  
	  With	  the	  title	  compound	  180	  at	  hand,	  efforts	  turned	  to	  the	  oxidation	  of	  the	  alcohol	  residue	  within	  it	  to	  the	  corresponding	  aldehyde.	  When	  this	  substrate	  was	  treated	  with	  pyridinium	  chlorochromate	   (PCC)	   in	  DCM	   in	   the	  presence	  of	  4	   Å	  molecular	  sieves	   (Scheme	   4-­‐9)	   complete	   consumption	   of	   starting	   material	   was	   observed	  within	  0.5	  h.	  This	  result	  stands	  in	  stark	  contrast	  to	  the	  lack	  of	  reactivity	  observed	  when	   the	   unprotected	   compound	  166	  was	   exposed	   to	   the	   same	   conditions	   (see	  Scheme	   4-­‐6).	   Contrary	   to	   expectations,	   however,	   two	   chromatographically	  inseparable	   compounds	  were	   isolated	   under	   these	   conditions	   (Scheme	   4-­‐9).	   So,	  along	  with	  the	  desired	  aldehyde	  182	  (49%),	  the	  chromatographically	  inseparable	  doubly-­‐oxidized	  keto-­‐aldehyde	  183	  (21%)	  was	  also	  obtained.	  Efforts	  to	  minimize	  the	   formation	   of	   the	   latter	   compound	   were	   fruitless.	   Lowering	   the	   reaction	  temperature	  or	  adding	  the	  oxidant	  slowly	  only	  led	  to	  incomplete	  consumption	  of	  starting	   material.	   Oxidation	   at	   C18	   seemed,	   therefore,	   to	   be	   taking	   place	   very	  rapidly	  after	  oxidation	  of	  the	  alcohol	  residue	  within	  substrate	  180.	  	   	  




Scheme	  4-­‐9.	  Oxidation	  of	  Boc-­‐protected	  compound	  180.	  Reagents	   and	   conditions:	  (i)	  PCC,	  4	  Å	  MS,	  DCM,	  18	  oC,	  0.5	  h.	  	  	  Disappointingly,	  various	  of	  the	  other	  oxidants	  screened	  failed	  to	  improve	  matters	  (Scheme	  4-­‐10).	  So,	  for	  example,	  when	  the	  Dess-­‐Martin	  periodinane	  was	  used	  only	  a	  low	  yield	  of	  Boc-­‐deprotected	  aldehyde	  179	  was	  obtained	  (and	  as	  a	  mixture	  with	  a	  significant	  number	  of	  unidentifiable	  products).	  No	  identifiable	  products	  could	  be	  isolated	   when	   a	   combination	   of	   TEMPO	   and	   various	   re-­‐oxidants	   [PhI(OAc)2	   or	  NMO	   for	   example]	   was	   employed.	   Under	   Swern	   conditions	   only	   an	   unstable	  chlorinated	   product,	   tentatively	   assigned	   as	   compound	   184,	   was	   isolated.	   This	  decomposed	   within	   a	   few	   hours	   at	   room	   temperature,	   a	   reactivity	   observed	   in	  related	  systems.53	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Scheme	  4-­‐10.	  Attempts	  to	  oxidize	  alcohol	  180.	  Reagents	   and	   conditions:	   (i)	  DMP,	  DCM,	  18	  oC,	  4	  h;	  (ii)	  DMSO,	  (COCl)2,	  DCM,	  Ϋ78	  oC,	  0.25	  h,	  then	  NEt3,	  Ϋ78	  to	  18	  oC,	  0.15	  h;	  (iii)	  TPAP,	  NMO,	  4	  Å	  MS,	  DCM,	  18	  oC,	  or	  TPAP,	  PhI(OAc)2,	  DCM,	  18	  oC.	  	  	  The	   over-­‐oxidation	   observed	   in	   the	   reaction	   of	   compound	   180	  with	   pyridinium	  chlorochromate	   could	   be	   addressed	   by	   employing	   a	   two-­‐step	   de-­‐oxygenation	  procedure54	  that	   allowed	   for	   the	   conversion	   183Î182.	   Details	   are	   presented	   in	  Section	  4.2.3.	  	  	  
4.2.3.	   One-­‐carbon	  homologation	  of	  aldehyde	  182	  
	  In	  initial	  attempts	  to	  homologate	  the	  side	  chain	  of	  aldehyde	  182,	  it	  was	  envisioned	  that	  cyanohydrin	  formation	  followed	  by	  acid-­‐promoted	  hydrolysis	  of	  the	  resulting	  
Ƚ-­‐hydroxy	  nitrile	  185	  would	   furnish	   the	  Ƚ-­‐hydroxy	  carboxylic	  acid	  186	  (Scheme	  4-­‐11).	   A	   related	   transformation	   involving	   the	   reaction	   of	   aldehyde	   182,	   under	  microwave	   irradiation	   conditions,	   with	   sodium	   trichloroacetate	   in	   CHCl3/H2O	   in	  the	  presence	  of	   the	  phase	  transfer	  reagent	   tert-­‐butylammonium	  bromide	  (TBAB)	  was	   also	   explored.55	   In	   this	   second	   reaction,	   it	   was	   hoped	   the	   trichloromethyl	  anion	   formed	   from	   the	   thermal	  decomposition	  of	   sodium	   trichloroacetate	  would	  add	   to	   the	   aldehyde	   residue	   and	   the	   resulting	   trichloromethylated	   alcohol	   187	  would	   then	   hydrolyze	   (under	   basic	   conditions)	   to	   form	   the	   Ƚ-­‐hydroxylated	  carboxylic	  acid	  186.	  However,	  no	  distinguishable	  products	  could	  be	   isolated	  as	  a	  result	  of	  attempting	  to	  implement	  either	  of	  these	  protocols.	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Scheme	   4-­‐11.	   Failed	   attempts	   to	   homologate	   compound	   182.	   Reagents	   and	  conditions:	  (i)	  NaCN,	  TMSCN,	  15-­‐crown-­‐5,	  DCM,	  18	  oC,	  16	  h;	  (ii)	  Cl3COONa,	  Bu4NBr,	  H2O/CHCl3,	  Ɋwave	  70	  W,	  2	  h.	  	  	  As	  a	  result	  of	  these	  failures,	  attention	  turned	  to	  installing	  the	  required	  additional	  carbon	  via	   a	  Wittig	  metheylenation	  reaction.	   In	   the	  event,	  when	  a	  7:3	  mixture	  of	  aldehyde	   182	   and	   its	   oxo-­‐derivative	   183	   was	   reacted	   with	  methyltriphenylphosphonium	   bromide	   and	   n-­‐BuLi	   at	   room	   temperature	   a	   7:3	  mixture	   of	   the	   now	   chromatographically	   separable	   olefins	   188	   and	   189	   was	  obtained	  in	  40%	  combined	  yield.	  These	  products	  were	  accompanied	  by	  the	  N-­‐Boc-­‐deprotected	  olefin	  190	  (15%	  yield)	  (Scheme	  4-­‐12).	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Scheme	   4-­‐12.	   Wittig	   olefination	   of	   aldehydes	   182	   and	   183.	   Reagents	   and	  conditions:	  (i)	  Ph3PMeBr,	  n-­‐BuLi,	  THF,	  18	  oC,	  2	  h.	  	  	  It	  was	   found	   that	   the	   formation	   of	   the	   last	   compound	   could	   be	   avoided	   and	   the	  combined	  yield	  of	  the	  desired	  olefins	  188	  and	  189	  increased	  to	  63%	  if	  the	  reaction	  was	   conducted	   at	   0	   oC	   then	   quenched	   as	   soon	   as	   consumption	   of	   the	   starting	  material	  was	  complete	  (ca.	  15	  min)	  (Scheme	  4-­‐13).	  	  	  
	  	  
Scheme	   4-­‐13.	   Optimized	  Wittig	   olefination	   of	   aldehydes	   182	   and	   183.	  Reagents	  and	  conditions:	  (i)	  Ph3PMeBr,	  n-­‐BuLi,	  THF,	  0	  oC,	  0.2	  h.	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In	   terms	   of	   the	   mode	   of	   formation	   of	   deprotected	   olefin	   190,	   it	   was	   thought	  (Scheme	   4-­‐14)	   that	   the	   ylide	   resulting	   from	   the	   reaction	   of	  methyltriphenylphosphonium	   bromide	   and	   n-­‐BuLi	   could	   deprotonate	   the	   indole	  and	   thus	   forming	   the	   conjugate	   base	   (188ΫH+)	   that	   itself	   deprotonates	   the	  Boc-­‐group	  on	  a	  neighbouring	  molecule	  and	  so	  triggering	  the	  illustrated	  fragmentation	  of	  the	  carbamate	  moiety	  and	  resulting	  in	  formation	  of	  compound	  190.	  Of	  course,	  the	  direct	  deprotonation	  of	  compound	  188	  by	  the	  ylide	  cannot	  be	  discounted.	  	  	  	  
	  	  
Scheme	  4-­‐14.	  Postulated	  mechanism	  for	  the	  deprotection	  of	  olefin	  188	  resulting	  
from	  excess	  ylide	  present	  in	  the	  reaction	  mixture.	  	  	  In	   order	   to	   investigate	   the	   possibility	   of	   deleting	   the	   ketone	   residue	   within	  carbazolone	  189,	  the	  associated	  Boc	  protecting	  group	  had	  to	  be	  removed	  (Scheme	  4-­‐15).	   Accordingly,	   the	   mixture	   of	   compounds	   188	   and	   189	  was	   subjected	   to	  reaction	  with	   TFA	   in	   DCM	  with	   the	   result	   that	   a	   chromatographically	   separable	  mixture	   of	   the	   corresponding	   amines	  190	   (54%)	   and	   191	   (36%)	  was	   obtained.	  Following	  ǯ ǡ54	   compound	   191	  was	   treated	   with	   LiAlH4	  so	   as	   to	  reduce	  the	  ketone	  residue	  to	  the	  corresponding	  alcohol	  and	  this	  was	  itself	  deleted	  through	   treatment	   with	   BF3yOEt2	   and	   Et3SiH	   in	   DCM.	   By	   such	   means	   190	  was	  obtained	  in	  35%	  yield.	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Scheme	   4-­‐15.	   Conversion	   of	   compounds	   188	   and	   189	   into	   amine-­‐olefin	   190.	  Reagents	  and	  conditions:	  (i)	  TFA,	  DCM,	  18	  oC,	  1	  h;	  (ii)	  LiAlH4,	  THF,	  Ϋ78	  to	  18	  oC,	  2	  h,	  then	  BF3yOEt2,	  Et3SiH,	  DCM,	  Ϋ78	  oC,	  0.17	  h.	  	  	  	  
4.2.4.	   Manipulating	  olefin	  190	  





Scheme	  4-­‐16.	  Retrosynthetic	  analysis	  of	  kopsihainanine	  A	  (125)	  based	  on	  using	  
compound	  190	  as	  starting	  material.	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Scheme	  4-­‐17.	  Expected	  spontaneous	  cyclization	  event	  upon	  oxidation	  of	  the	  diol	  
residue	  of	  compound	  193	  to	  form	  the	  Ƚ-­‐hydroxy	  lactam	  ring	  of	  kopsihainanine	  A.	  
	  
	  To	   prepare	   diol	   192	   from	   compound	   190,	   the	   Sharpless-­‐modification	   of	   the	  Upjohn	  protocol56	  was	  used.	  This	  involved	  using	  potassium	  osmate	  dihydrate	  and	  
N-­‐methylmorpholine	  oxide	  as	  co-­‐oxidants	  and	  citric	  acid	  as	  an	  additive.	  By	  keeping	  the	  reaction	  medium	  acidic,	  the	  secondary	  amine	  should	  be	  protonated	  throughout	  the	   course	   of	   the	   transformation	   and	   not,	   therefore,	   interfere	   with	   the	   osmium	  catalyst.	  Curiously,	  under	  these	  conditions,	  the	  product	  isolated	  from	  the	  reaction	  was	   not	   the	   expected	   diol	   192	   but,	   rather,	   the	   over-­‐oxidized	   compound	   197	  (Scheme	  4-­‐18),	  an	  outcome	  similar	  to	  that	  encountered	  earlier	  (see	  Scheme	  4-­‐9).	  Compound	   197	   was	   obtained	   in	   40%	   yield	   and	   as	   a	   ca.	   2:1	   mixture	   of	  diastereomers.	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Scheme	  4-­‐18.	  Dihydroxylation	  of	  olefin	  190.	  Reagents	  and	  conditions:	   (i)	  K2OsO4,	  NMO,	  citric	  acid,	  MeCN/H2O,	  18	  oC,	  1	  h.	  	  	  Despite	   formation	  of	   the	  over-­‐oxidation	  product	  197	  arising	   from	  the	  citric	  acid-­‐promoted	   dihydroxylation	   process,	   the	   availability	   of	   a	   reliable	   protocol	   for	   the	  reduction	   of	   oxo-­‐carbazoles	   detailed	   in	   the	   preceding	   section	   (Scheme	   4-­‐15)	  prompted	  studies	  wherein	  compound	  197	  was	  carried	  forward.	  	  	  
4.2.5.	   Conversion	  to	  the	  trans-­‐isomer	  
	  With	  diol	  197	   at	   hand,	   efforts	   turned	   to	   the	   isomerization	   of	   this	   cis-­‐configured	  system,	  through	  inversion	  of	  configuration	  at	  C21,	  into	  its	  trans	  counterpart	  using	  the	  two-­‐step	  sequence	  detailed	  earlier.	  Disappointingly,	  however,	  when	  compound	  
197	  was	  treated	  with	  iodosobenzene	  in	  DCM	  at	  room	  temperature	  no	  identifiable	  products	   could	   be	   obtained	   (Scheme	   4-­‐19).	   Essentially	   the	   same	   outcome	   was	  observed	   when	   the	   related	   amine-­‐alcohol	   166	  was	   subjected	   to	   the	   equivalent	  reaction	  conditions.	  	  	  
	  	  
Scheme	   4-­‐19.	   Attempts	   to	   effect	   oxidation	   of	   compounds	   197	   and	   166	   to	   the	  
corresponding	  imines.	  Reagents	  and	  conditions:	  (i)	  PhI=O,	  DCM,	  18	  oC,	  1	  h.	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The	   failure	   of	   these	   reactions	   is	   almost	   certainly	   due	   to	   the	   side-­‐chain	   hydroxyl	  groups	   H-­‐bonding	   to	   the	   amine	   and	   so	   interfering	   with	   the	   desired	   oxidation	  reaction.	  Clearly,	  protection	  of	  the	  diol	  residue	  was	  a	   logical	  move.	  To	  this	  end,	  a	  solution	  of	  diol	  197	  in	  2,2-­‐dimethoxypropane	  was	  treated	  with	  p-­‐toluenesulfonic	  acid	  (a	  few	  drops	  of	  DMSO	  were	  added	  to	  solubilize	  the	  starting	  material).	  By	  such	  means	   acetonide	   200	   was	   obtained	   in	   53%	   yield	   and	   as	   a	   2:1	   mixture	   of	  diastereomers	   (Scheme	   4-­‐20)	   and	   when	   this	   was	   subjected	   to	   the	   two-­‐step	  isomerization	  protocol	  used	  earlier,	  the	  trans	  congener	  202	  was	  obtained,	  as	  a	  2:1	  mixture	   of	   diastereomers	   (at	   the	   side-­‐chain),	   in	   quantitative	   yield	   over	   the	   two	  steps	  that	  must	  involve	  intermediate	  imine	  201.	  The	  relevant	  1H	  NMR	  spectra	  are	  shown	   in	   Figures	   4-­‐2,	   4-­‐3	   and	   4-­‐4	   (note	   the	   presence	   of	   the	   signals	   due	   to	   the	  diastereomeric	  C21	  protons	  in	  each	  epimer	  in	  both	  compounds	  200	  and	  202	  and	  the	  absence	  of	  an	  equivalent	  resonance	  in	  the	  spectrum	  of	  imine	  201).	  A	  downfield	  shift	  of	  the	  aromatic	  protons	  is	  observed	  upon	  isomerization.	  Unfortunately,	  when	  compound	   202	   was	   subjected	   to	   acetonide-­‐deprotection	   conditions,	   no	  identifiable	  products	  could	  be	  isolated	  from	  the	  reaction	  mixture	  (Scheme	  4-­‐20).	  	  	  
	  	  
Scheme	  4-­‐20.	  Attempts	  to	  prepare	  compound	  203.	  Reagents	  and	  conditions:	  (i)	  p-­‐TsOHyH2O,	  2,2-­‐DMP,	  DMSO,	  18	   oC,	  2	  h;	   (ii)	  PhI=O,	  DCM,	  18	   oC,	  16	  h;	   (iii)	  NaBH4,	  MeOH,	  18	  oC,	  0.08	  h;	  (iv)	  p-­‐TsOHyH2O,	  MeOH,	  18	  oC,	  1	  h.	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Figure	  4-­‐2.	  400MHz	  1H	  NMR	  spectrum	  (in	  CD3OD)	  of	  compound	  200	  (mixture	  of	  
diastereomers).	  	  
	  	  
Figure	  4-­‐3.	  400	  MHz	  1H	  NMR	  spectrum	  (in	  CD3OD)	  of	  the	  imine	  201(traces	  of	  
iodobenzene	  present	  as	  a	  by-­‐product	  of	  the	  oxidation).	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Figure	  4-­‐4.	  400	  MHz	  1H	  NMR	  spectrum	  (in	  CD3OD)	  of	  compound	  202	  (mixture	  of	  
diastereomers).	  	  Given	   the	   setbacks	   detailed	   above,	   the	   possibility	   of	   rearranging	   the	   reaction	  sequence	  so	  as	  to	  effect	  a	  late-­‐stage	  dihydroxylation	  process,	  whereby	  the	  CD-­‐ring	  junction	   stereochemistry	   is	   first	   inverted,	   was	   explored.	   To	   this	   end,	   carbamate	  
188	  was	  deprotected	  and	  the	  resulting	  amine	  190	  subjected	  to	  the	  isomerization	  process	   (Scheme	   4-­‐21).	   Gratifyingly	   the	   reaction	   proceeded	   smoothly	   affording,	  
via	   imine	   204,	   the	   trans-­‐configured	   compound	   143	   in	   68%	   yield	   over	   the	   two	  steps	  involved.	  Significantly,	  compound	  143	  represents	  an	  advanced	  intermediate	  associated	  with	  ǯ	   synthesis44	   of	   kopsihainanine	  A	   (see	   Scheme	  3-­‐5)	   and	   a	  comparison	  (Tables	  4-­‐1	  and	  4-­‐2)	  of	  the	  relevant	  1H	  and	  13C	  NMR	  data	  sets	  proved	  a	  good	  match.	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Scheme	   4-­‐21.	   Preparation	   of	   trans-­‐ring-­‐fused	   compound	   143.	   Reagents	   and	  conditions:	  (i)	  TFA,	  DCM,	  18	  oC,	  1	  h;	  (ii)	  PhI=O,	  DCM,	  18	  oC,	  1	  h;	  (iii)	  NaBH4,	  MeOH,	  18	  oC,	  0.08	  h.	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Table	  4-­‐1.	  Comparison	  of	  the	  1H	  NMR	  data	  recorded	  on	  compound	  143	  with	  those	  
reported44	  by	  Mukai.	  	  
Compound	  143	  
obtained	  in	  this	  worka	  
Ɂ,	  ppm	  (multiplicity,	  J,	  Hz)	  
ǯintermediatea	  
Ɂ,	  ppm	  (multiplicity,	  J,	  Hz)	  7.88	  (d,	  J	  =	  7.8	  Hz,	  1H)	   7.87	  (d,	  J	  =	  7.8	  Hz,	  1H)	  7.80	  (s,	  1H)	   7.78	  (brs,	  1H)	  7.26	  (d,	  J	  =	  7.4	  Hz,	  1H)	   7.23	  (d,	  J	  =	  7.3	  Hz,	  1H)	  7.07	  (d,	  J	  =	  7.3	  Hz,	  1H)	  7.02	  (d,	  J	  =	  7.3	  Hz,	  1H)	   7.08Ȃ6.99	  (m,	  2H)	  5.94Ȃ5.75	  (m,	  1H)	   5.89Ȃ5.79	  (m,	  1H)	  5.09	  (br	  s,	  1H)	   5.07	  (d,	  J	  =	  10.1	  Hz,	  1H)	  5.05	  (br	  s,	  1H)	   5.06	  (d,	  J	  =	  16.5	  Hz,	  1H)	  3.96	  (s,	  1H)	   3.95	  (s,	  1H)	  3.31	  (dd,	  J	  =	  12.9,	  4.9	  Hz,	  1H)	   3.30	  (dd,	  J	  =	  12.4,	  4.1	  Hz,	  1H)	  2.92	  (td,	  J	  =	  13.1,	  3.8	  Hz,	  1H)	   2.91	  (dd,	  J	  =	  12.9,	  3.5	  Hz,	  1H)	  2.81	  (dddd,	  J	  =	  17.9,	  11.9,	  6.3,	  2.5	  Hz,	  1H)	   2.82Ȃ2.73	  (m,	  1H)	  2.64	  (dd,	  J	  =	  16.6,	  6.8	  Hz,	  1H)	   2.60	  (dd,	  J	  =	  16.9,	  6.4	  Hz,	  1H)	  2.42	  (dd,	  J	  =	  14.6,	  7.4	  Hz,	  1H)	   2.40	  (dd,	  J	  =	  14.3,	  7.3	  Hz,	  1H)	  1.97	  (dd,	  J	  =	  14.6,	  7.6	  Hz,	  1H)	   1.95	  (dd,	  J	  =	  14.3,	  7.6	  Hz,	  1H)	  1.90Ȃ1.74	  (m,	  4H)	   1.86Ȃ1.74	  (m,	  4H)	  1.58Ȃ1.41	  (m,	  2H)	   1.53Ȃ1.43	  (m,	  2H)	  1.34Ȃ1.20	  (m,	  1H)	   1.28Ȃ1.21	  (m,	  1H)	  adata	  obtained	  at	  400	  MHz	  in	  CDCl3	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Table	  4-­‐2.	  Comparison	  of	  the	  13C	  NMR	  data	  recorded	  on	  compound	  143	  with	  those	  
reported44	  by	  Mukai.	  
	  
Compound	  143	  
obtained	  in	  this	  worka	  
ɁC	   ǯintermediatea	  ɁC	   ȟɁ	  136.0	   135.9	   +0.1	  135.3	   135.3	   0.0	  133.3	   133.3	   0.0	  127.1	   127.1	   0.0	  120.7	   120.6	   +0.1	  120.3	   120.2	   +0.1	  119.1	   119.0	  	   +0.1	  117.0	   117.0	   0.0	  110.9	   110.9	   0.0	  110.3	   110.3	   0.0	  63.8	   63.7	   +0.1	  47.2	   47.2	  	   0.0	  36.0	   35.9	   +0.1	  33.7	   33.6	   +0.1	  32.2	   32.1	   +0.1	  29.6	   29.6	   0.0	  22.2	   22.2	   0.0	  20.1	   20.0	   +0.1	  adata	  obtained	  at	  100	  MHz	  in	  CDCl3	  
	  In	   an	   effort	   to	   avoid	   the	   tedious	  protection/deprotection	   sequences	   reported	  by	  Mukai	  in	  carrying	  olefin	  143	  forward	  to	  kopsihainanine	  A,	  a	  direct	  dihydroxylation	  of	   the	   olefinic	   residue	   within	   compound	   143	   was	   examined	   as	   a	   means	   of	  obtaining	   diol	  193.	     ǯ ǡ     lead	  to	  a	  product	  that	  can	  spontaneously	  lactamize	  to	  give	  the	  Ƚ-­‐keto-­‐lactam	  196.	  Selective	  reduction	  of	  the	  ketone	  carbonyl	  within	  this	  last	  compound	  should	  then	  provide	   the	  natural	   product	   in	   just	   three	   steps	   (Scheme	  4-­‐22).	  Distressingly,	   the	  Sharpless-­‐modified	   version	   of	   the	   Upjohn	   dihydroxylation	   protocol,	   which	  operated	   effectively	   on	   the	   cis-­‐congener	   of	   the	   olefin	  190	   (Scheme	   4-­‐17),	   failed	  when	   applied	   to	   trans	   congener	  143.	   No	   identifiable	   products	   could	   be	   isolated	  from	  the	  reaction	  mixture.	  




Scheme	   4-­‐22.	       ǯ  
protocol	   to	   the	   unprotected	   substrate	   143.	  Reagents	   and	   conditions:	   (i)	   K2OsO4,	  NMO,	  citric	  acid,	  MeCN/H2O,	  18	  oC,	  1	  h.	  	  	  	  
4.3.	   Conclusion	  	  Through	  the	  studies	  described	  to	  this	  point,	  the	  chemical	  behaviours	  of	  the	  cis-­‐	  and	  
trans-­‐forms	   of	   the	   various	   tetracycles	   involved	   have	   been	   shown	   to	   vary	  dramatically.	   Hence,	   the	   precise	   ordering	   of	   the	   final	   synthetic	   events	   must	   be	  implemented	   very	   carefully	   in	   order	   to	   realize	   a	   synthesis	   of	   kopsihainanine	   A.	  These	  investigations	  have	  also	  highlighted	  the	  seemingly	  unavoidable	  need	  for	  the	  tedious	   protection/deprotection	   sequences	   involving	   the	   secondary	   amine	   and	  indole	   moieties	   of	   the	   various	   intermediates	   reported	   here	   so	   as	   to	   allow	   for	  further	  manipulation	   of	   the	   side	   chain	   and	   so	   validating	   the	   elaborate	   sequence	  reported44	  by	  Mukai.	  	  This	   Chapter	   thus	   describes	   a	   formal	   synthesis	   of	   kopsihainanine	   A	   from	   the	  versatile	   tetracyclic	   intermediate	   102	   (Scheme	   4-­‐23).	   The	   key	   steps	   involved	  include	  a	  facile	  protocol	  for	  the	  conversion	  of	  the	  cis-­‐perhydroquinoline	  190	  into	  its	   trans-­‐counterpart	   (143)	  via	   the	   formation	  of	   imine	  204.	   It	   is	   anticipated	   that	  this	   newly	   developed	   protocol	   can	   be	   used	   in	   future	   endeavours	   focused	   on	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syntheses	  of	  other	  Kopsia	  alkaloids	  possessing	  the	  unusual	  trans-­‐fused	  ABCD	  ring	  system.	  	  	  
	  
	  
Scheme	  4-­‐23.	  Summary	  of	  tǯ
formal	  total	  synthesis	  of	  (±)-­‐kopsihainanine	  A	  from	  tetracycle	  102.	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Chapter Five.  
Experimental Procedures Associated with Work Described in 
Chapters Two to Four 	  	  
5.1.	   General	  Experimental	  Procedures	  
	  Unless	   otherwise	   specified,	   proton	   (1H)	   and	   carbon	   (13C)	   NMR	   spectra	   were	  recorded	  at	  18	  °C	  in	  base-­‐filtered	  CDCl3	  on	  a	  Varian	  spectrometer	  operating	  at	  400	  MHz	   for	   proton	   and	   100	   MHz	   for	   carbon	   nuclei	   or	   a	   Varian	   Mercury	   machine	  operating	   at	   300	   MHz	   for	   proton	   and	   75	   MHz	   for	   carbon	   nuclei.	   For	   1H	   NMR	  spectra,	  signals	  arising	  from	  the	  residual	  protio-­‐forms	  of	  the	  solvent	  were	  used	  as	  the	   internal	   standards.	   1H	   NMR	   data	   are	   recorded	   as	   follows:	   chemical	   shift	   (Ɂ)	  [multiplicity,	   coupling	   constant(s)	   J	  (Hz),	   relative	   integral]	   where	   multiplicity	   is	  defined	   as:	   s	   =	   singlet;	   d	   =	   doublet;	   t	   =	   triplet;	   q	   =	   quartet;	   m	   =	   multiplet	   or	  combinations	  of	  the	  above.	  The	  central	  resonance	  of	  the	  CDCl3	  ǲǳat	   ɁC	   77.0	   was	   used	   to	   reference	   13C	   NMR	   spectra.	   Infrared	   spectra	   (ɋmax)	   were	  recorded	   on	   a	   Perkin-­‐Elmer	   1800	   Series	   FTIR	   Spectrometer.	   Samples	   were	  analyzed	  as	  thin	  films	  on	  KBr	  plates.	  A	  VG	  Fisons	  AutoSpec	  mass	  spectrometer	  was	  used	   to	  obtain	   low-­‐	  and	  high-­‐resolution	  electron	   impact	   (EI)	  mass	   spectra.	  Low-­‐	  and	   high-­‐resolution	   electrospray	   (ESI)	   mass	   spectra	   were	   obtained	   on	   a	   VG	  Quattro	  II	  triple-­‐quadrupole	  MS	  instrument	  operating	  in	  positive	  ionization	  mode.	  Melting	   points	   were	   measured	   on	   an	   Optimelt	   automated	  melting	   point	   system	  and	  are	  uncorrected.	  Analytical	   thin	   layer	  chromatography	  (TLC)	  was	  performed	  on	  aluminum-­‐backed	  0.2	  mm	  thick	  silica	  gel	  60	  F254	  plates	  as	  supplied	  by	  Merck.	  Eluted	  plates	  were	  visualized	  using	  a	  254	  nm	  UV	  lamp	  and/or	  by	  treatment	  with	  a	  suitable	   dip	   followed	   by	   heating.	   These	   dips	   included	   vanillin	   :	   sulfuric	   acid	   :	  ethanol	  (	  1	  g	  :	  1	  g	  :	  18	  mL)	  or	  potassium	  permanganate	  :	  potassium	  carbonate	  :	  5%	  sodium	   hydroxide	   aqueous	   solution	   :	   water	   (3	   g	   :	   20	   g:	   5	   mL	   :	   300	  mL).	   Flash	  chromatographic	  separations	  were	  carried	  out	  following	  protocols	  defined	  by	  Still	  
et	  al.57	  with	  silica	  gel	  60	  (40-­‐63	  Ɋm)	  as	  the	  stationary	  phase	  and	  using	  the	  AR-­‐	  or	  HPLC-­‐grade	   solvents	   indicated.	   Starting	   materials	   and	   reagents	   were	   generally	  available	   from	   the	   Sigma-­‐Aldrich,	   Merck,	   TCI,	   Strem	   or	   Lancaster	   Chemical	  Companies	   and	   were	   used	   as	   supplied.	   Drying	   agents	   and	   other	   inorganic	   salts	  were	   purchased	   from	   the	   AJAX,	   BDH	   or	   Unilab	   Chemical	   Companies.	  Tetrahydrofuran	  (THF),	  methanol	  and	  dichloromethane	  (DCM)	  were	  dried	  using	  a	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Glass	   Contour	   solvent	   purification	   system	   that	   is	   based	   upon	   a	   technology	  originally	  described	  by	  Grubbs	  et	  al.58	  Where	  necessary,	  reactions	  were	  performed	  under	  a	  nitrogen	  atmosphere.	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5.2.	   Experimental	   Procedures	   Associated	   with	   Work	   Described	   in	  
Chapter	  Two	  	  	  	  
3-­‐Bromocyclohex-­‐2-­‐en-­‐1-­‐one	  (80)	  	  
	  	  A	  magnetically	  stirred	  solution	  of	  1,3-­‐cyclohexanedione	  (79)	  (1.00	  g,	  8.92	  mmol)	  and	  dry	  N,N-­‐dimethyformamide	  (0.9	  mL,	  11.6	  mmol)	  in	  dry	  dichloromethane	  (25	  mL)	  maintained	  under	  nitrogen	  at	  0	  °C	  was	  treated	  dropwise	  with	  oxalyl	  bromide	  (5.35	  of	  a	  2	  M	  solution	  in	  dichloromethane,	  10.7	  mmol).	  The	  resulting	  mixture	  was	  left	  to	  stir	  at	  18	  °C	  for	  0.75	  h	  before	  being	  diluted	  with	  dichloromethane	  (10	  mL).	  The	  ensuing	  solution	  was	  washed	  with	  NH4Cl	  (1	  ×	  30	  mL	  of	  a	  saturated	  aqueous	  solution),	  NaHCO3	  (1	  ×	  30	  mL	  of	  a	  saturated	  aqueous	  solution)	  and	  brine	  (1	  ×	  30	  mL)	   before	   being	   dried	   (MgSO4),	   filtered	   and	   concentrated	   under	   reduced	  pressure.	   Subjection	   of	   the	   resulting	   orange	   oil	   to	   flash	   chromatography	   (silica,	  2:2.5:5.5	  v/v/v	  ethyl	  acetate/dichloromethane/hexane	  elution)	  and	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.6)	  afforded	  the	  title	  compound	  8026	  (1.34	  g,	  86%)	  as	  a	  clear,	  yellow	  oil.	  	  
1H	  NMR	  (300	  MHz,	  CDCl3ȌɁ͸ǤͶͶȋǡͳȌǡʹǤ͹ͻȋt,	  J	  =	  6.4	  Hz,	  2H),	  2.39	  (t,	  J	  =	  6.4	  Hz,	  2H),	  2.06	  (p,	  J	  =	  6.4	  Hz,	  2H).	  
13C	  NMR	  (75	  MHz,	  CDCl3ȌɁ196.2,	  150.1,	  132.5,	  36.3,	  36.2,	  22.9.	  
IR	  (KBr)	  ɓmax	  1675,	  1607,	  1282,	  1229,	  972	  cm-­‐1.	  
MS	  (EI,	  70	  eV)	  m/z	  175	  (M+y,	  74%),	  149	  (35),	  145	  (83),	  105	  (18),	  95	  (20),	  67	  (100),	  57	  (13).	  
HREIMS	  M+y	  calcd	  for	  C6H7BrO81	  175.9660,	  found	  175.9661.	  	  
	  
	   	  
	  	  100	  
3-­‐(3-­‐Oxocyclohex-­‐1-­‐en-­‐1-­‐yl)propanenitrile	  (81)	  	  
	  	  A	  magnetically	  stirred	  solution	  of	  bromide	  80	  (246	  mg,	  1.40	  mmol),	  acrylonitrile	  
ȋͶ͸ʹ Ɋǡ ͹ǤͲʹ Ȍ   ȋʹ͵ ǡ ͲǤͳͶ Ȍ    ȋ͹ Ȍmaintained	  under	  nitrogen	  at	  reflux	  was	  treated	  with	  Bu3SnH	  ȋͷʹɊǡͲǤͳͻȌevery	   0.5	   h	   for	   5	   h	   (total	   520	   Ɋ	   of	   Bu3SnH	   added).	   The	   resulting	  mixture	   was	  allowed	   to	   cool	   to	   18	   °C	   then	   concentrated	   under	   reduced	   pressure	   and	   the	  reddish-­‐orange	   oil	   thus	   obtained	   was	   subjected	   to	   flash	   chromatography	   (10%	  w/w	  K2CO3-­‐silica,	  2:2.5:5.5	  v/v/v	  ethyl	  acetate/dichloromethane/hexane	  elution).	  Concentration	  of	   the	   relevant	   fractions	   (Rf	   =	   0.5)	   afforded	   the	   title	  nitrile	  81	  (99	  mg,	  47%)	  as	  a	  clear,	  orange	  oil.	  	  
1H	  NMR	  (300	  MHz,	  CDCl3ȌɁͷǤͻͲȋǡͳȌǡʹǤ͵ͻȋǡJ	  =	  6.6	  Hz,	  1H),	  2.33	  (dd,	  J	  =	  6.6,	  1.5	   Hz,	   1H),	   2.09-­‐1.97	   (complex	   m,	   1H),	   1.68-­‐1.56	   (complex	   m,	   1H),	   1.42-­‐1.21	  (complex	  m,	  4H),	  0.91	  (t,	  J	  =	  6.6	  Hz,	  2H).	  
13C	  NMR	   (75	  MHz,	  CDCl3Ȍ Ɂ200.9,	   162.3,	   128.6,	   39.1,	   34.8,	   31.4,	   24.4,	   17.0	   (one	  signal	  obscured).	  
IR	  ȋȌɓmax	  2954,	  2926,	  2247,	  1671,	  1428,	  1256,	  887	  cm-­‐1.	  
MS	  (EI,	  70	  eV)	  m/z	  149	  (M+y,	  52%),	  121	  (100),	  106	  (22),	  93	  (32),	  81	  (35),	  66	  (30),	  53	  (32).	  




Method	   A:	   A	   magnetically	   stirred	   solution	   of	   enone	   81	   (90	   mg,	   0.60	   mmol)	   in	  methanol	  (2	  mL)	  maintained	  at	  0	  oC	  was	  treated	  with	  NaBH4	  (23	  mg,	  0.60	  mmol)	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and	  CeCl3yH2O	  (224	  mg,	  0.60	  mmol).	  The	  resulting	  mixture	  was	  left	  to	  stir	  at	  0	  °C	  for	  0.5	  h	  then	  diluted	  with	  diethyl	  ether	  (10	  mL)	  before	  being	  washed	  with	  water	  (1	  ×	  10	  mL)	  and	  brine	  (1	  ×	  10	  mL)	  then	  dried	  (MgSO4),	  filtered	  and	  concentrated	  under	   reduced	   pressure	   to	   afford	   the	   title	   alcohol	  78	   (63	   mg,	   70%)	   as	   a	   clear,	  yellow	  oil.	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  G	  5.55	  (broad	  t,	  J	  =	  1.6	  Hz,	  1H),	  4.16	  (broad	  d,	  J	  =	  1.6	  Hz,	  1H),	  2.43	  (t,	  J	  =	  7.0	  Hz,	  2H),	  2.33	  (broad	  s,	  1H),	  2.27	  (t,	  J	  =	  7.0	  Hz,	  2H),	  1.88	  (m,	  2H),	  1.83-­‐1.71	  (complex	  m,	  2H),	  1.59-­‐1.48	  (complex	  m,	  2H).	  
13C	  NMR	  (CDCl3,	  75	  MHz)	  G	  137.9,	  126.4,	  119.3,	  65.4,	  32.6,	  31.5,	  28.0,	  18.9,	  15.7.	  
IR	  ȋȌɓmax	  3402,	  2931,	  2862,	  2245,	  1430,	  1062,	  1033,	  959	  cm-­‐1.	  
MS	  (EI,	  70	  eV)	  m/z	  150	  (MΪȈ,	  8%),	  110	  (15),	  97	  (100),	  79	  (18),	  67	  (21),	  55	  (18).	  
HREIMS	  M+Ȉ	  calcd	  for	  C9H12NO	  150.0919,	  found	  150.0919.	  	  
	  	  
Method	  B:	  A	  magnetically	  stirred	  solution	  of	  xanthate	  8759	  (2.60	  g,	  23.6	  mmol)	  and	  vinyl	   epoxide	   9030	   (7.50	   g,	   47.3	   mmol)	   in	   dry	   dichloromethane	   (46	   mL)	  maintained	  under	  nitrogen	  at	  18	  °C	  was	  treated	  with	  triethylborane	  (70.8	  mL	  of	  a	  1	   M	   solution	   in	   hexane,	   70.8	   mmol)	   every	   0.5	   h	   for	   3	   h	   (total	   of	   424.8	   mL	   of	  triethylborane	  solution	  added).	  During	  each	  addition	  the	  tip	  of	  the	  syringe	  needle	  used	   to	   deliver	   the	   borane	   was	   placed	   below	   the	   surface	   of	   the	   solution.	  Furthermore,	   following	  each	  addition	  air	   (15	  mL)	  was	  syringed	   into	  the	   reaction	  mixture.	  The	  resulting	  mixture	  was	   left	   to	  stir	  at	  18	  °C	   for	  16	  h	  at	  which	  point	   it	  was	   diluted	   with	   dichloromethane	   (100	  mL).	   The	   ensuing	   solution	   was	   washed	  with	   water	   (1	   ×	   200	   mL)	   and	   brine	   (1	   ×	   200	  mL)	   before	   being	   dried	   (MgSO4),	  filtered	   and	   concentrated	   under	   reduced	   pressure.	   Subjection	   of	   the	   resulting	  light-­‐yellow	   oil	   to	   flash	   chromatography	   (silica,	   4:5:1	   v/v/v	   ethyl	  acetate/hexane/methanol	  elution)	  and	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.5)	  afforded	  the	  title	  compound	  78	  (2.56	  g,	  74%)	  as	  a	  clear,	  light-­‐yellow	  oil.	  This	  material	   was	   identical,	   in	   all	   respects,	   with	   an	   authentic	   sample	   prepared	   by	  Method	  A.	  
	  	  102	  
3-­‐(2-­‐Cyanoethyl)cyclohex-­‐2-­‐en-­‐1-­‐yl	  acetate	  (93)	  	  
	  	  A	   magnetically	   stirred	   solution	   of	   alcohol	   78	   (67	   mg,	   0.44	   mmol)	   in	   acetic	  anhydride	   (2	   mL)	   was	   treated	  with	   4-­‐(N,N-­‐dimethylamino)pyridine	   (5	  mg,	   0.04	  mmol)	  and	  pyridine	  (1	  mL)	  and	  the	  resulting	  solution	  stirred	  at	  18	  °C	  for	  1	  h.	  After	  this	  time	  the	  reaction	  mixture	  was	  diluted	  with	  diethyl	  ether	  (10	  mL)	  then	  washed	  with	  water	  (1	  ×	  20	  mL),	  HCl	  (1	  ×	  20	  mL	  of	  a	  1	  M	  aqueous	  solution),	  NaHCO3	  (1	  ×	  10	  mL	   of	   a	   saturated	   aqueous	   solution)	   and	   brine	   (1	   x	   10	   mL)	   before	   being	   dried	  (MgSO4),	   filtered	   and	   concentrated	   under	   reduced	   pressure	   to	   afford	   the	   title	  
acetate	  93	  (66	  mg,	  78%)	  as	  a	  clear,	  yellow	  oil.	  	  
1H	  NMR	  (300	  MHz,	  CDCl3ȌɁͷǤͷ4	  (s,	  1H),	  5.24	  (br	  s,	  1H),	  2.45	  (dd,	  J	  =	  7.1,	  1.3	  Hz,	  2H),	  2.33	  (dd,	  J	  =	  7.1,	  1.3,	  2H),	  2.02	  (s,	  3H),	  1.99-­‐1.92	  (complex	  m,	  2H),	  1.85-­‐1.59	  (complex	  m,	  4H).	  
13C	  NMR	  (75	  MHz,	  CDCl3ȌɁͳ͹ͲǤ͸ǡͳͶͲǤ͵ǡͳʹʹǤͲǡͳͳͻǤͳǡ͸ͺǤ0,	  32.7,	  27.9,	  21.3,	  18.8,	  15.5	  (one	  signal	  obscured	  or	  overlapping).	  
IR	  ȋȌɓmax	  2937,	  2246,	  1727,	  1371,	  1243,	  1021,	  922	  cm-­‐1.	  
MS	  (EI,	  70	  eV)	  m/z	  193	  (MΪȈ,	  12%),	  153	  (35),	  110	  (100),	  97	  (55),	  93	  (82),	  79	  (32).	  
HREIMS	  MΪȈ	  calcd	  for	  C11H15NO2	  193.1103,	  found	  193.1101.	  
	  
	  
	   	  
	  	   103	  
2-­‐(1-­‐(2-­‐Cyanoethyl)cyclohex-­‐2-­‐en-­‐1-­‐yl)-­‐N,N-­‐dimethylacetamide	  (97)	  	  
	  	  A	  magnetically	  stirred	  solution	  of	  compound	  78	  (1.90	  g,	  12.6	  mmol)	  in	  dry	  toluene	  (130	   mL)	   maintained	   under	   nitrogen	   at	   18	   °C	   was	   treated	   with	   N,N-­‐dimethylacetamide	  dimethyl	  acetal	  (9.20	  mL,	  62.8	  mmol)	  and	  the	  ensuing	  mixture	  heated	   at	   reflux	   for	   16	   h.	   The	   cooled	   reaction	  mixture	   was	   concentrated	   under	  reduced	   pressure	   and	   the	   ensuing	   light-­‐yellow	   oil	   subjected	   to	   flash	  chromatography	   (silica,	   6:3:1	   v/v/v	   ethyl	   acetate/hexane/methanol	   elution).	  Concentration	  of	  the	  relevant	  fractions	  (Rf	  	  =	  0.5)	  afforded	  the	  title	  amide	  97	  (2.30	  g,	  80%)	  as	  a	  clear,	  light-­‐brown	  oil.	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  G	  5.79	  (dt,	  J	  =	  10.0,	  4.0	  Hz,	  1H),	  5.49	  (d,	  J	  =	  10.0	  Hz,	  1H),	  3.00	  (s,	  3H),	  2.93	  (s,	  3H),	  2.50	  (d,	  J	  =	  14.8	  Hz,	  1H),	  2.35	  (m,	  2H),	  2.20	  (d,	  J	  =	  14.8	  Hz,	  1H),	  2.00	  (m,	  4H),	  1.63	  (m,	  4H).	  
13C	  NMR	  (CDCl3,	  75	  MHz)	  G	  170.5,	  132.1,	  129.0,	  120.5,	  40.8,	  38.2,	  37.0,	  35.4,	  34.6,	  32.4,	  24.8,	  18.7,	  12.4.	  
IR	  ȋȌɓmax	  3015,	  2932,	  2244,	  1638,	  1495,	  1451,	  1395,	  1260,	  1144,	  1080,	  1060,	  966,	  731,	  696,	  605	  cm-­‐1.	  
MS	  (EI,	  70	  eV)	  m/z	  220	  (MΪȈ,	  7%),	  180	  (6),	  166	  (12),	  134	  (11),	  93	  (16),	  87	  (100),	  77	  (13),	  72	  (51).	  
HREIMS	  MΪȈ	  calcd	  for	  C13H20N2O	  220.1576,	  found	  220.1574.	  
 
	  
	   	  




 A	   magnetically	   stirred	   solution	   of	   amide	   97	   (2.30	   g,	   10.4	   mmol)	   in	   dry	   ethyl	  acetate	   (70	  mL)	  was	   treated	  with	   tert-­‐butyl	   hydroperoxide	   (21.0	  mL	   of	   a	   5-­‐6	  M	  solution	   in	   decane,	   104.4	   mmol)	   and	   4	   Å	   molecular	   sieves	   (2.0	   g	   of	   activated	  material)	   and	   the	   resulting	   mixture	   stirred	   at	   18	   °C	   for	   0.5	   h.	   After	   this	   time	  manganese(III)	   acetate	   dihydrate	   (1.40	   g,	   0.52	  mmol)	  was	   added	   in	   one	   portion	  and	  the	  ensuing	  mixture	  stirred	  for	  a	  further	  16	  h	  at	  18	  °C	  then	  filtered	  through	  a	  pad	   of	   CeliteTM.	   The	   filtrate	  was	   concentrated	   under	   reduced	   pressure	   and	   the	  ensuing	   light-­‐yellow	   oil	   subjected	   to	   flash	   chromatography	   (silica,	   6:3:1	   v/v/v	  ethyl	   acetate/hexane/methanol	   elution).	   Concentration	   of	   the	   relevant	   fractions	  (Rf	  =	  0.4)	  afforded	  the	  title	  compound	  98	  (1.70	  g,	  74%)	  as	  a	  clear,	  pale-­‐yellow	  oil.	  
	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  G	  7.00	  (d,	  J	  =	  10.0	  Hz,	  1H),	  5.98	  (d,	  J	  =	  10.0	  Hz,	  1H),	  3.00	  (s,	  3H),	  2.92	  (s,	  3H),	  2.63	  (d,	  J	  =	  16.0	  Hz,	  1H),	  2.45	  (m,	  3H),	  2.37	  (m,	  2H),	  2.25	  (m,	  2H),	  2.03	  (m,	  2H).	  
13C	  NMR	  (CDCl3,	  75	  MHz)	  G	  197.8,	  169.1,	  154.9,	  128.9,	  119.5,	  38.9,	  37.7,	  35.4,	  33.4,	  32.9,	  31.6	  (two	  overlapping	  signals),	  12.6.	  
IR	  ȋȌɓmax	  2933,	  2246,	  1676,	  1639,	  1495,	  1452,	  1398,	  1257,	  1145,	  806	  cm-­‐1.	  
MS	  (EI,	  70	  eV)	  m/z	  234	  (MΪȈ,	  11%),	  194	  (7),	  180	  (8),	  138	  (12),	  107	  (16),	  87	  (100),	  79	  (13),	  72	  (58),	  57	  (12).	  
HREIMS	  M+Ȉcalcd	  for	  C13H18N2O2	  234.1368,	  found	  234.1367.	  	  
	  
	   	  
	  	   105	  
2-­‐(1-­‐(2-­‐Cyanoethyl)-­‐3-­‐iodo-­‐4-­‐oxocyclohex-­‐2-­‐en-­‐1-­‐yl)-­‐N,N-­‐
dimethylacetamide	  (100)	  	  
 
 A	   magnetically	   stirred	   solution	   of	   compound	   98	   (1.80	   g,	   7.7	   mmol)	   in	  chloroform/pyridine	   (70	   mL	   of	   a	   1:1	   v/v	   mixture)	   maintained	   at	   18	   °C	   under	  nitrogen	  was	  treated	  with	  molecular	  iodide	  (7.90	  g,	  30.9	  mmol)	  in	  small	  portions	  over	   0.2	   h.	   The	   resulting	   solution	   was	   stirred	   for	   16	   h	   then	   diluted	   with	  dichloromethane	  (100	  mL)	  before	  being	  washed	  with	  water	  (1	  ×	  50	  mL),	  HCl	  (2	  ×	  50	  mL	  of	  a	  1	  M	  aqueous	  solution),	  sodium	  metabisulfite	  (2	  ×	  50	  mL	  of	  a	  1:9	  w/v	  aqueous	   solution)	   and	   brine	   (1	   ×	   50	   mL)	   then	   dried	   (MgSO4),	   filtered	   and	  concentrated	   under	   reduced	   pressure	   to	   afford	   the	   title	   iodoenone	  100	   (2.00	   g,	  73%)	  as	  a	  clear,	  deep-­‐brown	  oil.	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  G	  7.85	  (s,	  1H),	  3.01	  (s,	  3H),	  2.94	  (s,	  3H),	  2.70	  (m,	  3H),	  2.50	  (d,	  J	  =	  16.0	  Hz,	  1H),	  2.42	  (m,	  2H),	  2.20	  (m,	  4H).	  
13C	  NMR	  (CDCl3,	  75	  MHz)	  G	  190.8,	  168.7,	  163.4,	  119.2,	  104.2,	  42.3,	  38.7,	  37.7,	  35.6,	  32.3,	  31.6,	  29.6,	  12.7.	  	  IR	  ȋȌɓmax	  3959,	  2026,	  2869,	  2245,	  1683,	  1636,	  1583,	  1495,	  1450,	  1398,	  1319,	  1261,	  1150,	  1119,	  1059,	  1020,	  952,	  881,	  802,	  728	  cm-­‐1.	  
MS	   (EI,	  70	  eV)	  m/z	  360	   (MΪȈ,	   63%),	  320	   (10),	  306	   (15),	  233	   (25),	  180	   (20),	  107	  (23),	  87	  (100),	  72	  (76).	  
HREIMS	  M+Ȉcalcd	  for	  C13H17IN2O2	  360.0335,	  found	  360.0338.	  	  	  
	   	  
	  	  106	  
2-­‐(3-­‐(2-­‐Cyanoethyl)-­‐2'-­‐nitro-­‐6-­‐oxo-­‐3,4,5,6-­‐tetrahydro-­‐[1,1'-­‐biphenyl]-­‐3-­‐yl)-­‐
N,N-­‐dimethylacetamide	  (101)	  	  
	  	  A	  magnetically	   stirred	   mixture	   of	   iodide	   100	   (2.0	   g,	   5.6	  mmol),	   freshly	   washed	  copper	   dustȘ	  (1.80	   g,	   28.2	   mmol),	   Pd2(dba)3	   (258	   mg,	   0.28	   mmol)	   and	   o-­‐iodonitrobenzene	  (2.80	  g,	  11.3	  mmol)	  in	  dry	  DMSO	  (100	  mL)	  was	  heated	  at	  70	  °C	  for	  0.5	  h	  then	  cooled	  and	  filtered	  through	  a	  pad	  of	  CeliteTM.	  The	  filtrate	  was	  diluted	  with	  dichloromethane	  (100	  mL)	  and	  the	  resulting	  solution	  washed	  with	  NH4Cl	  (1	  ×	  100	  mL	  of	   a	   saturated	  aqueous	   solution),	  water	   (1	  ×	  100	  mL)	  and	  brine	   (1	  ×	  50	  mL)	   before	   being	   dried	   (MgSO4),	   filtered	   and	   concentrated	   under	   reduced	  pressure.	  Subjection	  of	  the	  ensuing	  light-­‐yellow	  oil	  to	  flash	  chromatography	  (silica,	  6:3:1	   v/v/v	   ethyl	   acetate/hexane/methanol	   elution)	   gave,	   after	   concentration	   of	  the	   relevant	   fractions	   (Rf	  =	  0.4),	   the	   title	  compound	  101	   (1.7	   g,	   85%)	   as	   a	   brown	  foam.	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  G	  8.02	  (d,	   J	  =	  7.2	  Hz,	  1H),	  7.61	  (td,	   J	  =	  7.2,	  0.8	  Hz,	  1H),	  7.47	  (td,	  J	  =	  7.2,	  0.8	  Hz,	  1H),	  7.35	  (dd,	  J	  =	  7.2,	  0.8	  Hz,	  1H),	  7.07	  (s,	  1H),	  3.04	  (s,	  3H),	  2.95	  (s,	  3H),	  2.80	  (d,	  J	  =	  16.0	  Hz,	  1H),	  2.62	  (m,	  3H),	  2.50	  (m,	  2H),	  2.27	  (m,	  2H)	  2.15	  (m,	  2H).	  
13C	  NMR	  (CDCl3,	  75	  MHz)	  G	  195.1,	  169.2,	  151.1,	  148.1,	  138.0,	  133.6,	  131.7,	  131.5,	  128.9,	  124.0,	  119.6,	  39.4,	  38.2,	  37.7,	  35.4,	  33.7,	  33.1,	  31.1,	  12.6.	  
IR	  ȋȌɓmax	  2931,	  2870,	  2246,	  1681,	  1639,	  1573,	  1526,	  1452,	  1419,	  1399,	  1353,	  1261,	  1152,	  914,	  860,	  789,	  730	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  378	  [(M	  +	  Na)+,	  100%],	  356	  [(M	  +	  H)+,	  15].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H21N3O4	  356.1610,	  found	  356.1610.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Ș    Ǯǯ ȋʹǤͲ	  g	   of	   3	  micron	   dendritic	  material	   ex.	   Aldrich	   Chemical	   Co.)	   in	  EDTA	   (400	  mL	   of	   a	   0.02	  M	   solution	   in	   distilled	   water)	   was	   subjected	   to	   irradiation	   in	   a	   100	  W	  Branson	  ultrasonication	  bath	  at	  18	  °C	  for	  0.5	  h.	  The	  copper	  dust	  was	  then	  allowed	  to	  settle	  and	  the	  supernatant	  decanted.	  The	  residual	  solid	  was	  washed	  with	  deionized	  and	  deoxygenated	  water	  (4	  ×	  100	  mL)	   then	  acetone	  (3	  ×	  100	  mL)	  and	  methanol	   (2	  ×	  100	  mL).	  The	  material	  obtained	  after	   the	  final	  wash	  was	  transferred	  to	  a	  round-­‐bottom	  flask	  and	  the	  residual	  methanol	  removed	  by	  rotary	  evaporation	   and	   thus	   providing	   ca.	   1.8	   g	   of	   the	   activated	  metal.	   This	   was	   used	   promptly	   in	   the	  cross-­‐coupling	  reaction.60	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N,N-­‐Dimethyl-­‐2-­‐((4aS,11cS)-­‐1,2,3,4,5,6,7,11c-­‐octahydro-­‐4aH-­‐pyrido[3,2-­‐
c]carbazol-­‐4a-­‐yl)acetamide	  (102)	  and	  
2-­‐((4aS,11cS)-­‐7-­‐hydroxy-­‐1,2,3,4,5,6,7,11c-­‐octahydro-­‐4aH-­‐pyrido[3,2-­‐
c]carbazol-­‐4a-­‐yl)-­‐N,N-­‐dimethylacetamide	  (103)	  	  
 
 A	  mixture	  of	  compound	  101	  (1.20	  g,	  3.5	  mmol),	  p-­‐Ȉ2O	  (3.30	  g,	  17.5	  mmol)	  and	   freshly	   prepared	  Raney-­‐Co17	   (2.40	   g,	   200%	  w/w)	   in	  methanol	   (70	  mL)	  was	  stirred	  magnetically	   at	   40	   °C	   for	   16	   h	   under	   an	   atmosphere	   of	   dihydrogen.	   The	  cooled	  reaction	  mixture	  was	  purged	  with	  nitrogen	  then	  filtered	  through	  a	  pad	  of	  CeliteTM	   and	   the	   filtrate	   concentrated	   under	   reduced	   pressure.	   Subjection	   of	   the	  ensuing	   clear,	   colourless	   oil	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	  afforded,	  after	  concentration	  of	  the	  relevant	   fractions	   (Rf	  =	   0.5),	   the	   title	  compound	  102	   (922	  mg,	   85%)	   as	   a	   white,	  crystalline	  solid,	  mp	  152Ȃ154	  °C.	  	  
1H	  NMR	  (CD3OD,	  400	  MHz)	  Ɂ7.54	  (d,	  J	  =	  8.0	  Hz,	  1H),	  7.24	  (d,	  J	  =	  6.4	  Hz,	  1H),	  7.00	  (m,	  2H),	  3.95	  (s,	  1H),	  2.99	  (broad	  d,	  J	  =	  12.8	  Hz,	  1H),	  2.87	  (m,	  2H),	  2.85	  (s,	  3H),	  2.78	  (s,	  3H),	  2.77	  (dd,	  J	  =	  11.6,	  3.2	  Hz,	  2H),	  2.54	  (m,	  1H),	  2.43	  (d,	  J	  =	  14.4	  Hz,	  1H),	  2.23	  (d,	  J	  =	  14.4	  Hz,	  1H),	  1.90	  (m,	  1H),	  1.82	  (m,	  1H),	  1.72	  (m,	  1H),	  1.52	  (m,	  1H)	  (signals	  due	  to	  NH	  group	  protons	  not	  observed).	  
13C	  NMR	  (CD3OD,	  75	  MHz)	  Ɂ174.1,	  138.2,	  135.9,	  128.2,	  121.9,	  119.9,	  118.4,	  111.6,	  110.9,	  56.3,	  46.7,	  39.2,	  38.5,	  37.4,	  35.8,	  35.7,	  26.1,	  22.6,	  21.0.	  
IR	  ȋȌɓmax	  3400,	  3283,	  2923,	  2855,	  1621,	  1449,	  1395,	  1033,	  745,	  682	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  312	  [(M	  +	  H)+,	  100%],	  267	  (7).	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H25N3O	  312.2076,	  found	  312.2078.	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  When	   the	  abovementioned	  reaction	  was	  carried	  out	   for	   just	  4	  h	  and	   the	  product	  mixture	   subjected	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	  two	  fractions,	  A	  and	  B,	  were	  obtained.	  	  Concentration	  of	  fraction	  A	  (Rf	  =	  0.5)	  afforded	  the	  title	  compound	  102	  (42%),	  the	  1H	  and	   13C	  NMR	  spectral	  data	   for	  which	  were	   identical	   to	   those	  derived	   from	  an	  authentic	  sample.	  	  Concentration	  of	  fraction	  B	  (Rf	  =	  0.3)	  afforded	  the	  title	  compound	  103	  (42%)	  as	  a	  white,	  crystalline	  solid.	  	  
1H	  NMR	  (CD3OD,	  400	  MHz)	  Ɂ7.61	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.39	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.16	  (t,	   J	  =	  7.6	  Hz,	  1H),	  7.07	  (t,	   J	  =	  7.6	  Hz,	  1H),	  4.76	  (s,	  1H),	  3.26	  (broad	  d,	   J	  =	  12.4	  Hz,	  1H),	  3.10	  (td,	  J	  =	  12.4	  and	  2.8	  Hz,	  1H),	  3.00-­‐2.88	  (complex	  m,	  3H),	  2.86	  (s,	  3H),	  2.85	  (s,	   3	   H),	   2.49-­‐2.33	   (complex	   m,	   3H),	   2.10	   (td,	   J	  =	   14.0,	   4.4	   Hz,	   1H),	   1.99-­‐1.93	  (complex	  m,	  3H),	  1.83	  (broad	  m,	  1H)	  (signals	  due	  to	  the	  NH	  and	  OH	  group	  protons	  not	  observed).	  
13C	  NMR	  (CD3OD,	  75	  MHz)	  Ɂ172.9,	  136.2,	  135.8,	  122.9,	  122.7,	  120.6,	  118.3,	  109.3,	  100.3,	  55.3,	  45.4,	  38.4,	  38.2,	  37.1,	  35.9,	  33.7,	  26.0,	  19.8,	  18.7.	  
MS	  (ESI,	  +ve)	  m/z	  328	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H25N3O2	  328.2025,	  found	  328.2024.	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N,N-­‐Dimethyl-­‐2-­‐((4aS,11cS)-­‐1,2,3,4,5,6,7,11c-­‐octahydro-­‐4aH-­‐pyrido[3,2-­‐
c]carbazol-­‐4a-­‐yl)acetamide	  (102)	  and	  
(R)-­‐2-­‐(3-­‐(3-­‐aminopropyl)-­‐2,3,4,9-­‐tetrahydro-­‐1H-­‐carbazol-­‐3-­‐yl)-­‐N,N-­‐
dimethylacetamide	  (107)	  	  
	  	  A	  mixture	  of	  compound	  101	  (100	  mg,	  0.28	  mmol),	  p-­‐Ȉ2O	  (268	  g,	  1.41	  mmol)	  and	  Raney-­‐Ni	  (200	  mg,	  200%	  w/w)	  in	  methanol	  (20	  mL)	  was	  stirred	  magnetically	  at	  40	  °C	  for	  16	  h	  under	  an	  atmosphere	  of	  dihydrogen.	  The	  cooled	  reaction	  mixture	  was	  purged	  with	  nitrogen	   then	   filtered	   through	  a	  pad	  of	  CeliteTM	  and	   the	   filtrate	  concentrated	  under	  reduced	  pressure.	  Subjection	  of	  the	  ensuing	  brown	  oil	  to	  flash	  chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	   methanol/dichloromethane	  elution)	  afforded	  two	  fractions,	  A	  and	  B.	  	  Concentration	   of	   fraction	   A	   (Rf	  	   =	   0.5)	   afforded	   the	   title	   compound	  102	   (41	  mg,	  48%)	  as	  a	  white,	  crystalline	  solid.	  This	  material	  was	  identical,	  in	  all	  respects,	  with	  an	  authentic	  sample.	  	  Concentration	  of	  fraction	  B	  (Rf	  	  =	  0.2)	  afforded	  the	  title	  compound	  107	  (21	  mg,	  24	  %)	  as	  a	  clear,	  brown	  oil.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ7.32	  (d,	  J	  =	  8.0	  Hz,	  1H),	  7.23	  (d,	  J	  =	  8.0	  Hz,	  1H),	  6.99	  (m,	  1H),	  6.93	  (m,	  1H),	  2.87	  (s,	  3H),	  2.85	  (s,	  3H),	  2.73	  (t,	  J	  =	  7.2	  Hz,	  2H),	  2.66	  (d,	  J	  =	  15.2	  Hz,	  1H),	  2.59	  (s,	  2H),	  2.57	  (d,	  J	  =	  14.8	  Hz,	  1H),	  2.50	  (d,	  J	  =	  15.2	  Hz,	  1H),	  2.34	  (d,	  
J	  =	  14.8	  Hz,	  1H),	  2.00	  (m,	  1H),	  1.78	  (m,	  1H),	  1.56	  (m,	  4H)	  (signals	  due	  to	  NH	  group	  protons	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ 174.3,	   138.1,	   134.0,	   129.2,	   121.5,	   119.3,	   118.1,	  111.5,	  108.5,	  43.3,	  38.5,	  38.3,	  37.5,	  36.0,	  35.8,	  33.5,	  32.8,	  27.9,	  20.9.	  
IR	  ȋȌɓmax	  3272,	  3051,	  2926,	  2852,	  1628,	  1492,	  1466,	  1395,	  741	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  314	  [(M	  +	  H)+,	  100%],	  297	  (18).	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H28N3O	  314.2232,	  found	  314.2226.	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2-­‐((4aS,11cS)-­‐1-­‐(2-­‐Chloroacetyl)-­‐1,2,3,4,5,6,7,11c-­‐octahydro-­‐4aH-­‐
pyrido[3,2-­‐c]carbazol-­‐4a-­‐yl)-­‐N,N-­‐dimethylacetamide	  (108)	  	  
	  	  A	   magnetically	   stirred	   solution	   of	   compound	   102	   (43	   mg,	   0.14	   mmol)	   and	  
 ȋʹʹͲ Ɋǡ ͳ͵ǤͺȌ    ȋͳͷȌunder	   a	  nitrogen	   atmosphere	   at	   0	   °C	  was	   ǡ ǡȽ-­‐chloroacetyl	  
ȋͳ͹ɊǡͲǤʹͳȌǤͳͺιover	   2	   h	   then	   poured	   into	   water	   (20	   mL)	   and	   the	   separated	   aqueous	   phase	  extracted	  with	  dichloromethane	   (1	  ×	  5	  mL).	   The	   combined	  organic	   phases	  were	  then	  dried	  (MgSO4),	  filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  afford	  a	  brown	  oil.	  Subjection	  of	  this	  material	  to	  flash	  chromatography	  (silica,	  7:2:1	  v/v/v	  ethyl	   acetate/hexane/methanol	   elution)	   and	   concentration	   of	   the	   relevant	  fractions	  (Rf	  =	  0.5)	  afforded	  the	  title	  compound	  108	  (32	  mg,	  60%)	  as	  a	  clear,	  light-­‐yellow	  oil	   and	   a	   ca.	   1:1	  mixture	   of	   amide	   rotamers	  was	   observed	   in	   solution	   by	  NMR	  spectroscopy.	  	  
1H	  NMR	   (CDCl3,	   400	  MHz)	  Ɂ (ca.	  1:1	  mixture	   of	   amide	   rotamers)	   8.66	   (s,	   0.5H),	  8.57	  (s,	  0.5H),	  7.28	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.19	  (dd,	  J	  =	  7.6,	  4.0	  Hz,	  1H),	  7.07	  (t,	  J	  =	  7.6	  Hz,	  1H),	  6.97	  (m,	  1H),	  5.77	  (s,	  0.5H),	  5.68	  (s,	  0.5H),	  4.80	  (d,	  J	  =	  14.0	  Hz,	  0.5H),	  4.62	  (d,	  J	  =	  14.0	  Hz,	  0.5H),	  4.53	  (broad	  d,	   J	  =	  10.8	  Hz,	  0.5H),	  4.34	  (d,	   J	  =	  12.0	  Hz,	  0.5H),	  4.23	  (d,	  J	  =	  12.0	  Hz,	  0.5H),	  3.60	  (broad	  d,	  J	  =	  13.2	  Hz,	  0.5H),	  3.07	  (s,	  1.5H),	  3.02	  (s,	  1.5H),	  2.96	  (s,	  1.5H),	  2.95	  (s,	  1.5H),	  2.88-­‐2.73	  (complex	  m,	  2H),	  2.68-­‐2.32	  (complex	  m,	   3H),	   2.14	   (m,	   0.5H),	   2.03	   (broad	   d,	   J	  =	  13.2	  Hz,	   0.5H),	   1.84	   (m,	   2H),	   1.68	   (m,	  1.5H),	  1.41	  (m,	  1.5H).	  
13C	   NMR	   (CDCl3,	   75	   MHz)	   Ɂ (ca.	  1:1	   mixture	   of	   amide	   rotamers)	   171.5,	   171.2,	  166.6,	   166.3,	   136.2,	   136.1,	   135.2,	   134.3,	   125.9,	   125.8,	   121.2,	   121.1,	   119.8,	   119.4,	  117.9,	  110.7,	  110.6,	  106.7,	  106.5,	  55.9,	  54.6,	  42.6,	  42.4,	  41.5,	  38.2,	  38.1,	  37.6,	  37.5,	  37.2,	  36.8,	  36.7,	  35.6,	  35.5,	  32.0,	  30.9,	  28.1,	  23.8,	  21.9,	  20.6,	  19.5,	  19.3	  (one	  signal	  obscured	  or	  overlapping).	  
IR	  ȋȌɓmax	  3282,	  3053,	  2929,	  2857,	  1632,	  1455,	  1329,	  1259,	  1154,	  1095,	  1015,	  
	  	   111	  
737	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  410	  [(M	  +	  Na)+,	  84%],	  388	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C21H2635ClN3O2	  388.1792,	  found	  388.1793.	  	  
	  
N,N-­‐Dimethyl-­‐2-­‐((3aS,3aǯS,10bR)-­‐12-­‐oxo-­‐2,3,4,5,11,12-­‐hexahydro-­‐1H-­‐
indolizino[8,1-­‐cd]carbazol-­‐3a(3a1H)-­‐yl)acetamide	  (109)	  	  
	  	  A	  magnetically	   stirred	   solution	   of	   acetamide	  108	   (400	  mg,	   1.03	  mmol)	   and	   NaI	  (1.60	  g,	  10.3	  mmol)	  in	  dry	  acetone	  (6	  mL)	  was	  heated	  at	  reflux	  for	  2	  h	  then	  cooled	  to	   18	   oC	   and	   poured	   into	   dichloromethane	   (5	   mL).	   The	   resulting	   mixture	   was	  washed	  with	  water	  (1	  ×	  5	  mL)	  then	  brine	  (1	  ×	  5	  mL)	  before	  being	  dried	  (MgSO4),	  filtered	   and	   concentrated	   under	   reduced	   pressure	   to	   yield	   a	   brown	   oil	   that	  was	  taken	  up	  in	  dry	  dichloromethane	  (5	  mL).	  The	  resulting	  solution	  was	  treated	  with	  AgOTf	  (530	  mg,	  2.06	  mmol)	  then	  stirred	  at	  18	  °C	  for	  16	  h.	  The	  pale-­‐yellow	  reaction	  mixture	  thus	  formed	  was	  filtered	  through	  a	  pad	  of	  CeliteTM	  and	  the	  filtrate	  washed	  with	  NaHCO3	  (1	  ×	  5	  mL),	  water	  (1	  ×	  5	  mL)	  and	  brine	  (1	  ×	  5	  mL)	  before	  being	  dried	  (MgSO4),	  filtered	  and	  concentrated	  under	  reduced	  pressure.	  The	  ensuing	  yellow	  oil	  was	  subjected	  to	  flash	  chromatography	  (silica,	  1:9	  v/v	  methanol/dichloromethane	  elution)	  to	  provide,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.6),	  the	  title	  
compound	  109	  (344	  mg,	  61%)	  as	  a	  yellow	  foam.	  	  
1H	  NMR	  (CD3OD,	  400	  MHz)	  Ɂ7.47	  (m,	  2H),	  7.38	  (t,	   J	  =	  7.6	  Hz,	  1H),	  7.30	  (t,	   J	  =	  7.6	  Hz,	  1H),	  4.24	  (m,	  1H),	  4.17	  (d,	  J	  =	  2.0	  Hz,	  1H),	  3.15	  (dd,	  J	  =	  18.4,	  8.8	  Hz,	  1H),	  3.05-­‐2.85	  (complex	  m,	  2H),	  2.85	  (s,	  3H),	  2.79	  (s,	  3H),	  2.51	  (dd,	  J	  =	  18.4	  and	  1.6	  Hz,	  1H),	  2.29	  (m,	  1H),	  2.05-­‐1.97	  (complex	  m,	  5H),	  1.76-­‐1.54	  (complex	  m,	  3H).	  
13C	   NMR	   (CD3OD,	   100	   MHz)	   Ɂ 189.9,	   172.4,	   172.1,	   154.7,	   146.6,	   129.8,	   127.9,	  122.7,	  120.7,	  70.4,	  55.5,	  41.8,	  39.6,	  38.9,	  38.2,	  38.1,	  35.8,	  34.9,	  25.6,	  25.4,	  21.0.	  
IR	  ȋȌɓmax	  3468,	  2934,	  2866,	  1686,	  1636,	  1578,	  1456,	  1293,	  1260,	  1153,	  771,	  758	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  352	  [(M	  +	  H)+,	  100%],	  335	  (31).	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HRESIMS	  (M	  +	  H)+	  calcd	  for	  C21H25N3O2	  352.2025,	  found	  352.2018.	  	  	  
N,N-­‐Dimethyl-­‐2-­‐((3aS,3aǯS,5aS,10bS)-­‐2,3,4,5,5a,6,11,12-­‐octahydro-­‐1H-­‐
indolizino[8,1-­‐cd]carbazol-­‐3a(3aǯH)-­‐yl)ethan-­‐1-­‐amine	  (111)	  	  
	  	  A	  magnetically	  stirred	  solution	  of	  amide	  109	  (100	  mg,	  0.28	  mmol)	  in	  dry	  THF	  (5	  mL)	  maintained	  under	  a	  nitrogen	  atmosphere	  was	  treated	  with	  lithium	  aluminium	  hydride	  (2.84	  mL	  of	  a	  1	  M	  solution	  in	  THF,	  2.84	  mmol)	  and	  the	  resulting	  mixture	  stirred	  whilst	  under	  reflux	  for	  16	  h.	  The	  reaction	  mixture	  so	  obtained	  was	  cooled	  to	  18	  °C	  then	  ȋʹͲͲɊȌǡȋʹͲͲɊͳͷΨȀqueous	  solution)	     ȋ͹ͷͲ ɊȌ ǡ    (MgSO4),	   filtered	   and	  concentrated	  under	  reduced	  pressure.	  Subjection	  of	  the	  ensuing	  yellow	  oil	  to	  flash	  chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	   methanol/dichloromethane	  elution)	   gave,	   after	   concentration	   of	   the	   relevant	   fractions	   (Rf	   =	   0.2),	   the	   title	  
compound	  111	  (60	  mg,	  65%)	  as	  a	  clear,	  brown	  oil.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ͹ǤͳͶȋǡJ	  =	  7.5,	  1.0	  Hz,	  1H),	  6.97	  (td,	  J	  =	  7.5,	  1.0	  Hz,	  1H),	  6.72	  (td,	  J	  =	  7.5,	  1.0	  Hz,	  1H),	  6.67	  (d,	  J	  =	  7.5	  Hz,	  1H),	  3.45	  (dd,	  J	  =	  11.0,	  6.2	  Hz,	  1H),	  3.11	  (dd,	   J	  =	  7.5,	  2.6	  Hz,	  1H),	  3.05	  (d,	   J	  =	  9.3	  Hz,	  1H),	  2.39-­‐2.23	  (complex	  m,	  4H),	   2.05	   (complex	  m,	  3H),	   2.00	   (s,	   6H),	   1.82-­‐1.71	   (complex	  m,	   3H),	   1.66	   (d,	   J	   =	  15.5	  Hz,	  1H),	  1.54	  (dm,	  1H),	  1.50-­‐1.43	  (complex	  m,	  1H),	  1.39	  (dt,	  J	  =	  13.4,	  4.6	  Hz,	  1H),	   1.25	   (td,	   J	   =	   13.4,	  4.6	  Hz,	   1H),	   1.06	   (dm,	  1H),	   0.99	   (td,	   J	   =	   13.4,	  4.6	  Hz,	   1H)	  (signal	  due	  to	  NH	  group	  proton	  not	  observed).	  
13C	  NMR	  (100	  MHz,	  CD3ȌɁͳͷͲǤͻǡͳ͵͸ǤͻǡͳʹͺǤͶǡͳʹ͵ǤͻǡͳʹͲǤͶǡͳͳʹǤ͵ǡ͹ʹǤͻǡ͸͸ǤͶǡ54.8,	  54.5,	  54.2,	  53.9,	  45.0,	  39.7,	  36.4,	  36.2,	  36.0,	  28.5,	  24.1,	  22.6.	  
IR	  ȋȌɓmax	  3266,	  2927,	  2776,	  1607,	  1481,	  1463,	  1332,	  1261,	  1178	  1026,	  740	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  326	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C21H32N3	  326.2596,	  found	  326.2596.	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N,N-­‐Dimethyl-­‐2-­‐((3aS,3aǯS,5aS,10bS)-­‐2,3,4,5,5a,6,11,12-­‐octahydro-­‐1H-­‐
indolizino[8,1-­‐cd]carbazol-­‐3a(3aǯH)-­‐yl)ethan-­‐1-­‐amine	  (111)	  and	  
(±)-­‐limaspermidine	  (2)	  	  
	  	  A	   magnetically	   stirred	   solution	   of	   the	   borane-­‐dimethylamine	   complex	   (353	   mg,	  5.98	   mmol)	   in	   dry	   THF	   (3	   mL)	   maintained	   under	   a	   nitrogen	   atmosphere	   was	  cooled	   to	   0	   oC	   then	   treated	   with	   n-­‐butyllithium	   (3.7	   mL	   of	   a	   1.6	   M	   solution	   in	  hexane,	  5.98	  mmol).	  The	  resulting	  mixture	  was	  stirred	  at	  0	  °C	  for	  1	  h	  before	  being	  treated,	  dropwise,	  with	  a	  solution	  of	  compound	  109	   (210	  mg,	  0.60	  mmol)	   in	  dry	  THF	  (1	  mL	  followed	  by	  a	  1	  mL	  rinse).	  The	  resulting	  suspension	  was	  stirred	  at	  18	  °C	  for	  2.5	  h	  then	  heated	  under	  reflux	  for	  16	  h.	  The	  reaction	  mixture	  so	  obtained	  was	  cooled	  to	  0	  °C	  then	  quenched	  with	  HCl	  (5	  mL	  of	  a	  3	  M	  aqueous	  solution).	  After	  0.5	  h	  the	  aqueous	  layer	  was	  separated	  and	  extracted	  with	  dichloromethane	  (4	  ×	  4	  mL).	  Sufficient	   sodium	   hydroxide	   was	   added	   to	   the	   aqueous	   layer	   at	   0	   °C	   so	   as	   to	  achieve	  a	  pH	  >7	  and	  this	  was	  then	  extracted	  with	  dichloromethane	  (4	  ×	  4	  mL).	  The	  combined	  organic	  layers	  were	  then	  dried	  (MgSO4),	  filtered	  and	  concentrated	  under	  reduced	   pressure.	   Subjection	   of	   the	   resulting	   deep-­‐brown	   oil	   to	   flash	  chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	   methanol/dichloromethane	  elution)	  afforded	  two	  fractions,	  A	  and	  B.	  	  	  Concentration	  of	  fraction	  A	  (Rf	  	  =	  0.6)	  afforded	  (±)-­‐limaspermidine	  [(±)-­‐2]	  (70	  mg,	  39%)	  as	  a	  white,	  crystalline	  solid,	  mp	  153Ȃ156	  °C	  [lit.	  mp5	  227-­‐228	  oC,	  (+)-­‐form	  of	  limaspermidine].	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  Ɂ7.09	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.01	  (t,	  J	  =	  7.6	  Hz,	  1H),	  6.73	  (t,	  J	  =	  7.2	  Hz,	  1H),	  6.64	  (d,	  J	  =	  7.2	  Hz,	  1H),	  3.62	  (m,	  1H),	  3.53	  (m,	  2H),	  3.07	  (broad	  d,	  J	  =	  10.4	   Hz,	   1H),	   2.28	   (m,	   3H),	   2.01	   (m,	   3H),	   1.80-­‐1.63	   (complex	   m,	   5H),	   1.52-­‐1.42	  (complex	  m,	  3H),	  1.30-­‐1.14	  (complex	  m,	  2H),	  1.03	  (dm,	  J	  =	  13.2	  Hz,	  1H)	  (signal	  due	  to	  one	  of	  the	  OH	  or	  NH	  group	  protons	  not	  observed).	  
13C	  NMR	   (CDCl3,	  200	  MHz)	  Ɂ149.5,	  135.3,	  127.4,	  122.7,	  119.2,	  110.5,	  70.7,	  65.3,	  58.6,	  53.7,	  53.4,	  52.8,	  40.5,	  38.6,	  35.4,	  29,7,	  28.2,	  24.3,	  21.7.	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IR	  ȋȌɓmax	  3431,	  3312,	  2930,	  2853,	  2814,	  1607,	  1463,	  1043,	  742	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  299	  (M	  +	  H+,	  100%).	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H27N2O	  299.2123,	  found	  299.2120.	  	  Concentration	   of	   fraction	   B	   (Rf	  	   =	   0.2)	   afforded	   the	   title	   compound	  111	   (70	  mg,	  36%)	  as	  a	   clear,	  brown	  oil.	  This	  material	  was	   identical,	   in	  all	   respects,	  with	   that	  obtained	  as	  described	  above.	  	  	  
(±)-­‐Limaspermidine	  (2)	  	  
	  	  A	  magnetically	  stirred	  solution	  of	  diisopropylamine	  (1.0	  mL,	  7.3	  mmol)	  in	  dry	  THF	  (2	  mL)	  maintained	  under	  a	  nitrogen	  atmosphere	  was	  cooled	  to	  Ȃ78	  °C	  then	  treated	  with	  n-­‐butyllithium	  (4.5	  mL	  of	  a	  1.6	  M	  solution	  in	  hexane,	  7.2	  mmol).	  The	  resulting	  mixture	  was	   stirred	   at	  Ȃ78	   °C	   for	   0.2	   h	   then	  warmed	   to	   0	   °C	   and	   stirred	   at	   this	  temperature	   for	   a	   further	   0.2	   h	   before	   being	   treated,	   in	   one	   portion,	   with	   the	  borane-­‐ammonia	   complex	   (223	   mg,	   7.2	   mmol).	   The	   resulting	   suspension	   was	  stirred	   at	   0	   °C	   for	   0.25	  h	   then	   at	   18	   °C	   for	   the	   same	  period	  before	   being	   cooled	  again	   to	  0	  °C	   then	  treated,	  dropwise,	  with	  a	  solution	  of	  compound	  109	  (169	  mg,	  0.48	  mmol)	  in	  dry	  THF	  (1	  mL	  followed	  by	  a	  1	  mL	  rinse).	  The	  reaction	  mixture	  so	  obtained	  was	  allowed	  to	  stir	  at	  18	  °C	  for	  16	  h	  then	  cooled	  0	  °C	  and	  quenched	  with	  HCl	  (5	  mL	  of	  a	  3	  M	  aqueous	  solution).	  After	  0.5	  h	  the	  aqueous	  layer	  was	  separated	  and	  extracted	  with	  dichloromethane	  (4	  ×	  4	  mL).	  Sufficient	  sodium	  hydroxide	  was	  added	   to	   the	   aqueous	   layer	   at	   0	   °C	   so	   as	   to	   achieve	   a	   pH	   >7	   and	   this	  was	   then	  extracted	  with	   dichloromethane	   (4	   ×	   4	  mL).	   The	   combined	   organic	   layers	   were	  then	  dried	  (MgSO4),	  filtered	  and	  concentrated	  under	  reduced	  pressure.	  Subjection	  of	   the	   resulting	   pale-­‐yellow	   oil	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	  methanol/dichloromethane	   elution)	   afforded,	   after	   concentration	   of	   the	   relevant	  fractions	  (Rf	  =	  0.4),	  (±)-­‐limaspermidine	  [(±)-­‐2]	  (87	  mg,	  60%)	  as	  a	  white,	  crystalline	  solid.	  This	  material	  was	   identical,	   in	  all	  respects,	  with	   that	  obtained	  as	  described	  above.	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(±)-­‐N-­‐Acetyllimaspermidine	  (120)	  	  
	  	  (±)-­‐Limaspermidine	  (2)	  (22	  mg,	  0.07	  mmol)	  was	  added	  to	  a	  magnetically	  stirred	  
    ȋͺ Ɋǡ ͲǤͳͳ Ȍ   ȋ͵ Ȍmaintained	   at	   0	   °C	  under	   a	  nitrogen	   atmosphere.	  After	  1	  h	   the	   reaction	  mixture	  was	  poured	   into	  water	   (5	  mL)	   then	  extracted	  with	  dichloromethane	   (3	   ×	  3	  mL).	  The	  combined	  organic	  layers	  were	  dried	  (MgSO4),	  filtered	  and	  concentrated	  under	  reduced	   pressure	   and	   the	   light-­‐yellow	   oil	   so	   obtained	   was	   subjected	   to	   flash	  chromatography	   (silica,	   1:9	   v/v	   methanol/	   dichloromethane	   elution)	   to	   afford,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.6),	  the	  title	  compound	  1208	  (25	  mg,	  100%)	  as	  a	  clear,	  colourless	  oil	  and	  a	  ca.	  4:1	  mixture	  of	  amide	  rotamers	  was	  observed	  in	  solution	  by	  NMR	  spectroscopy.	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  Ɂ(major	  rotamer)	  8.10	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.18	  (m,	  2H),	  7.03	  (td,	  J	  =	  7.6,	  0.8	  Hz,	  1H),	  4.05	  (dd,	  J	  =	  11.2,	  6.4	  Hz,	  1H),	  3.70-­‐3.46	  (complex	  m,	  2H),	   3.12	   (td,	   J	  =	   9.6	   and	   3.2	  Hz,	   1H),	   3.05	   (broad	   d,	   J	  =	   11.2	  Hz,	   1H),	   2.40-­‐2.23	  (complex	  m,	  2H),	  2.24	  (s,	  3H),	  2.14-­‐2.03	  (complex	  m,	  2H),	  2.00-­‐1.90	  (complex	  m,	  2H),	  1.82-­‐1.64	  (complex	  m,	  3H),	  1.59-­‐1.46	  (complex	  m,	  3H),	  1.32-­‐1.11	  (complex	  m,	  4H).	  
13C	  NMR	   (CDCl3,	   100	  MHz)	  Ɂ (major	   rotamer)	   168.4,	   140.6,	   138.0,	   127.6,	   124.4,	  122.3,	  118.3,	  70.3,	  67.9,	  58.2,	  53.6,	  52.8,	  52.4,	  40.3,	  39.4,	  35.2,	  35.0,	  25.8,	  24.1,	  23.2,	  21.5.	  
IR	  (KBr)	  ɓmax	  3400,	  2933,	  2786,	  2728,	  1645,	  1597,	  1479,	  1460,	  1403,	  1334,	  1292,	  1265,	  1176,	  1049,	  1019,	  912	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  363	  [(M	  +	  Na)+,	  5%],	  341	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C21H29N2O2	  341.2229,	  found	  341.2229.	  
	  
	  
	   	  




	  A	  magnetically	  stirred	  solution	  of	  (±)-­‐N-­‐acetyllimaspermadine	  (120)	  (22	  mg,	  0.07	  mmol)	   in	   acetic	   acid/water	   (3	   mL	   of	   a	   5:95	   v/v	   mixture)	   was	   treated	   with	  mercury(II)	  acetate	  (110	  mg,	  0.32	  mmol)	  and	  the	  resulting	  mixture	  heated	  at	  65	  °C	  for	  16	  h	  then	  cooled	  and	  concentrated	  under	  reduced	  pressure.	  The	  residue	  thus	  obtained	   was	   diluted	   with	   dichloromethane	   (3	   mL)	   and	   the	   precipitated	   metal	  salts	  removed	  by	  filtration.	  The	  filtrate	  was	  concentrated	  under	  reduced	  pressure	  and	   the	   residue	   so-­‐formed	   subjected	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	  fractions	   (Rf	   =	   0.6),	   (±)-­‐1-­‐acetylaspidoalbidine11	   (3)	   (7	   mg,	   30%)	   as	   a	   white,	  crystalline	   solid,	   mp	   99-­‐102	   °C	   [lit.	   mp6a	   173-­‐174	   oC,	   (+)-­‐form	   of	   1-­‐acetylaspidoalbidine].	  	  
1H	  NMR	  (CDCl3,	  400	  MHz)	  Ɂ(major	  rotamer)	  8.14	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.59	  (d,	  J	  =	  7.6	  Hz,	  1H),	  7.19	  (t,	  J	  =	  7.6	  Hz,	  1H),	  7.05	  (td,	  J	  =	  7.6,	  1.2	  Hz,	  1H),	  4.17	  (t,	  J	  =	  8.4	  Hz,	  1H),	  4.09	  (m,	  1H),	  3.86	  (dd,	   J	  =	  10.4	  and	  5.2	  Hz,	  1H),	  3.02	  (td,	   J	  =	  8.8	  and	  4.4	  Hz,	  1H),	  2.92	  (m,	  1H),	  2.79	  (tm,	  J	  =	  11.6	  Hz,	  1H),	  2.65	  (dm,	  J	  =	  10.8	  Hz,	  1H),	  2.26	  (s,	  3H),	  2.09	  (m,	  1H),	  1.98-­‐1.65	  (complex	  m,	  8H),	  1.43	  (dt,	  J	  =	  14.0	  and	  4.0	  Hz,	  1H),	  1.38	  (broad	  d,	  J	  =	  10.8	  Hz,	  1H),	  1.26	  (m,	  1H).	  
13C	  NMR	   (CDCl3,	   100	  MHz)	  Ɂ (major	   rotamer)	   168.1,	   141.1,	   137.8,	   127.4,	   124.8,	  124.7,	   117.8,	   102.0,	   68.8,	   65.0,	   58.2,	   48.9,	   43.9,	   39.6,	   37.1,	   34.7,	   33.1,	   26.5,	   25.4,	  23.4,	  21.1.	  
IR	   (KBr)	  ɓmax	   2934,	   2861,	   1659,	   1574,	   1474,	   1459,	   1397,	   1283,	   1017,	   952,	   843,	  754	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  361	  [(M	  +	  Na)+,	  100%],	  339	  [(M	  +	  H)+,	  8%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C21H27N2O2	  339.2073,	  found	  339.2074.	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5.3.	   Experimental	   Procedures	   Associated	   with	   Work	   Described	   in	  
Chapter	  Three	  	  
(S)-­‐2-­‐(2,3,4,5,6,7-­‐Hexahydro-­‐4aH-­‐pyrido[3,2-­‐c]carbazol-­‐4a-­‐yl)-­‐N,N-­‐
dimethylacetamide	  (159)	  	  
	  	  
Method	  A:	  A	  magnetically	  stirred	  solution	  of	  compound	  102	  (100	  mg,	  0.32	  mmol)	  in	  dry	  dichloromethane	   (5	  mL)	  maintained	  at	  0	   oC	  under	  a	  nitrogen	  atmosphere	  was	   treated,	   in	   one	   portion,	   with	  N-­‐chlorosuccinimide	   (43	  mg,	   0.32	  mmol).	   The	  resulting	   mixture	   was	   allowed	   to	   warm	   to	   18	   °C	   over	   3	   h	   then	   diluted	   with	  dichloromethane	   (10	   mL)	   before	   being	   washed	   with	   NH4Cl	   (1	   ×	   30	   mL	   of	   a	  saturated	  aqueous	  solution),	  NaHCO3	  (1	  ×	  30	  mL	  of	  a	  saturated	  aqueous	  solution)	  and	   brine	   (1	   ×	   30	   mL)	   then	   dried	   (MgSO4),	   filtered	   and	   concentrated	   under	  reduced	   pressure.	   The	   residue	   thus	   obtained	   was	   subjected	   to	   flash	  chromatography	   (silica,	   1.5:8.5	   v/v	   ammonia-­‐saturated	   methanol/dichloro-­‐methane	  elution)	  to	  afford,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.3),	  a	  1:05	  mixture	  of	  the	  chromatographically	   inseparable	   imines	  159	  and	  161	  (80	  mg,	  81%)	  as	  a	  clear,	  yellow	  oil.	  	  A	   magnetically	   stirred	   solution	   of	   the	   imines	  159	   and	   161	  (80	   mg,	   0.26	   mmol)	  obtained	   as	   detailed	   above	   in	   dry	   dichloromethane	   (5	   mL)	   maintained	   at	   0	   oC	  under	  a	  nitrogen	  atmosphere	  was	  treated,	  in	  portions	  over	  0.15	  h,	  with	  potassium	  
tert-­‐butoxide	  (29	  mg,	  0.26	  mmol).	  The	  resulting	  deep-­‐green	  mixture	  was	  allowed	  to	   warm	   to	   18	   °C.	   After	   16	   h	   the	   reaction	   mixture	   was	   diluted	   with	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dichloromethane	  (10	  mL)	  and	  the	  ensuing	  mixture	  was	  washed	  with	  NH4Cl	  (1	  ×	  30	  mL	  of	  a	  saturated	  aqueous	  solution),	  NaHCO3	  (1	  ×	  30	  mL	  of	  a	  saturated	  aqueous	  solution)	   and	   brine	   (1	   ×	   30	   mL)	   then	   dried	   (MgSO4),	   filtered	   and	   concentrated	  under	   reduced	   pressure.	   The	   residue	   thus	   obtained	   was	   subjected	   to	   flash	  chromatography	   (silica,	   1.5:8.5	   v/v	   ammonia-­‐saturated	   methanol/dichloro-­‐methane	  elution)	  to	  afford,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.3),	  a	  1:0.2	  mixture	  of	  the	  chromatographically	  inseparable	  imines	  159	  and	  161	  (64	  mg,	  80%)	  as	  a	  clear,	  yellow	  oil.	  	  Compound	  159:	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ͹ǤͻͷȋǡJ	  =	  7.6,	  0.8	  Hz,	  1H),	  7.31	  (dd,	  J	  =	  7.6,	  0.8	  Hz,	  1H),	   be	   7.11	   (dd,	   J	   =	   7.6,	   1.4	   Hz,	   1H),	   7.07	   (dd,	   J	   =	   7.6,	   1.4	   Hz,	   1H),	   3.91-­‐3.81	  (complex	  m,	  1H),	  3.69-­‐3.58	  (complex	  m,	  1H),	  3.14-­‐3.03	  (complex	  m,	  1H),	  2.91	  (s,	  3H),	  2.90-­‐2.87	  (complex	  m,	  1H),	  2.84	  (s,	  3H),	  2.80	  (d,	  J	  =	  15.9	  Hz,	  1H),	  2.56	  (ddd,	  J	  =	  13.5,	  5.3,	  1.6	  Hz,	  1H),	  2.49	  (d,	  J	  =	  15.9	  Hz,	  1H),	  2.27	  (dt,	  J	  =	  13.5,	  3.7	  Hz,	  1H),	  1.94-­‐1.84	  (complex	  m,	  2H),	  1.78-­‐1.69	  (complex	  m,	  1H),	  1.55	  (dd,	   J	  =	  13.5,	  3.2	  Hz,	  1H)	  (signal	  due	  to	  NH	  group	  proton	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳ͹͵ǤͲǡ ͳ͹ͲǤͻǡ ͳͶͷǤͷǡ ͳ͵ͻǤʹǡ ͳʹ͸ǤͶǡ ͳʹ͵Ǥʹǡ ͳʹͳǤ͸ǡ121.5,	   112.3,	   110.6,	   39.3,	   38.3,	   36.4,	   36.2,	   35.9,	   32.0,	   21.5,	   20.0	   (one	   signal	  obscured	  or	  overlapping).	  
IR	  (KBr)	  ɓmax	  3246,	  2929,	  1622,	  1471,	  1454,	  1395,	  746	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  310	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H24N3O	  310.1919,	  found	  310.1919.	  	  
Method	  B:	  A	  magnetically	  stirred	  solution	  of	  compound	  102	  (200	  mg,	  0.64	  mmol)	  in	  dry	  dichloromethane	  (5	  mL)	  maintained	  at	  18	  oC	  under	  a	  nitrogen	  atmosphere	  was	   treated	   with	   freshly	   prepared	   iodosobenzene49	   (71	   mg,	   0.32	   mmol).	   The	  ensuing	   mixture	   was	   stirred	   at	   18	   oC	   for	   16	   h	   then	   filtered	   through	   a	   pad	   of	  CeliteTM	  and	   the	   filtrate	   concentrated	   under	   reduced	   pressure.	   The	   residue	   thus	  obtained	   was	   subjected	   to	   flash	   chromatography	   (silica,	   1.5:8.5	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	  to	  afford,	  after	  concentration	  of	  the	  relevant	   fractions	   (Rf	   =	   0.3	   in	   1:9	   v/v	   ammonia-­‐saturated	   methanol/dichloro-­‐methane),	   the	   title	   compound	   159	   (196	   mg,	   99%)	   as	   a	   clear,	   yellow	   oil.	   This	  material	  was	  identical,	  in	  all	  respects,	  with	  the	  major	  imine	  obtained	  via	  Method	  A.	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N,N-­‐Dimethyl-­‐2-­‐((4aS,11cR)-­‐1,2,3,4,5,6,7,11c-­‐octahydro-­‐4aH-­‐pyrido[3,2-­‐
c]carbazol-­‐4a-­‐yl)acetamide	  (158)	  	  
	  	  A	  magnetically	  stirred	   solution	  of	   imine	  159	  (18	  mg,	  0.06	  mmol)	   in	  methanol	   (5	  mL)	  maintained	   at	   18	   oC	  was	   treated	  with	   finely	   ground	   sodium	  borohydride	   (3	  mg,	   0.06	   mmol).	   After	   the	   sodium	   borohydride	   has	   completely	   dissolved,	   the	  resulting	   solution	   was	   concentrated	   under	   reduced	   pressure.	   The	   residue	   thus	  obtained	   was	   subjected	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	  to	  afford,	  after	  concentration	  of	  the	  relevant	   fractions	   (Rf	   =	   0.4),	   the	   title	   compound	  158	   (16	   mg,	   89%)	   as	   a	   white,	  amorphous	  solid.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ͹Ǥ͸ͺȋǡJ	  =	  7.9	  Hz,	  1H),	  7.24	  (d,	  J	  =	  7.9	  Hz,	  1H),	  6.99	  (ddd,	  J	  =	  8.2,	  7.1,	  1.3	  Hz,	  1H),	  6.93	  (ddd,	  J	  =	  8.2,	  7.1,	  1.3	  Hz,	  1H),	  3.90	  (s,	  1H),	  3.25	  (dm,	   1H),	   2.95	   (s,	   3H),	   2.89	   (s,	   3H),	   2.87	   (dd,	   J	   =	   12.3,	   4.2	   Hz,	   1H),	   2.83-­‐2.80	  (complex	  m,	  1H),	  2.76-­‐2.69	  (complex	  m,	  2H),	  2.55	  (ddd,	  J	  =	  12.3,	  4.2,	  1.9	  Hz,	  1H),	  2.35-­‐2.23	   (complex	  m,	  2H),	  1.78	  (qt,	   J	  =	  12.3,	  4.2	  Hz,	  1H),	  1.60-­‐1.46	   (complex	  m,	  2H),	   1.28	   (ddd,	   J	   =	   12.3,	   5.7,	   1.9	   Hz,	   1H)	   (signals	   due	   to	   NH	   group	   protons	   not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳ͹ͷǤͳǡ ͳ͵ͺǤͲǡ ͳ͵ͷǤͳǡ ͳʹ͹Ǥ͹ǡ ͳʹͳǤ͵ǡ ͳͳͻǤͻǡ ͳͳͻǤ͸ǡ111.7,	  110.1,	  66.4,	  48.3,	  38.5,	  38.2,	  35.8,	  34.8,	  33.4,	  28.9,	  22.9,	  21.4.	  
IR	  ȋȌɓmax	  3278,	  2927,	  2854,	  1628,	  1450,	  1395,	  1326,	  736	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  312	  [(M	  +	  H)+,	  30%],	  267	  (100).	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C19H26N3O	  312.2076,	  found	  312.2080.	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2-­‐((4aS,11cS)-­‐1,2,3,4,5,6,7,11c-­‐Octahydro-­‐4aH-­‐pyrido[3,2-­‐c]carbazol-­‐4a-­‐
yl)ethan-­‐1-­‐ol	  (166)	  	  
	  	  A	  magnetically	   stirred	   solution	   of	   amide	  102	  (1.00	   g,	   3.21	  mmol)	   in	   dry	   THF	   (5	  mL)	  maintained	  at	  18	  oC	  under	  a	  nitrogen	  atmosphere	  was	  treated,	  dropwise,	  with	  lithium	  triethylborohydride	  (16	  mL	  of	  a	  1.0	  M	  solution	  in	  THF,	  16.03	  mmol).	  After	  1	  h	  the	  reaction	  mixture	  was	  quenched	  with	  methanol	  (15	  mL)	  then	  concentrated	  under	   reduced	   pressure.	   Subjection	   of	   the	   ensuing	   yellow	   oil	   to	   flash	  chromatography	   (silica,	   2:8	   v/v	   ammonia-­‐saturated	   methanol/dichloromethane	  elution)	  afforded,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.3	  in	  1:9	  v/v	  ammonia-­‐saturated	  methanol/dichloromethane),	  the	  title	  compound	  166	  (770	  mg,	  89%)	  as	  a	  clear,	  yellow	  oil.	  
	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ͹Ǥͷ͵ȋǡJ	  =	  8.0	  Hz,	  1H),	  7.24	  (d,	  J	  =	  8.0	  Hz,	  1H),	  7.01	  (dd,	  J	  =	  8.0,	  1.3	  Hz,	  1H),	  6.97	  (dd,	  J	  =	  8.0,	  1.3	  Hz,	  1H),	  3.68	  (s,	  1H),	  3.65	  (dd,	  J	  =	  15.7,	  8.0	   Hz,	   2H),	   2.95	   (d,	   J	   =	   12.0	   Hz,	   1H),	   2.84-­‐2.78	   (complex	   m,	   2H),	   2.78-­‐2.66	  (complex	  m,	  1H),	  2.50-­‐2.39	  (complex	  m,	  1H),	  1.80	  (d,	   J	  =	  12.0	  Hz,	  1H),	  1.74-­‐1.65	  (complex	  m,	  2H),	  1.62	  (dd,	   J	  =	  12.0,	  3.3	  Hz,	  1H),	  1.55-­‐1.41	  (complex	  m,	  2H),	  1.33	  (ddd,	   J	   =	   15.7,	   8.0,	   4.5	   Hz,	   1H)	   (signals	   due	   to	   NH	   or	   OH	   group	   protons	   not	  observed).	  
13C	  NMR	  (100	  MHz,	  CD3ȌɁͳ͵ͺǤͳǡͳ͵ͷǤ͹ǡͳʹͺǤͶǡͳʹͳǤ͸ǡͳͳͻǤ͹ǡͳͳͺǤ͵ǡͳͳͳǤͷǡͷͻǤͳǡ57.4,	  46.8,	  40.9,	  36.4,	  35.4,	  25.7,	  22.9,	  21.0	  (one	  signal	  obscured	  or	  overlapping).	  
IR	  ȋȌɓmax	  3400,	  2935,	  1623,	  1467,	  1433,	  1329,	  1265,	  1037,	  1011,	  741,	  702	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  271	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C17H23N2O	  271.1810,	  found	  271.1810.	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2-­‐((4aS,11cR)-­‐1,2,3,4,5,6,7,11c-­‐Octahydro-­‐4aH-­‐pyrido[3,2-­‐c]carbazol-­‐4a-­‐
yl)ethan-­‐1-­‐ol	  (167)	  	  
	  	  
    ȋ͹ʹ͵ Ɋǡ ͷǤͳ͸Ȍ  THF	  (3	  mL)	  maintained	  under	  a	  nitrogen	  atmosphere	  at	  Ȃ78	  oC	  was	  treated	  with	  n-­‐butyllithium	  (3.2	  mL	  of	  a	  1.6	  M	  solution	  in	  hexane,	  5.09	  mmol)	  and	  stirred	  for	  0.2	  h	  then	  warmed	   to	   0	   °C	   and	   stirred	   at	   this	   temperature	   for	   a	   further	   0.2	   h	   before	  being	   treated,	   in	   one	   portion,	   with	   the	   borane-­‐ammonia	   complex	   (158	  mg,	   5.09	  mmol).	  The	  resulting	  suspension	  was	  stirred	  at	  0	  °C	  for	  0.25	  h	  then	  at	  18	  °C	  for	  the	  same	   period	   before	   being	   cooled	   again	   to	   0	   °C	   then	   treated,	   dropwise,	   with	   a	  solution	  of	  compound	  159	  (105	  mg,	  0.34	  mmol)	  in	  dry	  THF	  (1	  mL	  followed	  by	  a	  1	  mL	  rinse).	  The	  reaction	  mixture	  thus	  obtained	  was	  allowed	  to	  stir	  at	  18	  °C	  for	  16	  h	  then	  cooled	  0	  °C	  and	  quenched	  with	  HCl	  (5	  mL	  of	  a	  3	  M	  aqueous	  solution).	  After	  0.5	   h	   the	   aqueous	   layer	  was	   separated	   and	   extracted	  with	   ethyl	   acetate	   (4	   × 4	  mL).	  Sufficient	  sodium	  hydroxide	  was	  added	  to	  the	  aqueous	  layer	  at	  0	  °C	  so	  as	  to	  achieve	   a	   pH	   >7	   and	   this	  was	   then	   extracted	  with	   ethyl	   acetate	   (4	   ×	   4	  mL)	   and	  dichloromethane	   (4	   ×	   4	   mL).	   The	   combined	   organic	   layers	   were	   then	   dried	  (MgSO4),	   filtered	   and	   concentrated	   under	   reduced	   pressure.	   Subjection	   of	   the	  resulting	   pale-­‐yellow	   oil	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	  afforded,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.5),	  the	  title	  compound	  167	  (66	  mg,	  72%)	  as	  a	  fine,	  white	  powder.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ͹Ǥ͹ͲȋǡJ	  =	  8.1	  Hz,	  1H),	  7.22	  (d,	  J	  =	  8.1	  Hz,	  1H),	  6.97	  (ddd,	  J	  =	  8.1,	  7.0,	  1.3	  Hz,	  1H),	  6.90	  (ddd,	  J	  =	  8.1,	  7.0,	  1.3	  Hz,	  1H),	  3.86	  (s,	  1H),	  3.73-­‐3.57	  (complex	  m,	  2H),	  3.28-­‐3.20	  (complex	  m,	  1H),	  2.87	  (dd,	   J	  =	  13.4,	  3.9	  Hz,	  2H),	  2.70	  (dd,	   J	  =	  13.4,	  3.9	  Hz,	  1H),	  2.00-­‐1.79	  (complex	  m,	  4H),	  1.60-­‐1.45	  (complex	  m,	  3H),	   1.25	   (dd,	   J	   =	   13.4,	   3.9	  Hz,	   1H)	   (signals	   due	   to	  NH	  or	  OH	   group	  protons	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳ͵ͺǤͲǡ ͳ͵ͶǤͻǡ ͳʹ͹Ǥͻǡ ͳʹͳǤͲǡ ͳʹͲǤʹǡ ͳͳͻǤͶǡ ͳͳͳǤͷǡ110.2,	  65.9,	  59.6,	  48.1,	  36.8,	  35.2,	  33.9,	  28.7,	  22.9,	  21.2.	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IR	  ȋȌɓmax	  	  3384,	  3269,	  2918,	  2851,	  1463,	  1049,	  740	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  271	  [(M	  +	  H)+,	  100%].	  





Method	  A:	  A	  magnetically	   stirred	   solution	   of	   alcohol	  167	   (50	  mg,	   0.19	  mmol)	   in	  benzene	  (5	  mL)	  was	  treated	  with	  Dess-­‐Martin	  periodinane61	  (785	  mg,	  1.86	  mmol)	  and	  the	  resulting	  mixture	  stirred	  at	  18	  °C	   for	  16	  h	   then	   filtered	  through	  a	  pad	  of	  CeliteTM.	  The	   filtrate	  was	   concentrated	  under	   reduced	  pressure	   and	   the	   resulting	  oil	   subjected	   to	   flash	   chromatography	   (silica,	   1.5:8.5	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	  fractions	  (Rf	  =	  0.3	  in	  1:9	  v/v	  ammonia-­‐saturated	  methanol/dichloromethane),	  the	  
title	  hemiaminal	  168	  (30	  mg,	  60%)	  as	  a	  clear,	  yellow	  oil.	  
	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ͹Ǥ͹ͳȋǡJ	  =	  8.0	  Hz,	  1H),	  7.31	  (d,	  J	  =	  8.0	  Hz,	  1H),	  7.11	  (t,	  J	  =	  7.2	  Hz,	  1H),	  7.04	  (t,	  J	  =	  7.2	  Hz,	  1H),	  5.17	  (t,	  J	  =	  6.5	  Hz,	  1H),	  4.47	  (s,	  1H),	  3.61-­‐3.49	  (complex	  m,	  1H),	  3.42	  (td,	   J	   =	  12.9,	  4.8	  Hz,	  1H),	  3.08-­‐2.94	   (complex	  m,	  1H),	  2.84-­‐2.74	  (complex	  m,	  1H),	  2.45-­‐2.32	  (complex	  m,	  1H),	  2.32-­‐2.18	  (complex	  m,	  1H),	  1.95-­‐1.68	  (complex	  m,	  4H)	  (signals	  due	  to	  NH	  or	  OH	  groups	  proton	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ 138.3,	   131.9,	   127.7,	   122.7,	   120.5,	   120.3,	   119.0,	  112.1,	  90.6,	  69.3,	  49.9,	  37.2,	  30.8,	  30.0,	  20.0,	  19.6.	  
IR	  (KBr)	  ɓmax	  3384,	  2931,	  2866,	  2847,	  1466,	  1452,	  1323,	  1007,	  745	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  267	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C17H19N2O	  267.1497,	  found	  267.1496.	  	  
Method	  B:	  A	  magnetically	  stirred	  solution	  of	  alcohol	  167	  (20	  mg,	  0.07	  mmol)	  in	  dry	  ethyl	   acetate	   (3	  mL)	  maintained	   under	   a	   nitrogen	   atmosphere	  was	   treated	  with	  freshly	   prepared	   2-­‐iodoxybenzoic	   acid61	   (104	  mg,	   0.37	  mmol),	   and	   the	   resulting	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mixture	  was	  heated	  under	  reflux	   for	  16	  h.	  The	  reaction	  mixture	  so	  obtained	  was	  cooled	  to	  18	  °C	  and	  subjected	  directly	  to	  flash	  chromatography	  (silica,	  1.5:8.5	  v/v	  ammonia-­‐saturated	   methanol/dichloromethane	   elution).	   Concentration	   of	   the	  relevant	   fractions	   (Rf	   =	   0.3	   in	   1:9	   v/v	   ammonia-­‐saturated	   methanol/dichloro-­‐methane)	  afforded	   the	   title	  hemiaminal	  168	  (11	  mg,	  55%)	  as	  a	   clear,	   yellow	  oil.	  This	  material	  was	  identical,	  in	  all	  respects,	  with	  that	  obtained	  by	  Method	  A.	  	  	  
(1S,4aS,11cR)-­‐3,4,5,6,7,11c-­‐Hexahydro-­‐2H-­‐1,4a-­‐ethanopyrido[3,2-­‐
c]carbazole	  (171)	  	  
	  	  A	   magnetically	   stirred	   solution	   of	   compound	   167	   (44	   mg,	   0.16	   mmol),	  
 ȋͳͲͲ ɊȌ  N-­‐methylimidazole	   (28	   mg,	   0.18	   mmol)	   in	  dichloromethane	   (3	   mL)	   maintained	   at	   0	   oC	   under	   a	   nitrogen	   atmosphere	   was	  
     ȋʹ͸ Ɋǡ ͲǤͳͺ ȌǤ  resulting	  mixture	  was	  allowed	  to	  warm	  to	  room	  temperature	  over	  2	  h,	  after	  which	  time	   it	  was	   concentrated	   under	   reduced	   pressure.	   The	   residue	   thus	   obtained	   was	  subjected	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	  fractions	  (Rf	  =	  0.5	  in	  1.5:8.5	  v/v	  ammonia-­‐saturated	  methanol/dichloromethane),	  the	  title	  compound	  171	  (34	  mg,	  84%)	  as	  a	  white,	  crystalline	  solid,	  mp	  218	  oC.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ7.67	  (d,	  J	  =	  8.1	  Hz,	  1H),	  7.22	  (d,	  J	  =	  8.1	  Hz,	  1H),	  7.02	  (dd,	  J	  =	  8.1,	  1.3	  Hz,	  1H),	  6.94	  (dd,	  J	  =	  8.1,	  1.3	  Hz,	  1H),	  3.90	  (s,	  1H),	  3.07	  (dd,	  J	  =	  12.1,	  4.0	   Hz,	   2H),	   2.98-­‐2.81	   (complex	   m,	   2H),	   2.77-­‐2.62	   (complex	   m,	   2H),	   2.08-­‐1.94	  (complex	  m,	  1H),	  1.90	  (dd,	  J	  =	  12.1,	  4.0	  Hz,	  1H),	  1.84	  (dd,	  J	  =	  9.0,	  3.3	  Hz,	  2H),	  1.70	  (td,	  J	  =	  12.3,	  5.0	  Hz,	  1H),	  1.65-­‐1.47	  (complex	  m,	  3H),	  1.27	  (complex	  m,	  1H)	  (signal	  due	  to	  NH	  group	  proton	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳ͵ͺǤʹǡ ͳ͵͸Ǥ͸ǡ ͳʹ͹Ǥͻǡ ͳʹͳǤͺǡ ͳʹͲǤͲǡ ͳͳ9.5,	   111.4,	  109.0,	  70.8,	  56.6,	  51.4,	  43.9,	  39.5,	  31.2,	  30.4,	  21.3,	  20.4.	  
IR	  ȋȌɓmax	  2931,	  2866,	  2847,	  1466,	  1452,	  1323,	  1007,	  745	  cm-­‐1.	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MS	  (ESI,	  +ve)	  m/z	  253	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C17H21N2	  253.1705,	  found	  253.1706.	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5.4.	   Experimental	   Procedures	   Associated	   with	   Work	   Described	   in	  





Method	  A:	  Step	  1	  -­‐	  A	  magnetically	  stirred	  solution	  of	  compound	  166	  (557	  mg,	  2.06	  mmol)	  in	  dry	  dichloromethane	   (20	  mL)	  maintained	  at	   18	   oC	  under	  a	  nitrogen	  atmosphere	  was	   trea  ȋͷ͹ͷ ɊȌ 	   di-­‐tert-­‐butyl	   dicarbonate	   (899	  mg,	  4.12	  mmol).	  The	  resulting	  mixture	  was	  stirred	  at	  18	  oC	  for	  16	  h	  then	  poured	  into	  water	  (30	  mL)	  and	  the	  separated	  aqueous	  phase	  extracted	  with	  dichloromethane	  (3	  × 10	  mL).	  The	  combined	  organic	  phases	  were	  washed	  with	  brine	  (1	  ×	  40	  mL)	  before	  being	  dried	  (MgSO4),	   filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  afford	  a	  yellow	  oil.	  This	  material	  was	  subjected	  to	  flash	  chromatography	  (silica,	  7:3	  v/v	   ethyl	   acetate/hexane	   elution)	   to	   afford,	   after	   concentration	   of	   the	   relevant	  fractions	  (Rf	  =	  0.6),	  compound	  181	   (632	  mg,	  65%)	  as	  a	  clear,	  yellow	  oil	  and	  a	  ca.	  3:2	  mixture	  of	  carbamate	  rotamers.	  	  
1H	  NMR	  (400	  MHz,	  CDCl3ȌɁ(mixture	  of	  carbamate	  rotamers)	  8.59	  (s,	  0.6H),	  8.55	  (s,	  0.4H),	  7.41	  (d,	   J	  =	  7.9	  Hz,	  1H),	  7.28	  (t,	   J	  =	  7.9	  Hz,	  1H),	  7.08	  (dd,	  J	  =	  7.9,	  1.3	  Hz,	  1H),	  6.98	  (dd,	  J	  =	  7.9,	  1.3	  Hz,	  1H),	  5.26	  (s,	  0.6H),	  5.04	  (s,	  0.4H),	  4.21-­‐4.12	  (complex	  m,	  2H),	  4.06	  (d,	  J	  =	  13.2	  Hz,	  0.4H),	  3.79	  (d,	  J	  =	  13.2	  Hz,	  0.6H),	  2.77-­‐2.49	  (complex	  m,	  3H),	  2.21-­‐2.07	  (complex	  m,	  1H),	  1.91-­‐1.42	  (complex	  m,	  5H),	  1.58	  (s,	  6H),	  1.54	  (s,	  3H),	  1.51	  (s,	  9H),	  1.36-­‐1.21	  (complex	  m,	  2H).	  
13C	  NMR	  (100	  MHz,	  CDCl3ȌɁ(mixture	  of	  carbamate	  rotamers)	  153.4,	  153.4,	  149.9,	  149.7,	   148.0,	   147.6,	   136.2,	   134.7,	   134.5,	   125.8,	   125.8,	   121.1,	   121.1,	   119.6,	   119.5,	  118.1,	  118.0,	  110.7,	  110.6,	  106.1,	  106.1,	  84.8,	  84.8,	  81.9,	  81.8,	  77.2,	  63.3,	  63.2,	  57.6,	  56.1,	  40.8,	  39.6,	  35.4,	  35.3,	  33.9,	  33.8,	  31.9,	  28.5,	  27.7,	  27.4,	  27.3,	  25.1,	  24.8,	  21.1,	  20.3,	  19.2.	  
	  	  126	  
IR	  (KBr)	  ɓmax	  3386,	  2980,	  2936,	  1782,	  1737,	  1370,	  1280,	  1255,	  1161,	  1107,	  1064,	  740	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  493	  [(M	  +	  Na)+,	  100%],	  471	  [(M	  +	  H)+,	  65%].	  
HRESIMS	  (M	  +	  Na)+	  calcd	  for	  C27H38N2O5Na	  493.2678,	  found	  493.2676.	  	  Step	  2	  -­‐	  A	  magnetically	  stirred	  solution	  of	  compound	  181	  (100	  mg,	  0.06	  mmol)	  in	  methanol	  (10	  mL)	  maintained	  at	  18	  oC	  was	  treated	  with	  potassium	  carbonate	  (500	  mg).	  The	  resulting	  suspension	  was	  stirred	  at	  18	  oC	  for	  16	  h	  then	  poured	  into	  water	  (30	  mL)	  and	  the	  aqueous	  phase	  extracted	  with	  dichloromethane	  (3	  ×	  30	  mL).	  The	  combined	  organic	  phases	  were	  then	  washed	  with	  brine	  (1	  ×	  40	  mL)	  before	  being	  dried	   (MgSO4),	   filtered	   and	   concentrated	   under	   reduced	   pressure	   to	   afford	   a	  yellow	  oil.	  This	  material	  was	  subjected	  to	  flash	  chromatography	  (silica,	  0.5:9.5	  v/v	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	  fractions	  (Rf	  =	  0.5	  in	  1:9	  v/v	  methanol/dichloromethane),	  the	  title	  alcohol	  180	  (78	  mg,	   100%)	   as	   a	   pale-­‐yellow	   solid,	   mp	   207	   oC	   and	   ca.	  1:1	   mixture	   of	   carbamate	  rotamers.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁȋcarbamate	  rotamers)	  7.25	  (d,	  J	  =	  7.9	  Hz,	  1H),	  7.19	  (d,	  J	  =	  7.9	  Hz,	  1H),	  7.00	  (dd,	  J	  =	  7.9,	  3.5	  Hz,	  1H),	  6.88	  (dd,	  J	  =	  7.9,	  3.5	  Hz,	  1H),	  5.24	  (s,	  0.4H),	  5.22	  (s,	  0.6H),	  3.95	  (d,	  J	  =	  13.1	  Hz,	  1H),	  3.80-­‐3.63	  (complex	  m,	  2H),	   2.79	   (ddd,	   J	   =	   11.8,	   5.9,	   2.4	   Hz,	   1H),	   2.74-­‐2.64	   (complex	   m,	   1H),	   2.53-­‐2.33	  (complex	  m,	  1H),	  1.99-­‐1.65	  (complex	  m,	  6H),	  1.60	  (s,	  3H),	  1.57	  (s,	  6H),	  1.36-­‐1.21	  (complex	  m,	  2H)	  (signals	  due	  to	  NH	  or	  OH	  group	  protons	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ȋ 	   carbamate	   rotamers)	   157.4,	   157.4,	  138.2,	   136.2,	   135.9,	   127.7,	   121.7,	   119.8,	   119.7,	   118.9,	   118.8,	   111.7,	   111.7,	   108.1,	  81.4,	  81.0,	  59.1,	  57.0,	  55.9,	  40.7,	  39.6,	  39.4,	  36.5,	  33.8,	  33.7,	  29.0,	  28.8,	  27.2,	  26.8,	  22.4,	  22.0,	  20.3.	  
IR	  (KBr)	  ɓmax	  	  3280,	  2924,	  2857,	  1661,	  1425,	  1365,	  1172,	  1150,	  1015,	  744	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  393	  [(M	  +	  Na)+,	  55%],	  371	  [(M	  +	  H)+,	  28%].	  
HRESIMS	   (M	  +	  Na)+	  calcd	   for	  C22H30N2NaO3	  393.2154,	   found	  393.2151,	   (M	  +	  H)+	  calcd	  for	  C22H31N2O3	  371.2335,	  found	  371.2335.	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Method	  B:	  A	  magnetically	  stirred	  solution	  of	  compound	  166	  (423	  mg,	  1.57	  mmol)	  in	   THF/water	   (18	   mL	   of	   a	   1:1	   v/v	   mixture)	   maintained	   under	   a	   nitrogen	  atmosphere	   was	   treated	   with	   NaHCO3	   (657	   mg,	   7.82	   mmol)	   and	   di-­‐tert-­‐butyl	  dicarbonate	  (1.03	  g,	  4.69	  mmol).	  The	  resulting	  turbid	  mixture	  was	  stirred	  at	  18	  °C	  for	  16	  h	  then	  diluted	  with	  H2O	  (30	  mL)	  and	  extracted	  with	  ethyl	  acetate	  (3	  ×	  20	  mL).	   The	   combined	   organic	   layers	  were	   washed	  with	   brine	   (1	   ×	   40	  mL)	   before	  being	  dried	  (MgSO4),	   filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  afford	  the	  title	  compound	  180	  (504	  mg,	  87%)	  as	  a	  pale-­‐yellow	  solid.	  This	  material,	  which	  was	   identical,	   in	   all	   respects,	   with	   that	   obtained	   by	   Method	   A	   and	   was	   used	  immediately	  in	  the	  next	  step	  of	  the	  reaction	  mixture.	  	  	  
tert-­‐Butyl	  (4aS,11cS)-­‐4a-­‐(2-­‐oxoethyl)-­‐2,3,4,4a,5,6,7,11c-­‐octahydro-­‐1H-­‐
pyrido[3,2-­‐c]carbazole-­‐1-­‐carboxylate	  (182)	  and	  
tert-­‐Butyl	  (4aR,11cS)-­‐6-­‐oxo-­‐4a-­‐(2-­‐oxoethyl)-­‐2,3,4,4a,5,6,7,11c-­‐octahydro-­‐
1H-­‐pyrido[3,2-­‐c]carbazole-­‐1-­‐carboxylate	  (183)	  	  
	  	  A	   magnetically	   stirred	   solution	   of	   alcohol	   180	   (332	   mg,	   0.90	   mmol)	   in	   dry	  dichloromethane	   (10	   mL)	   containing	   4	   Å	   molecular	   sieves	   (200	   mg)	   and	  maintained	   under	   a	   nitrogen	   atmosphere	   at	   18	   oC	   was	   treated	  with	   pyridinium	  chlorochromate	   (213	   mg,	   0.99	   mmol).	   The	   resulting	   deep-­‐brown	   mixture	   was	  stirred	   for	   0.5	   h	   at	   18	   oC	   then	   filtered	   through	   a	   pad	   of	   CeliteTM	  and	   the	   filtrate	  concentrated	  under	  reduced	  pressure.	  The	  residue	  thus	  obtained	  was	  subjected	  to	  flash	  chromatography	  (silica,	  1:1	  v/v	  ethyl	  acetate/hexane	  elution)	  to	  afford,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.5	  in	  7:3	  v/v	  ethyl	  acetate/hexane),	  a	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ca.	  7:3	  mixture	  of	  the	  title	  compound	  182	  and	  its	  oxo-­‐derivative	  183	  (232	  mg,	  70%)	  as	  a	   clear,	  bright	  yellow	  oil.	  This	  mixture	  was	   immediately	   subjected	   to	   the	  next	  step	  of	  the	  reaction	  sequence.	  	  Compound	  182:	  
1H	  NMR	   (400	  MHz,	  CDCl3ȌɁ ȋ3:2	  mixture	  of	   carbamate	   rotamers)	  9.97	  (s,	  0.6H),	  9.95	  (s,	  0.4H),	  8.11	  (s,	  0.6H),	  8.06	  (s,	  0.4H),	  7.33	  (t,	  J	  =	  8.0	  Hz,	  1H),	  7.28	  (d,	  J	  =	  8.0	  Hz,	  1H),	  7.12	  (dd,	  J	  =	  14.5,	  7.6	  Hz,	  1H),	  7.03	  (dd,	  J	  =	  14.5,	  7.6	  Hz,	  1H),	  5.51	  (s,	  0.4H),	  5.47	   (s,	   0.6H),	   4.13	   (d,	   J	   =	   13.3	   Hz,	   0.6H),	   3.97	   (d,	   J	   =	   13.3	   Hz,	   0.4H),	   2.95-­‐2.76	  (complex	  m,	  1H),	  2.76-­‐2.41	  (complex	  m,	  2H),	  2.15-­‐1.66	  (complex	  m,	  6H),	  1.60	  (s,	  3H),	  1.55	  (s,	  6H),	  1.45-­‐1.29	  (complex	  m,	  1H),	  1.29-­‐1.17	  (complex	  m,	  1H).	  
13C	  NMR	   (100	  MHz,	  CDCl3Ȍ Ɂ ȋ3:2	  mixture	  of	   carbamate	   rotamers)	   203.2,	   202.6,	  155.5,	   155.3,	   136.1,	   134.0,	   133.8,	   126.2,	   121.4,	   121.3,	   119.9,	   119.6,	   118.5,	   110.5,	  110.4,	  108.0,	  80.2,	  79.7,	  77.2,	  55.0,	  54.0,	  49.4,	  49.2,	  39.4,	  38.1,	  36.6,	  36.5,	  32.8,	  32.6,	  28.6,	  28.5,	  27.8,	  27.5,	  27.5,	  26.6,	  26.1,	  21.2,	  20.8,	  19.5,	  19.4.	  
IR	  (KBr)	  ɓmax	  3320,	  2971,	  2930,	  2865,	  1717,	  1664,	  1422,	  1365,	  1278,	  1169,	  1152,	  740	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  391	  [(M	  +	  Na)+,	  33%].	  
HRESIMS	  (M	  +	  Na)+	  calcd	  for	  C22H28N2NaO3	  391.1998,	  found	  391.1998.	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tert-­‐Butyl	  (4aS,11cS)-­‐4a-­‐allyl-­‐2,3,4,4a,5,6,7,11c-­‐octahydro-­‐1H-­‐pyrido[3,2-­‐
c]carbazole-­‐1-­‐carboxylate	  (188)	  and	  
tert-­‐Butyl	  (4aR,11cS)-­‐4a-­‐allyl-­‐6-­‐oxo-­‐2,3,4,4a,5,6,7,11c-­‐octahydro-­‐1H-­‐
pyrido[3,2-­‐c]carbazole-­‐1-­‐carboxylate	  (189)	  	  
	  	  A	  magnetically	  stirred	  mixture	  of	  methyltriphenylphosphonium	  bromide	  (449	  mg,	  1.25	  mmol)	  in	  dry	  THF	  (3	  mL)	  maintained	  under	  a	  nitrogen	  atmosphere	  at	  Ȃ15	  oC	  was	   treated	   with	   n-­‐butyllithium	   (791	   ɊL	   of	   a	   1.51	   M	   solution	   in	   hexanes,	   1.19	  mmol).	   The	   resulting	   suspension	   was	   stirred	   at	   Ȃ15	   °C	   for	   0.5	   h	   then	   treated,	  dropwise,	   with	   a	   solution	   of	   aldehyde	   182	   (220	   mg,	   0.60	   mmol,	   as	   a	   ca.	   7:3	  mixture	  with	   compound	  183)	   in	   dry	  THF	   (1	  mL	   followed	  by	   a	   1	  mL	   rinse).	  The	  reaction	  mixture	  so	  obtained	  was	  allowed	  to	  stir	  at	  Ȃ15	  °C	  for	  0.25	  h	  then	  poured	  into	   NH4Cl	   (10	   mL	   of	   a	   saturated	   aqueous	   solution)	   and	   extracted	   with	   ethyl	  acetate	  (3	  ×	  5	  mL).	  The	  combined	  organic	  phases	  were	  dried	  (MgSO4),	  filtered,	  and	  concentrated	   under	   reduced	   pressure,	   and	   the	   residue	   thus	   obtained	   was	  subjected	  to	  flash	  chromatography	  (silica,	  1:4	  v/v	  ethyl	  acetate/hexane	  elution)	  to	  afford	  two	  fractions,	  A	  and	  B.	  	  Concentration	  of	  fraction	  A	  (Rf	  	  =	  0.6	  in	  4:6	  v/v	  ethyl	  acetate/hexane)	  afforded	  the	  
title	  olefin	  188	  (97	  mg,	  44%)	  as	  a	  clear,	  yellow	  oil.	  	  
1H	  NMR	   (400	  MHz,	  CDCl3ȌɁ ȋ3:2	  mixture	  of	   carbamate	  rotamers)	  8.08	  (s,	  0.6H),	  8.00	  (s,	  0.4H),	  7.38	  (d,	   J	  =	  7.7	  Hz,	  1H),	  7.26	  (d,	   J	  =	  7.7	  Hz,	  1H),	  7.11	  (t,	   J	  =	  7.7	  Hz,	  1H),	   7.03	   (t,	   J	   =	   7.7	   Hz,	   1H),	   6.01-­‐5.79	   (complex	  m,	   1H),	   5.36	   (s,	   0.4H),	   5.24	   (s,	  0.6H),	  5.18-­‐5.09	  (complex	  m,	  2H),	  4.11	  (d,	  J	  =	  13.3	  Hz,	  0.6H),	  3.93	  (d,	   J	  =	  13.3	  Hz,	  0.4H),	  2.84-­‐2.71	  (complex	  m,	  1H),	  2.71-­‐2.60	  (complex	  m,	  1H),	  2.55-­‐2.15	  (complex	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m,	  3H),	  1.85-­‐1.65	  (complex	  m,	  5H),	  1.61	  (s,	  3H),	  1.57	  (s,	  6H),	  1.38-­‐1.23	  (complex	  m,	  1H).	  
13C	  NMR	   (100	  MHz,	  CDCl3Ȍ Ɂ ȋ3:2	  mixture	  of	   carbamate	   rotamers)	   155.6,	   155.4,	  136.2,	   136.2,	   134.5,	   134.4,	   134.3,	   126.6,	   126.5,	   121.1,	   121.0,	   119.6,	   119.4,	   118.6,	  117.9,	  117.8,	  110.4,	  110.3,	  108.9,	  108.8,	  79.8,	  79.2,	  77.2,	  55.0,	  53.9,	  40.5,	  39.5,	  38.3,	  36.2,	  36.2,	  32.2,	  28.7,	  28.6,	  28.3,	  26.0,	  25.6,	  21.1,	  20.7,	  19.6,	  19.6.	  
IR	  ȋȌɓmax	  3314,	  2975,	  2931,	  2856,	  1686,	  1663,	  1462,	  1426,	  1365,	  1170,	  1141,	  1152,	  739	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  389	  [(M	  +	  Na)+,	  100%].	  
HRESIMS	  (M	  +	  Na)+	  calcd	  for	  C23H30N2NaO2	  389.2205,	  found	  389.2209.	  	  Concentration	  of	  fraction	  B	  (Rf	  	  =	  0.5	  in	  4:6	  v/v	  ethyl	  acetate/hexane)	  afforded	  the	  
title	  olefin	  189	  (42	  mg,	  19%)	  as	  a	  clear,	  yellow	  oil.	  
	  
1H	  NMR	   (400	  MHz,	  CDCl3ȌɁ ȋ3:2	  mixture	  of	  carbamate	  rotamers)	  9.74	  (s,	  0.6H),	  9.69	  (s,	  0.4H),	  7.59-­‐7.43	  (complex	  m,	  2H),	  7.35	  (t,	  J	  =	  7.8	  Hz,	  1H),	  7.11	  (t,	  J	  =	  7.8	  Hz,	  1H),	  5.99-­‐5.84	  (complex	  m,	  1H),	  5.88	  (s,	  0.4H),	  5.71	  (s,	  0.6H),	  5.25-­‐5.13	  (complex	  m,	  2H),	  4.19	  (d,	  J	  =	  13.4	  Hz,	  0.6H),	  4.01	  (d,	  J	  =	  13.4	  Hz,	  0.4H),	  2.83	  (d,	  J	  =	  16.6	  Hz,	  0.6H),	  2.81	  (d,	  J	  =	  16.6	  Hz,	  0.4H),	  2.60-­‐2.45	  (complex	  m,	  3H),	  2.42-­‐2.29	  (complex	  m,	  1H),	  1.87-­‐1.71	  (complex	  m,	  2H),	  1.62	  (s,	  3H),	  1.57	  (s,	  6H),	  1.50-­‐1.39	  (complex	  m,	  1H),	  1.35-­‐1.22	  (complex	  m,	  1H).	  
13C	  NMR	   (100	  MHz,	  CDCl3Ȍ Ɂ ȋ3:2	  mixture	  of	   carbamate	   rotamers)	   189.9,	   155.3,	  155.2,	   138.4,	   133.5,	   133.3,	   130.5,	   127.0,	   126.8,	   125.7,	   125.5,	   125.1,	   121.5,	   121.3,	  120.9,	  119.2,	  119.1,	  112.8,	  112.8,	  80.5,	  80.1,	  77.2,	  55.1,	  53.9,	  48.8,	  48.7,	  43.2,	  43.0,	  40.0,	  40.0,	  38.7,	  28.6,	  28.6,	  28.5,	  28.5,	  20.8,	  20.4.	  
IR	  ȋȌɓmax	  3273,	  2976,	  2934,	  2865,	  1689,	  1660,	  1474,	  1419,	  1365,	  1251,	  1173,	  1144,	  743	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  403	  [(M	  +	  Na)+,	  100%].	  
HRESIMS	  (M	  +	  Na)+	  calcd	  for	  C23H28N2NaO3	  403.1998,	  found	  403.1993.	  	  Compounds	  188	  and	  189	  were	  subjected	  as	  a	  mixture	  to	   the	  reaction	  conditions	  described	  below.	  	  	  	  







	  A	  magnetically	   stirred	   7:3	  mixture	  of	   compound	  188	  and	   its	   oxo-­‐derivative	  189	  (46	  mg,	  0.13	  mmol)	   in	  dichloromethane	  (5	  mL)	  maintained	  at	  18	   oC	  was	   treated	  dropwise	  with	  trifluoroacetic	  anhydride	  (1	  mL).	  The	  resulting	  solution	  was	  stirred	  at	   18	   oC	   for	   2	   h,	   after	   which	   time	   sufficient	   ammonia-­‐saturated	   methanol	   was	  added	   so	   as	   to	   achieve	   a	   pH	   >7.	   The	   resulting	  mixture	   was	   concentrated	   under	  reduced	   pressure	   and	   the	   residue	   thus	   obtained	   was	   subjected	   to	   flash	  chromatography	   (silica,	   0.5:9.5	   to	   1:4	   v/v	   ammonia-­‐saturated	   methanol/ethyl	  acetate	  gradient	  elution)	  to	  afford	  two	  fractions,	  A	  and	  B.	  	  Concentration	  of	  fraction	  A	  (Rf	  	  =	  0.3	  in	  1:9	  v/v	  ammonia-­‐saturated	  methanol/ethyl	  acetate)	  afforded	  the	  title	  compound	  190	  (26	  mg)	  as	  a	  clear,	  pale-­‐yellow	  oil.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ7.62	  (d,	  J	  =	  7.7	  Hz,	  1H),	  7.34	  (d,	  J	  =	  7.7	  Hz,	  1H),	  7.12	  (t,	  J	  =	  7.7	  Hz,	  1H),	  7.07	  (t,	  J	  =	  7.7	  Hz,	  1H),	  5.97-­‐5.80	  (complex	  m,	  1H),	  5.12	  (dd,	  J	  =	  10.1,	  1.9	  Hz,	  1H),	  4.98	  (dd,	   J	  =	  16.6,	  1.8	  Hz,	  1H),	  4.30	  (s,	  1H),	  3.26	  (d,	   J	  =	  12.8	  Hz,	  1H),	  3.12	  (dd,	  J	  =	  12.8,	  3.2	  Hz,	  1H),	  2.96-­‐2.88	  (complex	  m,	  2H),	  2.45-­‐2.32	  (complex	  m,	   1H),	   2.20	   (dd,	   J	   =	   13.9,	   7.5	  Hz,	   1H),	   2.02	   (dd,	   J	   =	   13.9,	   7.5	  Hz,	   1H),	   1.92-­‐1.78	  (complex	  m,	  4H),	  1.70-­‐1.60	  (complex	  m,	  1H)	  (signals	  due	  to	  NH	  group	  protons	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳ͵ͺǤͳǡ ͳ͵͸Ǥ͵ǡ ͳ͵ͷǤ͵ǡ ͳʹͺǤͲǡ ͳʹʹǤͲǡ ͳʹͲǤͲǡ ͳͳͺǤͶǡ118.2,	  111.7,	  109.5,	  56.9,	  46.4,	  42.7,	  36.2,	  35.6,	  25.5,	  21.9,	  20.6.	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IR	  ȋȌɓmax	  3221,	  2928,	  2848,	  1455,	  1329,	  910,	  743	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  267	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C18H23N2	  267.1861,	  found	  267.1862.	  	  Concentration	  of	  fraction	  B	  (Rf	  	  =	  0.6	  in	  1:9	  v/v	  ammonia-­‐saturated	  methanol/ethyl	  acetate)	  afforded	  the	  title	  compound	  191	  (7	  mg)	  as	  a	  clear,	  pale-­‐yellow	  oil.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ7.80	  (d,	  J	  =	  7.8	  Hz,	  1H),	  7.45	  (d,	  J	  =	  7.8	  Hz,	  1H),	  7.34	  (t,	   J	  =	  7.8	  Hz,	  1H),	  7.14	  (t,	   J	  =	  7.8	  Hz,	  1H),	  5.85-­‐5.67	  (m,	  1H),	  5.01	  (d,	   J	  =	  11.3	  Hz,	  1H),	  4.84	  (d,	  J	  =	  11.3	  Hz,	  1H),	  4.06	  (s,	  1H),	  3.30	  (d,	  J	  =	  13.9	  Hz,	  1H),	  3.04	  (d,	  J	  =	  13.9	  Hz,	  1H),	  2.79	  (d,	  J	  =	  14.8	  Hz,	  1H),	  2.20	  (d,	  J	  =	  14.8	  Hz,	  1H),	  2.17-­‐2.09	  (complex	  m,	  1H),	   2.08-­‐1.98	   (complex	   m,	   1H),	   1.76-­‐1.60	   (complex	   m,	   4H)	   (signals	   due	   to	   NH	  group	  protons	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳͻʹǤͻǡ ͳͶͲǤʹǡ ͳ͵ͶǤͶǡ ͳ͵ͳǤͻǡ ͳʹͺǤ͵ǡ ͳʹ͹Ǥͺǡ ͳʹ͸Ǥ͸ǡ122.2,	  121.6,	  119.0,	  113.8,	  56.5,	  46.4,	  44.7,	  43.5,	  41.9,	  35.1,	  23.0.	  
IR	  ȋȌɓmax	  3271,	  2928,	  2852,	  1649,	  1331,	  745	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  281	  [(M	  +	  H)+,	  100%].	  





	  A	   magnetically	   stirred	   solution	   of	   compound	   190	   (22	   mg,	   0.08	   mmol)	   in	  acetonitrile/water	   (1	  mL	   of	   a	   4:1	   v/v	  mixture)	  maintained	   at	   18	   °C	  was	   treated	  with	   citric	   acid	   (45	  mg,	   0.24	  mmol),	  N-­‐methylmorpholine	  N-­‐oxide	   (18	  mg,	   0.16	  mmol)	  and	  potassium	  osmate	  dihydrate	  (3	  mg,	  0.01	  mmol).	  The	  resulting	  mixture,	  which	  developed	  a	  green	  coloration	  within	  a	  few	  minutes,	  was	  stirred	  vigorously	  at	   18	   °C	   for	   2	   h.	   The	   resulting	   light-­‐brown	   mixture	   was	   then	   subjected	   in	   its	  entirety	   to	   flash	   chromatography	   (silica,	   1:4	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	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fractions	  (Rf	  =	  0.5),	  the	  title	  compound	  197	  (10	  mg,	  40%)	  as	  a	  clear,	  yellow	  oil	  and	  
ca.	  2:1	  mixture	  of	  diol	  diastereomers.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁ(mixture	  of	  diastereomers)	  7.82	  (d,	  J	  =	  8.2	  Hz,	  1H),	  7.44	  (d,	  J	  =	  8.2	  Hz,	  1H),	  7.32	  (ddd,	  J	  =	  8.2,	  6.9,	  1.1	  Hz,	  1H),	  7.13	  (ddd,	  J	  =	  8.2,	  6.9,	  1.1	  Hz,	  1H),	  4.36	  (s,	  0.7H),	  4.07	  (s,	  0.3H),	  3.79-­‐3.70	  (complex	  m,	  1H),	  3.26	  (d,	  J	  =	  16.1	  Hz,	  1H),	  3.20	  (dd,	  J	  =	  12.5,	  6.5	  Hz,	  2H),	  3.03	  (d,	  J	  =	  12.5	  Hz,	  1H),	  2.85-­‐2.76	  (complex	  m,	  1H),	  2.60	  (d,	  J	  =	  16.1	  Hz,	  0.3H),	  2.18	  (	  J	  =	  14.9	  Hz,	  0.7H),	  1.92-­‐1.86	  (complex	  m,	  1H),	  1.81-­‐1.64	  (complex	  m,	  3H),	  1.54	  (dd,	  J	  =	  14.7,	  9.2	  Hz,	  1H),	  1.41-­‐1.28	  (complex	  m,	  1H)	  (signals	  due	  to	  NH	  and	  OH	  group	  protons	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ (mixture	   of	   diastereomers)	   193.2,	   140.1,	   132.2,	  128.5,	  127.6,	  126.7,	  122.2,	  121.5,	  113.7,	  69.3,	  68.3,	  57.4,	  49.8,	  46.3,	  43.2,	  41.0,	  35.5,	  23.1.	  
IR	  ȋȌɓmax	  3416,	  1651,	  1332,	  1203,	  751	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  337	  [(M	  +	  Na)+,	  47%],	  315	  [(M	  +	  H)+,	  100%].	  





	  A	   magnetically	   stirred	   solution	   of	   diol	   197	   (10	   mg,	   0.03	   mmol)	   in	   2,2-­‐dimethoxypropane	   (2	   mL)	   maintained	   at	   18	   °C	   was	   treated	   with	   dimethyl	  sulfoxide	   (0.5	  mL)	   and	   p-­‐TsOHyH2O	   (6	   mg,	   0.03	  mg).	   The	   ensuing	   mixture	   was	  stirred	  at	  18	  oC	  for	  2	  h	  then	  filtered	  through	  a	  pad	  of	  basic	  alumina	  and	  the	  filtrate	  concentrated	  under	  reduced	  pressure.	  The	  residue	  thus	  obtained	  was	  subjected	  to	  flash	   chromatography	   (silica,	   0.5:9.5	   v/v	   ammonia-­‐saturated	  methanol/dichloro-­‐methane	  elution)	  to	  afford,	  after	  concentration	  of	  the	  relevant	  fractions	  (Rf	  =	  0.5),	  the	  title	  acetonide	  200	  (6	  mg,	  53%)	  as	  a	  clear,	  colorless	  oil	  and	  ca.	  2:1	  mixture	  of	  diastereomers.	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1H	  NMR	  (400	  MHz,	  CD3ȌɁ(major	  diastereomer)	  7.82	  (dd,	   J	  =	  8.2,	  1.1	  Hz,	  1H),	  7.46	  (dd,	  J	  =	  8.2,	  1.1	  Hz,	  1H),	  7.35	  (ddd,	  J	  =	  8.2,	  6.9,	  1.1	  Hz,	  1H),	  7.16	  (ddd,	  J	  =	  8.2,	  6.9,	  1.1	  Hz,	  1H),	  4.27-­‐4.19	  (complex	  m,	  1H),	  4.11	  (s,	  1H),	  3.93	  (dd,	   J	  =	  8.0,	  6.0	  Hz,	  1H),	  3.21	  (dd,	  J	  =	  16.0,	  8.3	  Hz,	  2H),	  3.13-­‐3.05	  (complex	  m,	  1H),	  2.86	  (t,	  J	  =	  11.4	  Hz,	  1H),	  2.58	  (d,	  J	  =	  17.1	  Hz,	  1H),	  1.93-­‐1.84	  (complex	  m,	  1H),	  1.80	  (dm,	  J	  =	  14.4	  Hz,	  1H),	  1.78-­‐1.68	   (complex	  m,	   3H),	  1.41	   (dm,	   J	   =	  14.4	  Hz,	  1H),	  1.27	   (s,	  3H),	   1.23	   (s,	  3H)	  (signals	  due	  to	  NH	  group	  proton	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ (major	   diastereomer)	   192.7,	   140.1,	   127.8	  (overlapping	  signal),	  126.6,	  122.1,	  121.7,	  113.8,	  110.3,	  73.3,	  71.2,	  64.8,	  57.2,	  46.2,	  44.1,	  41.2,	  40.4,	  35.3,	  27.1,	  26.0	  (one	  signal	  obscured).	  
IR	  ȋȌɓmax	  3302,	  2983,	  2929,	  2855,	  1655,	  1473,	  1330,	  1250,	  1053,	  748	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  355	  [(M	  +	  H)+,	  100%].	  




	  A	   magnetically	   stirred	   solution	   of	   amine	   190	   (23	   mg,	   0.09	   mmol)	   in	   dry	  dichloromethane	   (3	  mL)	  maintained	   at	   18	   oC	   under	   a	   nitrogen	   atmosphere	  was	  treated	  with	   freshly	  prepared	   iodosobenzene49	   (95	  mg,	  0.43	  mmol).	  The	  ensuing	  mixture	  was	  stirred	  at	  18	  oC	  for	  1	  h	  then	  filtered	  through	  a	  pad	  of	  CeliteTM	  and	  the	  filtrate	   concentrated	   under	   reduced	   pressure.	   The	   residue	   thus	   obtained	   was	  subjected	   to	   flash	   chromatography	   (silica,	   1:4	   v/v	   ammonia-­‐saturated	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	  fractions	  (Rf	  =	  0.4	  in	  1.5:8.5	  v/v	  ammonia-­‐saturated	  methanol/dichloromethane),	  the	  title	  imine	  204	  (17	  mg,	  73%)	  as	  a	  clear,	  pale-­‐yellow	  oil.	  	  
1H	  NMR	  (400	  MHz,	  CD3ȌɁͺǤͲͷȋǡJ	  =	  7.5	  Hz,	  1H),	  7.51	  (d,	  J	  =	  7.5	  Hz,	  1H),	  7.36	  (m,	  2H),	  6.03-­‐5.80	  (complex	  m,	  1H),	  5.30	  (d,	   J	  =	  6.7	  Hz,	  1H),	  5.27	  (d,	   J	  =	  10.4	  Hz,	  1H),	  3.92	  (dd,	  J	  =	  14.5,	  7.7	  Hz,	  1H),	  3.81-­‐3.68	  (complex	  m,	  1H),	  3.27	  (dd,	  J	  =	  12.6,	  6.0	  Hz,	  1H),	  3.07	  (dd,	  J	  =	  18.6,	  6.0	  Hz,	  1H),	  2.63	  (dd,	  J	  =	  14.5,	  7.7	  Hz,	  1H),	  2.51	  (dd,	  J	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=	  14.5,	  7.7	  Hz,	  1H),	  2.26	  (dd,	  J	  =	  14.5,	  7.7	  Hz,	  1H),	  2.16-­‐1.96	  (complex	  m,	  4H),	  1.66	  (dd,	  J	  =	  14.2,	  3.3	  Hz,	  1H)	  (signal	  due	  to	  NH	  group	  proton	  not	  observed).	  
13C	   NMR	   (100	   MHz,	   CD3Ȍ Ɂ ͳ͹ͺǤͲǡ ͳͷͷǤͶǡ ͳ͵ͻǤʹǡ ͳ͵ʹǤͻǡ ͳʹͷǤͺǡ ͳʹͶǤ͸ǡ ͳʹͶǤͳǡ120.8,	  120.5,	  113.8,	  105.7,	  45.2,	  39.9,	  38.7,	  34.1,	  28.7,	  21.0,	  17.3.	  
IR	  ȋȌɓmax	  2923,	  2848,	  1617,	  1472,	  1331,	  749	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  265	  [(M	  +	  H)+,	  100%].	  





	  A	  magnetically	  stirred	   solution	  of	   imine	  204	   (10	  mg,	  0.04	  mmol)	   in	  methanol	   (3	  mL)	  maintained	   at	   18	   oC	  was	   treated	  with	   finely	   ground	   sodium	  borohydride	   (3	  mg,	   0.08	   mmol).	   After	   the	   sodium	   borohydride	   has	   completely	   dissolved,	   the	  resulting	   solution	   was	   concentrated	   under	   reduced	   pressure.	   The	   residue	   thus	  obtained	   was	   subjected	   to	   flash	   chromatography	   (silica,	   1:9	   v/v	  methanol/dichloromethane	  elution)	   to	  afford,	  after	  concentration	  of	   the	  relevant	  fractions	  (Rf	  =	  0.5),	  the	  amine	  14344	  (9	  mg,	  90%)	  as	  a	  white,	  amorphous	  solid.	  	  
1H	  NMR	  (400	  MHz,	  CDCl3ȌɁ͹ǤͺͺȋǡJ	  =	  7.8	  Hz,	  1H),	  7.80	  (s,	  1H),	  7.26	  (d,	  J	  =	  7.4	  Hz,	  1H),	  7.07	  (d,	   J	  =	  7.3	  Hz,	  1H),	  7.02	  (d,	   J	  =	  7.3	  Hz,	  1H),	  5.94-­‐5.75	  (complex	  m,	  1H),	  5.09	  (br	  s,	  1H),	  5.05	  (br	  s,	   J	  =	  3.6	  Hz,	  1H),	  3.96	  (s,	  1H),	  3.31	  (dd,	   J	  =	  12.9,	  4.9	  Hz,	  1H),	  2.92	  (td,	  J	  =	  13.1,	  3.8	  Hz,	  1H),	  2.81	  (dddd,	  J	  =	  17.9,	  11.9,	  6.3,	  2.5	  Hz,	  1H),	  2.64	  (dd,	  J	  =	  16.6,	  6.8	  Hz,	  1H),	  2.42	  (dd,	  J	  =	  14.6,	  7.4	  Hz,	  1H),	  1.97	  (dd,	   J	  =	  14.6,	  7.6	  Hz,	  1H),	  1.90-­‐1.74	  (complex	  m,	  4H),	  1.58-­‐1.41	  (complex	  m,	  2H),	  1.34-­‐1.20	  (complex	  m,	  1H).	  
13C	  NMR	  (100	  MHz,	  CDCl3ȌɁͳ͵͸ǤͲǡͳ͵ͷǤ͵ǡͳ͵͵Ǥ͵ǡͳʹ͹ǤͳǡͳʹͲǤ͹ǡͳʹͲǤ͵ǡͳͳͻǤͳǡͳͳ͹ǤͲǡ110.9,	  110.3,	  63.8,	  47.2,	  36.0,	  33.7,	  32.2,	  29.6,	  22.2,	  20.1.	  
IR	  ȋȌɓmax	  3271,	  2923,	  2853,	  1637,	  1455,	  1327,	  739	  cm-­‐1.	  
MS	  (ESI,	  +ve)	  m/z	  267	  [(M	  +	  H)+,	  100%].	  
HRESIMS	  (M	  +	  H)+	  calcd	  for	  C18H23N2	  267.1861,	  found	  267.1869.	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